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Abstract 
Nucleic acids are not only expected to assume a pivotal position as ‘drugs’ in the treatment of 
genetic and acquired diseases, but could also act as molecular cues to control the 
microenvironment during tissue regeneration. Despite this promise the efficient delivery of 
nucleic acids to their side of action is still the major hurdle. One among many prerequisites for a 
successful carrier system for nucleic acids is a high stability in the extracellular environment, 
accompanied by an efficient release of the cargo in the intracellular compartment. A promising 
strategy to create such an interactive delivery system that adapts its properties to the conditions 
of the microenvironment, is to exploit the redox gradient between the extra- and intracellular 
compartment. In this review, emphasis is placed on the biological rationale for the synthesis of 
redox sensitive, disulfide-based carrier systems for nucleic acids as well as the extra- and 
intracellular processing of macromolecules containing disulfide bonds. Moreover, the basic 
synthesis approaches for introducing disulfide bonds into carrier molecules together with 
examples which demonstrate the benefit of disulfides at the individual stages of nucleic acid 
delivery will be presented.  
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1. Introduction 
The delivery of nucleic acids is a promising strategy for the modulation of gene expression inside 
cells. On the one hand, it offers the opportunity to insert therapeutic genes via DNA, on the other 
hand the expression of non-functional or harmful proteins can be inhibited by the application of 
therapeutic RNA. Both approaches can be used for the therapy of inherited or acquired diseases 
as well as for the regeneration of defective tissue. For tissue regeneration the delivery of nucleic 
acids could be very beneficial, because a controlled environment which promotes cell 
proliferation and regeneration is needed.[1-3] Here, the right cues, e.g. for the synthesis of growth 
factors, must be present at the right time point and for the appropriate time period. While many 
signalling proteins have a very short half-life, genes are expressed over a longer period and, 
thus, provide longer effects. 
Despite this promise, the effective delivery of nucleic acids remains a major problem and the 
carrier has to overcome many natural barriers in order to transport its cargo to the side of 
action.[4] The carrier, which should be non-toxic, non-immunogenic, and preferably 
biodegradable, must compact the nucleic acid into small particles to prevent degradation. 
Beyond this, the carrier must prevent non-specific interactions with the biological environment 
and allow cellular uptake in a target specific-manner. After successful cellular uptake, the next 
hurdle that a delivery system must clear is endosomolysis. During this stage, the system should 
release the nucleic acid into the cytosol of the cell.[5-10] Subsequently, to induce gene expression, 
the DNA must enter the nucleus.[11-13] In contrast, therapeutic RNAs need only to be present 
within the cytoplasm for activity. Lipids and polymers (lipids form lipoplexes and polymers 
polyplexes, respectively, with nucleic acids) are of special interest as delivery vehicles, as they 
can easily be modified with functional domains to fulfil these demands. Several polymer-based 
materials such as poly(L-lysine) (pLL) [14-18] or poly(ethylene imine) (PEI) [19-23], natural 
polymers  [24-35] and lipids [24, 36-38] have been shown to overcome some of the inherent challenges 
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discussed herein. However, each is associated with its own concerns, and a comprehensive 
building plan for an ideal delivery system remains elusive. To this end, the most important issue 
to address involves determining how to assemble a carrier system such that presentation of the 
appropriate functional domain for each specific task occurs at the correct spatiotemporal point, 
both inside and outside the cell. Presenting the appropriate signals at the appropriate time point 
is a major challenge, e.g. for regenerative medicine the concomitant action of multiple factors is 
indispensable for tissue regeneration. Carrier systems with multifunctional domains which are 
triggerable based on conditions prevailing in the physiological environment, such as pH, redox 
gradients, the osmotic pressure or the presence of enzymes could be highly convenient for this 
purpose. 
In this context, disulfide bonds play an exceedingly important role because they can exploit the 
redox potential gradient between the extra- and intracellular space. Consequently, outside of 
cells they provide for a temporarily high stability of the delivery system, but are rapidly cleaved 
inside cells facilitating the release of therapeutic nucleic acids. Especially for tissue engineering 
(TE) a long-term stability of the delivery system in the extracellular compartment followed by an 
efficient release of cargo in the target cell is an important concern, since the tissue regeneration 
may last for weeks or even months. Although, the delivery of nucleic acids in the field of TE is 
quite auspicious, this approach still remains in its experimental phases [39-54], and only a very 
limited number of studies have been conducted that apply carriers that rely on the described 
redox potential gradient.[55, 56]  
This review will focus on the redox-potential trigger between the extra- and intracellular 
environment. Furthermore, the basic synthesis approaches for introducing disulfide bonds into 
molecules will be described. Additionally, the review will provide examples that demonstrate the 
significance of disulfide bonds for the different aspects of delivery. 
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2. Redoxsensitive carriers 
Countless redoxsensitive carrier systems for non-viral nucleic acid delivery have been previously 
described in literature. Although oxidation-sensitive block copolymers based on poly(propylene 
sufide) (PPS) have been tried for the use of nucleic acid delivery, the field is dominated by 
disulfides (symbolized as –SS- in this review).[57, 58] The fact that disulfide containing carriers can 
take advantage of the large intra-/extracellular redoxgradient makes them very attractive for the 
design of gene delivery systems. Once inside the cell their cargo is very quickly released. In 
contrast, the cleavage of widely used acid-labile linkages like esters or hydrazones is a rate 
dependent phenomenon, i.e. the hydrolysis is proportional to the pH. For these linkages, a 
decrease of one pH unit a 10-fold difference in the hydrolysis rate can be expected.[59] Therefore, 
premature (extracellular) release of cargo in an acidic environment found in the vicinity of tumors 
or inflamed tissue is possible. This is a significant concern in cancer therapy as well as in tissue 
engineering applications as they are often associated with inflammation.[60] Hence, acid-labile 
linkages must compromise between a fast hydrolysis rate in the intracellular compartment and a 
slower hydrolysis in the extracellular space.[59, 61] 
3. Biological rationale 
3.1. Cellular uptake 
This section gives a short overview of the cellular uptake of non-viral gene carriers. The first 
barrier a gene delivery vehicle has to overcome on its way into the cell is the plasma membrane. 
Cationic polymers and lipids primarily enter cells via endocytosis and are, therefore, directed to 
the endolysosomal compartment (Figure 1).[62, 63] In general, many different endocytotic 
pathways are known: 1) unspecific (adsorptive, Figure 1, (2)) und specific (receptor mediated, 
Figure 1, (3)) clathrin dependent, 2) lipid-raft mediated (caveoline dependent and independent, 
Figure 1, (1)) endocytosis, 3) phagocytosis and 4) macropinocytosis. For carriers without 
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receptor ligands the main entrance to the cell is suggested to be the non-specific, adsorptive, 
clathrin dependent endocytosis. In this case an electrostatic interaction between the positively 
charged cationic carrier and the negatively charged syndecans on the cell membrane is 
assumed.[64] In case of ligand containing carriers, besides this unspecific uptake the receptor-
mediated endocytosis plays a role. The receptors can then be recycled back to the plasma 
membrane in early endosomes, while their ligands (including the carrier) are trafficked to later 
stages of the pathway.[65] A distinct separation, however, cannot be made as the extent of 
participation of the different pathways seems to be dependent on cell type, carrier composition 
and carrier size.[66, 67] For instance, PEI/DNA polyplexes are believed to be taken up by caveolae 
and clathrin-coated pits, while lipoplexes made from N-(1-(2,3-dioleoyloxy)propyl)-N,N,N-
trimethylammonium chloride (DOTAP)/DNA proceed solely by clathrin dependent endocytosis.[62] 
In a recent study the transport of PEI/DNA polyplexes could be followed by live-cell imaging, 
beginning from binding to the cell surface until the active transport inside of endosomes along 
microtubules.[64] It would certainly be of great benefit to perform similar experiments with 
disulfide containing gene carriers in order to gain more insight into their degradation and 
trafficking. 
Once inside the endolysosomal system, nucleic acids must escape into the cytoplasm in order to 
reach their target and to circumvent lysosomal degradation by nucleases. The precise escape 
mechanism is dependent on the type of carrier, but for carriers with buffering capacity like PEI, 
the most common explanation, among others, is the proton sponge mechanism. Polymers like 
poly-L-lysine (pLL) lack this ability to avoid lysosomal trafficking.[62, 68] For cationic lipid based 
vectors, an interaction between the liposomes and anionic lipids in the endosomal membrane 
has been proposed.[62] 
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Figure 1. Into the cell – simplified scheme of the cellular trafficking of non-viral gene delivery 
systems: The two most common non-viral gene delivery systems, polyplexes and lipoplexes ( ), 
are taken up mainly by endocytosis. Several different mechanisms are known: Calveoli 
formation (1), adsorptive (2) or receptor mediated (3) endocytosis. The last two mechanisms can 
also be clathrin independent. After rapid uncoating the newly formed vesicle fuses with early 
endosomes (sorting endosomes and recycling endosomes (4)). The processing of ligand-
receptor complexes also takes place here: Sorting endosomes are slightly acidic which leads to 
a dissociation of ligands from their receptors. These receptors can then be recycled back to the 
plasma membrane whereas their ligands are trafficked differently. After further acidification the 
endosome carrier vehicle (ECV) transfers material from early endosomes to late endosomes (5). 
These are the main site for proteolysis and stay in dynamic equilibrium with lysosomes (6). In 
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order to avoid lysosomal degradation and to reach their targets (8) in the cytosol (most RNA 
therapeutics) or nucleus (pDNA) the nucleic acids must escape endosomal entrapment (7). The 
stage at which the nucleic acid dissociates from its carrier depends on the carrier system. 
The versatility of disulfide carriers has been shown in many different approaches, but the 
underlying biological rationale is poorly understood thus far. Where and how internalized 
disulfides are processed is still a disputable matter. Some evidence discussed here suggests 
that disulfide cleavage occurs along the endolysosomal pathway.[69-71] However, there are other 
indications that this is not the case.[72, 73] It seems that the process of disulfide reduction, like the 
uptake of the carrier, depends on numerous variables. It must also be remembered that the 
cellular redox environment is not static, as it varies throughout the different stages of the cell 
cycle.[74] Furthermore, many studies which our knowledge of cellular disulfide reduction is based 
on were not performed with cationic polymers, and as such, the relevance of these studies for 
non-viral gene carriers is unknown.[72, 75] 
3.2. Cellular redox environment 
The existence of a redox gradient between intra- and extracellular space was shown some time 
ago. While the extracellular space is oxidizing, most cellular compartments are reducing.[76] 
Nature has exploited this fact for the “delivery” of toxins (like diphtheria or cholera toxin) and 
viruses that have served as templates for artificial therapeutic disulfide conjugates like 
Gemtuzumab ozogamicin (Mylotarg®).[70] In recent years, more non-viral vectors employing 
disulfides to promote nucleic acid delivery have emerged. 
In order to pinpoint the location of disulfide cleavage, detailed knowledge about the cellular 
redox environment is essential. The term “redox environment” was defined by Schafer et al.: 
“The redox environment of a linked set of redox couples […] is the summation of the products of 
the reduction potential and reducing capacity of the linked redox couples present.”.[74] 
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Cellular disulfide reduction and isomerization is mediated by small redox molecules, either alone 
or in conjunction with redox proteins. These redox active proteins typically need the presence of 
cofactors or enzymes to regenerate their activity.[70, 76] In the eukaryotic cytosol, two main redox 
systems are responsible for maintaining protein thiols in their reduced state: the thioredoxin (Trx) 
and the glutaredoxin (Grx) system.[70, 77] Trx is regenerated by the enzyme thioredoxin reductase 
and Grx is non-enzymatically reduced by another important redox factor: glutathione (GSH). In 
principle, both Trx and Grx can catalyze redox reactions in both directions. However, due to the 
high cytosolic abundance of GSH and thioredoxin reductase, they are primarily reducing.[70] 
 
3.2.1. Compartmentation of GSH 
The high level of GSH, which can reach millimolar concentrations (cintracell.(GSH)=1-11 mM, 
cextracell.(GSH)=10 µM 
[74, 76]) is maintained by glutathione reductase (GR). This enzyme 
regenerates GSH from glutathione disulfide (GSSG).[74, 77] GSH by far outnumbers any other 
cellular redox system (c(Trx)~1/100-1/1000 c(GSH)) so the GSH/GSSG system therefore is, 
regarded as the major cellular redox buffer. It serves as a representative redox couple to 
measure the redox environment.[74] In literature, the cellular redox state is mostly described by 
the GSH:GSSG ratio (cytosol: GSH:GSSG=30:1 to 100:1 [74]), but according to Nernst’s equation 
the reduction potential depends on [GSH]²/[GSSG]. Thus, absolute GSH concentration must be 
known.[74] 
A large GSH-pool with similar or even higher GSH-levels than in the cytosol is found in the 
nucleus.[76] In terms of gene delivery, it is important to know that nuclear GSH is required for 
DNA synthesis and repair, and it keeps a number of transcription factors in reduced state. For 
polyplexes, it was concluded that reduction primarily takes place in the cytosol or the nucleus.[76] 
This finding, however, does not necessarily apply to all types of gene carriers. In a recent report 
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the roles of nuclear and cytosolic GSH on the relative transfection activities of reducible pLL 
(rpLL: -(Cys-Lys10-Cys)n-) and non-reducible pLL polyplexes (including DOTAP to enhance 
endosomal escape) were investigated. The polyplexes were formed with two nuclearly (pDNA, 
asODN) and two cytosolically (mRNA, siRNA) active nucleic acids. The authors used Bcl-2 
protein (B-cell lymphoma 2) overexpressing cells that have an increased intracellular GSH level 
(compared to non-Bcl-2 overexpressing cells: 1.5- to 2-fold) and a partial GSH redistribution to 
the nucleus (60-67 % of total cellular glutathione). Polyplexes composed of mRNA showed a 
much higher increase in relative transfection activity (control: 5 and Bcl-2: 79) when compared 
with polyplexes of pDNA (control: 3 and Bcl-2: 5.7). Hence, an increased GSH-level was more 
benefical for mRNA- than for pDNA-delivery. The authors concluded that the difference in 
behavior must be due to differences in subcellular trafficking and disassembly of the carriers. 
While it appeared that, there is an efficient nuclear unpacking mechanism for pDNA-polyplexes 
there was no evidence for a similar mechanism that processes cytoplasmic mRNA-polyplexes. 
An increased GSH-level consequently has a higher influence on mRNA-polyplexes. The 
influence of the GSH concentration on the enhancement of relative activity of asODN and siRNA 
complexes was less pronounced. The disulfide reduction is likely to have a smaller effect on low 
molecular weight nucleic acids due to a smaller influence of the polycation size on the unpacking 
rates.[78] 
The endoplasmic reticulum (ER), which is topologically connected to the extracellular space, is 
about one hundred times more oxidizing than the cytosol or nucleus (GSH:GSSG ranging from 
1:1 to 3:1 [74]).[70] The ER is responsible for the synthesis and processing of secretory and 
membrane proteins to which protein disulfide bonds are mainly restricted to. An environment 
favoring the formation of disulfides is, therefore, pivotal for correct protein folding and 
processing.[70, 79] One enzyme of the thioredoxin family, disulfide isomerase (PDI), plays an 
important role in these activities. Its relevance for processing internalized disulfides will be 
discussed in the next section. 
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3.2.2. Cellular disulfide processing 
3.2.2.1. Surface reduction 
Despite the oxidizing extracellular space, thiol containing redox enzymes are found on the 
plasma membrane, suggesting a cellular microenvironment that supports redox reactions, e.g. 
reductions.[70, 76] One of those redox enzymes is the highly abundant PDI. 
It is found throughout the endocytotic pathway. On the cell surface PDI is only a reductant while 
in the ER it acts both as oxidant and disulfide isomerase. Cell surface associated PDI was 
shown to cleave disulfides in the gp120 HIV-protein, thus triggering the membrane fusion 
process eventually resulting in HIV entry.[80] PDI is also supposed to play a role in processing 
macromolecular drugs. In order to investigate the involvement of PDI in disulfide reduction, 
inhibitors including monoclonal anti-PDI antibodies and membrane impermeant reagents like 
DTNB (5,5’-dithio-bis(2-nitrobenzoic acid)) or the antibiotic bacitracin were developed.[80] 
Feener et al. linked [125I]iodotyramine through a disulfide spacer to poly(D-lysine), which resists 
degradation by lysosomal proteases.[73] They demonstrated that the linker’s reductive cleavage 
consists of two phases. The first phase began immediately after internalization and was 
sensitive against DTNB and, as shown later, against an anti-PDI antibody. Even so, after a lag-
time of thirty minutes, the reduction process continued. This not only implies a reduction along 
the endolysosomal pathway, but also suggests participation of PDI in the first phase. Similar 
results with diphtheria toxin show that disulfide bond reduction of macromolecules might begin at 
the cell surface and progress into early endosomes due to co-internalized surface enzymes.[70] 
The significance of this surface related reduction remains unclear, but several facts indicate that 
this mode of cleavage, especially as mediated by PDI, is irrelevant. First, efficient PDI function 
requires an efficient regenerating system outside of cells.[70, 80] While such an intracellular system 
has already been found, its extracellular counterpart has not yet been identified. Second, after 
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internalization, endosomes are quickly acidified, and proteins of the thioredoxin family have an 
activity optimum at neutral pH. Therefore, high PDI activity would be restricted to only the initial 
endocytotic compartments.[70] The relevance of this reduction mode has further been brought 
into question by several more recent studies that used different disulfide containing constructs. 
Shen et al. linked methotrexate (MTX), an antimetabolitic drug, to the polycationic carrier poly(D-
lysine).[69] This conjugate inhibits cell growth of wild type and of MTX transport-defective CHO 
mutants. If surface cleavage was a major factor, the MTX transport-defective cells would be less 
affected by MTX-SS-poly(D-lysine), as the extracellularly released free MTX alone would not be 
taken up. However this was not the case. Similar conclusions were drawn by Saito et al.[81] They 
developed an enhanced disulfide containing cytosolic gene delivery system by using the pore 
forming, cytotoxic agent lysteriolysin O (LLO) coupled with protamine (PN). In its uncleaved 
form, the LLO-SS-PN construct was not cytotoxic. The ratio of free LLO to LLO-SS-PN strongly 
suggested that linker reduction was more dominant after internalization. Moreover, LLO-SS-PN 
was only cytotoxic at high concentrations, presumably indicating infrequent reduction events on 
the cell surface. Austin et al. used rhodamine red (RR) linked to the anti-HER2 antibody 
trastuzumab (trastuzumab-SPP-RR).[72] Rhodamine red showed self-quenching at higher 
labeling ratios, allowing it to be used in a dequenching assay as an indicator for the SPP linker 
cleavage (Figure 2). Their observations also revealed that surface cleavage must be very 
ineffective. The same results using another cell-line were obtained in the work of Yang et al., 
where a disulfide reduction sensitive FRET probe was coupled to folate.[75] In a another current 
work, a bioresponsive non-viral gene carrier composed of poly(aspartamide) (P[Asp(DET)]) 
shielded with polyethylene glycol (PEG) was investigated.[71] The outer PEG layer reduced the 
electrostatic interaction between cell membrane and polyplex thus preventing unspecific 
endocytosis. The authors hypothesized that if surface reduction took place, a larger amount of 
PEG-SS-P[Asp(DET)] would be taken up in comparison to non-reducible PEG-P[Asp(DET)], as 
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the removal of the PEG shielding would restore the membrane-polyplex interaction, but this was 
not the case. 
3.2.2.2. Endolysosomal compartment 
These studies above all leave the question unanswered where, if not at the cell surface or in the 
earliest endocytotic compartment, disulfides are cleaved. The redox properties of endosomes 
and lysosomes are not as well characterized as those of the cytosol or the ER. A case can be 
made both for and against the possibility of reduction in the endolysosomal pathway. Feener et 
al. assessed the second phase of intracellular reduction by using percoll gradient subcellular 
fractionation and excluded the participation of endosomes, lysosomes or the endoplasmic 
reticulum, leaving only the Golgi apparatus as a possible location for reduction.[73] Unfortunately, 
the techniques used were not suitable to provide a high resolution picture of disulfide 
processing. It is possible that organelles might have been ruptured during work up cross 
contaminating compartments of different redox properties.[75] The group around Yang et al. was 
unable to verify the involvement of the Golgi apparatus in the reduction process.[75] 
Several studies on specialized cells of the immune system, the professional antigen presenting 
cells (APCs) like macrophages or activated B-cells, could shed a new light on these subjects as 
they imply a reducing capacity in endolysosomal organelles. APCs present fragments of 
endocytosed proteins (antigens) on their surface.[82] Prior to this presentation these proteins are 
digested by cathepsines and proteases in endosomes and lysosomes.[82, 83] Disulfide reduction 
was shown to be a prerequisite for efficient antigen processing.[84] It is believed that this 
enhancement of substrate proteolysis might be a general effect which is not limited to antigen 
processing.[65] In this context, Collins et al. proposed the following model: after endocytosis, 
antigens pass through early and late endosomes (LEs) where they are only partially 
proteolytically degraded as proteolysis is restricted to those regions that are easily accessible to 
endosomal enzymes. Disulfides usually remain intact, thus limiting further antigen unfolding.[82] 
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Figure 2. Rhodamine Red (RR) fluorescence dequenching of a dual-labeled 488trastuzumab-
SPP-RR4.5 conjugate upon geldanamycin-induced routing to the lysosomal pathway: Alexa-488 
(green) was conjugated to trastuzumab-SPP-RR4.5 to serve as a reference. SKBr3 cells with 
surface-bound conjugate were incubated with (D–F) or without (A–C) geldanamycin. Red 
fluorescence dequenching upon lysosomal routing can be recognized as a red shift in the 
merged dual color image (compare C with F). The dequenching is not a result of disulfide 
cleavage but lysosomal degradation of the antibody. (Scale bars: 20 μm) [72] 
After transfer to lysosomes, the disulfide bonds are reduced due to a high cysteine (Cys) 
concentration there. Previously inaccessible regions are now exposed to lysosomal enzymes 
The validity of this model was underpinned in a later study where the cysteine transport 
pathways of macrophage hybridoma and B cell lymphoma were investigated.[84] It was 
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suggested that organelles with Cys-transport activity, in this case endosomes and/or lysosomes 
depending on the cell type, could be the locations where antigens are processed.Such Cys and 
Cys2-specific transporters that produce a net influx of Cys and efflux of Cys2 in endolysosomes 
are required to achieve a high Cys/Cys2-ratio. Although the exact parameters are unknown a 
ratio of 500-600:1 would be necessary according to the Nernst equation to have an environment 
as reducing as the cytosol (-221 mV to -236 mV). The reason for this is the unfavored thiol 
deprotonation (-SH  -S- + H+) at the acidic conditions in the endolysosomal system. Such 
nucleophilic thiolate anions (S-) are required for disulfide exchange reactions in biological 
systems.[65, 75] 
Endolysosomal reduction mediated only by Cys would have a low specificity and efficiency, and 
it therefore requires for enzymatic support. One of such an enzyme, the Gamma-interferon-
inducible lysosomal thiol reductase (GILT), was observed in antigen presenting and other 
cells.[85] GILT is a 30 kDa thiol reductase that is constitutively expressed in APCs. It is distantly 
related to the members of the thioredoxin family. Precursor-GILT (35 kDa), which is also 
catalytically active can be found in the EE, ER and Golgi apparatus. It is proteolytically 
processed to mature GILT along the endocytotic pathway.[85] Mature GILT exclusively 
colocalizes in MHC class II containing compartments, so it was suggested that precursor-GILT 
reduces internalized antigens in early endosomes, while mature GILT is responsible for disulfide 
cleavage in subsequent endolysosomal compartments.[70] A number of characteristics 
distinguish GILT from members of the thioredoxin family. To begin with, thioredoxins typically 
have exhibit optimal activity in a pH range from 6 to 7. Contrastingly, GILT is much more efficient 
at pH ranging from 4 to 5, as is found in late endocytotic compartments.[85] Another difference is 
the choice of co-reductands as, unlike PDI, GILT is activated only by cysteine, not by 
glutathione.[83] It is not yet clear if similar redox proteins are present in endosomes or lysosomes 
of other cells, but some evidences suggest that this might indeed be the case.[70] For the 
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construction of bioresponsive carriers it would also be interesting to know if these oxireductases 
recognize all synthetic disulfide linkers.[72] 
Additionally, some recent workings indicate the participation of other enzymes which are usually 
not associated with thiol reduction of internalized disulfides. Our current models might be overly 
simplistic: Yang et al. not only excluded PDI as a major reducing factor in KB cells but also 
showed that the cellular reduction machinery is active all along the endocytotic folate receptor 
pathway.[75] This machinery was neither associated with any particular trafficking organelle, nor 
relied on fusion with lysosomes or an interaction with the Golgi network (Figure 3). So far, no 
GILT expression has been observed in this cell line; nonetheless, the results signaled the 
presence of an endosomal redox function. They speculated that this function might be 
associated with the transferrin receptor (TfR) pathway, as the folate receptor (FR) is rapidly 
colocalized with TfR after uptake. The disulfide cleavage could be mediated by an endosomal 
ferrireductase that normally converts Fe3+ to Fe2+ in the TfR cycle. This and a later study of this 
group also have interesting implications for the trafficking of receptor ligand-based targeted gene 
delivery vehicles.[86] Multivalent folate conjugates, as they would be used in cationic polymeric 
carriers, rapidly traffic to LEs or lysosomes, whereas trafficking of monovalent conjugates does 
not involve acidic compartments. Hence, in case of gene delivery with targeting receptor ligands, 
it would be advantageous to use acid labile linkers instead of disulfide linkers. The experiments 
done with the selfquenching trastuzumab-SPP-rhodamine red construct (Austin et al. [72]) further 
emphasize our still limited knowledge on cellular disulfide cleavage. In spite of extensive 
trafficking through the endocytotic recycling pathway, their construct unexpectedly resulted in 
little dequenching, i.e. linker reduction. They also diverted their probe to lysosomes using 
geldanamycin, where dequenching was observed. They showed that this was not attributed to 
disulfide reduction but to proteolytic degradation of the antibody. Lysosomal reduction appeared 
to be rather ineffective. These findings were confirmed with fusion proteins of redox sensitive 
roGFP1 (reduction-oxidation-sensitive green fluorescent protein) with different endocytotic  
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Figure 3. Lysosomes or Golgi/trans-Golgi network (TGN) system are involved in disulfide bond 
reduction of a folate-FRET reporter: The FRET probe consisted of rhodamine linked via a 
disulfide bond to BODIPY-folate. The intact conjugate shows red fluorescence. (A) Lysosomes 
are no significant site of disulfide reduction. Neither the folate-FRET reporter nor its reduced 
fragments localize in lysosomes. (B) The collapse of the Golgi network induced by brefeldin A 
(BFA) does not interrupt disulfide reduction of the folate-FRET conjugate. (C) The Folate-FRET 
conjugate is not trafficked to the Golgi/TGN system. (Ceramide is a Golgi/TGN-marker). [75] 
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markers. Surprisingly, endosomes and lysosomes were found to be oxidizing. Minor subsets of 
reducing lysosomes, however, could not be detected with this method because the average 
fluorescence of the whole endocytotic compartment was measured. Besides, the lysosomal 
proteins used were membrane bound such that subregions (middle of the lumen) of reducing 
potential within any one endolysosome could not be excluded.[72] The comparability to other 
studies is also unclear. For example, Trastuzumab-SS-RR might have been directed to another 
pathway with other redox characteristics than the folate-probe from Yang et al., or redox active 
enzymes could not recognize this linker.[86] 
If we assume that the endolysosomal compartment is indeed oxidizing then why do so many 
studies indicate a reducing environment? The proteolysis of antigens in APCs might already be 
so efficient that there is no need for an additional disulfide reduction step. Also, GILT-like 
enzymes could act reducing despite oxidizing conditions.[72] In case of disulfide bearing drugs, 
the experimental setup might explain their in vitro and in vivo potency. The disulfide cleavage 
might indeed be very slow and ineffective but given that in vitro cytotoxicity studies typically 
require several days (and even longer in in vivo studies) before proliferation effects can be 
observed still a sufficient amount of drug should be released.[72] 
The multitude of (sometimes contradicting) results and the uncertainty in whether or not those 
results can be transferred directly to cationic gene delivery devices leave many unanswered 
questions. Among many other factors, cellular disulfide reduction seems to depend on the 
expression level and location of redox enzymes (PDI, GILT, etc.). Vesicular trafficking properties 
vary with carrier type, composition and the type of delivered nucleic acid.[66, 67, 87] It is also likely 
that the linker has an influence, but this factor has not examined in detail yet. 
It must also be kept in mind that the cell lines used in most in vitro studies are not directly 
comparable to primary cells, as they tend to have adapted to the in vitro culture environment.[1] 
In a study related to this three different cell lines and primary cultures of fibroblast and BMM 
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(bone marrow-derived macrophages) were transfected with LLO-SS-PN/luciferase.[81] 
Expression levels were tested in the presence of the membrane-impermeant thiol blocker DTNB. 
DTNB treatment resulted in higher luciferase levels in BMM exclusively indicating that the 
situation in primary cells may be much different..[1] 
4. Synthesis of disulfides 
Although contradictory results are obtained in some studies, there is no doubt that disulfides are 
an advantageous functional group. However, disulfides are not as commonly used as, for 
example, amine groups and, but many different ways for the conversion of other groups as well 
as the use of linkers are known.  
4.1. Use of inherently present thiol groups 
The easiest way to form disulfide bonds is by oxidizing thiol groups that are inherently present in 
the chosen molecule. Oxidation of the thiol to disulfide can be accomplished with oxygen or with 
a mild oxidizing reagent like dimethyl sulfoxide (DMSO).[88] A great advantage of DMSO is that 
the disulfide formation is very controllable, resulting in products with well-defined molecular 
weights.[89] This was shown for linear PEI that was synthesized by connecting low molecular 
weight PEI molecules with terminal thiol groups.[90] 
4.2. Conversion of other functional groups 
If no thiol group is present in the molecule of interest, other functional groups can be used for its 
formation. One possibility is to convert a hydroxyl group through the addition of a thioacetate 
which is subsequently cleaved to the thiol group (Table 1).[90-93] 
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4.2.1. Conversion of amino groups 
The most common way of introducing thiol groups starting from amino groups is by using 2-
iminothiolane, commonly known as Traut´s reagent (Table 1). This compound reacts easily with 
primary amines at pH 7-10 [94-96] in both molecules with low molecular weight and 
macromolecules such as chitosan.[97] This is advantageous in that the positive charge inherent in 
primary amine groups at physiologic pH is maintained after the reaction.[98] Moreover, a number 
of derivatives of Traut´s reagent have been synthesized allowing the creation of a more stable 
disulfide bond.[99, 100] An alternative way to accomplish the same thing involves the ring-opening 
addition of N-acetylhomocysteine thiolactone [101, 102] or methyl thiirane [103] to primary amino 
groups. The introduction of a protected thiol group is possible if S-acetylmercaptosuccinic 
anhydride (SAMSA) is applied (Table 1). The anhydride ring can be opened, thereby creating a 
free carboxylate group that exhibits a negative charge, in contrast to the positively charged 
amino group present in the molecule initially.[104] Insertion of protected thiol groups is especially 
convenient because this allows for long-term storage and the formation of a mixed molecule 
consisting of two different thiol-containing substances. Protected thiols can also be inserted if N-
succinimidyl S-acetylthioacetate (SATA) or succinimdyl acetylthiopropionat (SATP) are used. 
These two differ only in chain length, and both of them form stable amide bonds. The protection 
of the thiol group ensures the formation of a single product as seen for SAMSA.[94, 95, 105] 
Table 1. Conversion of different functional groups into thiol groups 
Conversion of hydroxyl groups  
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Conversion of amino groups  using Traut´s reagent 
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4.2.2. Conversion of carbonyl groups 
2-acetamido-4-mercaptobutyric acid hydrazide (AMBH) contains a thiol group and is reactive 
with aldehydes and ketones. These carbonyl compounds can be easily created from 
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carbohydrates by oxidation with sodium periodate under mild conditions. When ketones and 
aldehydes react with the hydrazide group of AMBH, they form hydrazone linkages (Table 1).[95] 
Cystamine can also be used for this purpose. In this case, the amine group of cystamine reacts 
with the carbonyl group, creating a thiol group at the end of the conjugate after reductive 
cleavage of the disulfide bond.[106] 
4.2.3. Conversion of carboxyl groups  
Cystamine can not only be conjugated with carbonyl groups, but it is also beneficial for 
conjugation with activated carboxyl groups, leading to the formation of a stable amide bond. 
Further conjugation steps can be carried out with the second amino group of cystamine (Table 
1).[106-110] 
4.3. Use of linkers 
In many cases, the use of linkers may be preferable to the conversion of functional groups, as 
linkers usually require fewer reaction steps and therefore provide higher yields. There are two 
main classes of linkers, homo- and heterobifunctional ones. Homobifunctional linkers possess 
the same terminal functional groups, so they are ideally suited for the connection of similar 
molecules forming dimers. In contrast, heterobifunctional linkers are generally utilized if two 
different molecules need to be connected selectively. 
4.3.1. Homobifunctional linkers 
4.3.1.1. Amine-reactive linkers 
Among the homobifunctional linkers, amine reactive linkers are especially important because 
amines are ubiquitous in biological molecules. One of the most popular crosslinkers containing a 
central disulfide bridge is dithiobis(succinimidylpropionate) (DSP), also known as Lomant´s 
reagent (Table 2). Here, the two NHS-ester moieties rapidly react with primary and secondary 
Chapter 1                                           Delivery of nucleic acids via disulfide-based carrier systems 
 
26 
 
aliphatic amino groups to yield stable amide bonds. For conjugation reactions in aqueous 
phases, the hydrophobic linker molecule must be dissolved in polar organic solvents before 
being added to the reaction solution, which would ideally be a buffer at pH of 7-9.[95] In order to 
create a water-soluble linker dithiobis(sulfosuccinimidyl propionate (DTSSP), which includes two 
sulfonated NHS-ester groups, was synthesized.[95, 111] 
Another homobifuctional amine-reactive linker is dimethyl 3,3`-dithiobispropionimidate (DTBP), 
commonly called Wang and Richard´s reagent (Table 2). The water-soluble molecule reacts with 
amines in a pH range of 7-10. The special feature of this linker is that it preserves the positive 
charges of the amino groups due to the linker molecule`s intrinsic positive charge.[95, 109, 112] 
Cystamine bisacrylamide (CBA) is also able to crosslink amino groups by Michael addition, 
yielding reductively cleavable products.[113, 114] 
4.3.1.2. Thiol-reactive linkers 
One example in which linkers react with thiol groups involves 1,4-di[3`-(2`-
pyridyldithio)propionamido]butane (DPDPB) (Table 2). Both ends of this 14-atom linker are 
dithiopyridyl groups that are able to undergo disulfide exchanges with free thiols resulting in a 
product containing two disulfide bridges.[95, 115] 
4.3.1.3. Photo-reactive linkers 
While the linkers mentioned herein react specifically with one particular functional group, 
unspecific reactions with many different functional groups can be obtained with bis-[β-(4-
acidosalicylamido)ethyl]disulfide (BASED), a symmetrical photoreactive linker with a disulfide 
bridge in its center (Table 2). The aryl azide groups at the linker’s ends are substituted with a 
hydroxyl group, which activates it for nucleophilic attacks and allows for radioiodination with 125I 
prior to conjugation. After crosslinking, the central disulfide bond can be cleaved while the 
radioiodide label is still available on each of the formerly crosslinked molecules.[95] 
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Table 2. Homobifunctional linkers 
 Amine reactive linkers 
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4.3.2. Heterobifunctional linkers 
Although crosslinkages between two equal groups can be easily performed with 
homobifunctional linkers, this approach lacks selectivity. If a conjugate of two different molecules 
is desired, the use of heterobifunctional linkers must be considered. If a disulfide bond should be 
present in the conjugate, amine-and thiolreactive linkers are especially advantageous, as would 
be linkers that are photosensitive and amine- or thiolreactive. 
4.3.2.1. Amine-and thiol-reactive linkers 
One of the most common heterobifunctional crosslinkers is N-succinimidyl 3-(2-
pyridyldithio)propionate (SPDP) (Table 3). One end of this molecule contains an NHS-ester 
moiety that reacts selectively with amines at pH 7-9 and allows for the differentiation between ε- 
and α-amino groups through variation of the pH. The product can be stored since the 2-dipyridyl 
disulfide acts as a protecting group. In the presence of thiol groups, disulfide exchange takes 
place.[116] Analogous linkers include LC-SPDP (the long chain version of SPDP) [95], sulfo-LC-
SPDP (water-soluble long-chain derivate) [95] and SPP (N-succinimidyl 4-(2-
pyridyldithio)pentanoate) (a branched, longer chain derivative).[72] 
S-4-succinimidyloxycarbonyl benzyl thiosulfate (SBT) is another linker that is able to connect 
amines with thiol groups via an NHS-ester moiety and a thiosulfate group (Table 3). Here, the 
attachment of the thiol group is quite labor-intensive as there are many reaction steps 
involved.[117] The same applies to the sterically more demanding and, thus, more stable structure 
analogue, S-4-succinimidyloxycarbonyl-αmethyl-benzyl thiosulfate (SMBT).[118]   
Similar in structure, but easier to work with due to fewer reaction steps, are 4-
succinimidyloxycarbonyl-α-methyl-α(2-pyridyldithio)toluene (SMPT) and the water-soluble 
analog sulfosuccinimidyl-6-[α-methyl-α-(2-pyridyldithio)toluamido] hexanoate (Sulfo-LC-SMPT). 
Both form disulfide bridges by simple disulfide exchanges.[118] Another possibility for crosslinking 
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amines is the reaction with thioimidate groups, as in the case of 3-(4-carboxyamidophenyldithio)-
propionthioimidate (CDPT) and ethyl S-acetyl-propionimidate (AMPT) (Table 3). Both linkers can 
be used for controlled reactions because of their protected thiol moiety.[119, 120] Disulfide bridges 
with sulfosuccinimidyl N-[3-(acetylthio)-3-methylbytyryl-β-alaninate (sNHS-ATMBA) are very 
stable due to a sterically hindered α-carbon atom.[121] 
4.3.2.2. Thiol- and carbonyl-reactive linkers 
Due to its pyridyl disulfide end, 3-(2-pyridyldithio)propionyl hydrazide (PDPH) undergoes 
disulfide exchanges (Table 3). The hydrazide reacts with carbonyl compounds and, thus, the 
molecule is extremely useful if glycoproteins or antibodies are coupled, because the 
carbohydrate moieties usually are far away from the active centers. As a result, their activity is 
not impaired.[95, 122] 
4.3.2.3. Amine- and photo-reactive linkers 
The great advantage of photoreactive linkers is the fact that they can be made reactive “on 
demand” by simple exposure to light. Most linkers contain aryl azide moieties that are activated 
by irradiation with light in the long UV region. The optimal excitation wavelength depends on the 
substituents at the aryl azide. If a nitro group is present, the molecule can be photolysed with 
light of a wavelength of about 350 nm, due to the electron withdrawing effect of the substituent. 
In contrast, if the aryl azide is substituted with a hydroxyl group, the linker can undergo 
electrophilic substitutions. Hence, radioiodide labelling prior to use of the linker is possible. 
Though these linkers exhibit many advantages due to their flexibility, they lack specificity for 
particular functional groups and yields are generally not high: in many cases only around 10 % 
of the linker react.[95, 115] 
Two examples of photoreactive linkers containing disulfides are the water-insoluble N-
succinimidyl(4-azidophenyl)-1,3`-dithiopropionate (SADP) (Table 3) and its water-soluble analog 
Chapter 1                                           Delivery of nucleic acids via disulfide-based carrier systems 
 
30 
 
N-sulfo- succinimidyl(4-azidophenyl)-1,3`-dithiopropionate (Sulfo-SADP). They can be activated 
by irradiation in the range of 265-275 nm [95], while sulfosuccinimidyl-2-(m-azido-o-
nitrobenzamido)-ethyl-1,3`-dithiopropionate (SAND), substituted at the benzyl ring with an nitro 
group, can be activated  with light of a slightly lower wavelength (Table 3).[95] Sulfosuccinimidyl-
2-(p-acidosalicylamido)ethyl-1,3`-dithiopropionate (SASD) (Table 3) is a linker that is suitable for 
radioiodination.[95, 123] Further developments in linker design have led to the synthesis of 
sulfosuccinimidyl-2(7-azido-4-methyl coumarin-3-acetamide)ethyl-1,3`-dithiopropionate (SAED) 
(Table 3). This reagent becomes fluorecescent after initiation of the photolysis, indicating the 
amount of molecules modified by the intensity of fluorescence detectable.[95] 
 
Table 3. Heterobifunctional linkers 
 Amine- and thiol-reactive linkers 
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4.3.2.4. Thiol- and photo-reactive linkers 
Though amine reactive photolinkers are predominant, a thiol reactive linker exists, namely the 
radioiodinatable N-[4-(p-azidosalicylamido)butyl]-3`-(2`-pyridyldithio)propionamide (ADPD), 
which undergoes disulfide exchanges (Table 3).[123, 124] 
5. Examples for the use of disulfides  
5.1. Disulfides for the stabilization of the carrier 
A prerequisite for every systemic nucleic acid delivery system is stability in the blood stream 
prior to reaching its target cell. Therefore, the carrier must prevent the premature release of its 
load. As already discussed, especially in tissue engineering applications, long-term stability, 
which is adjusted to tissue formation, is a major requirement as well. In order to enhance the 
stability of the delivery system either the surface of the carriers was crosslinked, or the low 
molecular weight materials were sulfhydryl polymerized.[125-129] 
The principle of stabilization via disulfide bonds has been demonstrated for many liposome-
based carriers, e.g. for C12CCP. This cationic detergent was synthesized by amide bond 
formation between dodecanoic acid, cysteinyl-cysteine and diaminopropane. Due to 
intermolecular disulfide bond formation, stable liposomes with pDNA were obtained. These 
lipoplexes were indifferent towards anion exchange, but when treated with 1,4-dithiothreitol  
(DTT), their load was released immediately as shown by gel retardation. However, the disulfides 
could not be destabilized by glutathione, the natural reducing cofactor present within cells.[130] 
Guanidinocysteine N-decylamide (C10-C
G+), a cationic amphiphile, was also used to form 
disulfide stabilized particles with individual pDNA molecules. These complexes were “frozen” on 
the template DNA when the cysteine detergent was dimerized by oxidation, and the resulting 
spherical polyplexes remained unchanged at physiological salt concentrations for several days 
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(Figure 4).[131] Another kind of template polymerization was investigated with bis(2-aminoethyl)-
1,3-propandiamine (AEDP). It was polymerized by crosslinking with disulfide containing linkers 
such as DTBP. The formation of polyplexes was only possible if pDNA was present during the 
polymerization reaction. After treatment with DTT the disulfides were reduced, thereby releasing 
pDNA, which led to significantly increased transfection efficiency.[132] The same “caging effect” 
could be observed when pLL was crosslinked with DTBP in presence of pDNA.[133]  
 
Figure 4. Schematic representation of a disulfide-stabilized liposome. First, the detergent 
molecules are collapsing in presence of a template such as DNA, thereby forming 
detergent/DNA-particles. Thereafter, the oxygen of the air slowly oxidizes the detergent 
molecules forming stable, disulfide-crosslinked lipid/DNA particles.[131] 
Another liposome that benefited from disulfide bonds in terms of enhanced stability was formed 
from 1,2-dioleoyl-sn-glycero-3-succinyl-2-hydroxyethyl disulfide ornithine conjugate (DOGSDSO) 
and  L-dioleoyl phosphatidyl ethanolamine (DOPE). The disulfide bond was cleaved in reducing 
media in vitro, thus destabilizing the liposome/DNA complex and increasing the pDNA release. 
This led to enhanced transfection activity in different neural animal cell lines. Compared to its 
Chapter 1                                           Delivery of nucleic acids via disulfide-based carrier systems 
 
35 
 
non-disulfide analogue, up to a 50-fold higher transgene production was obtained.[134, 135] 
However, using this delivery vehicle did not significantly diminish cytotoxicity. It is speculated 
that the linker was probably too strong to be degraded on the required time scale. To overcome 
this problem, another cationic lipid, cholesteryl hemidithioglycolyl tris(aminoethyl)amine 
(CHDTAEA), was synthesized. Herein, dithioglycolic acid was used as a trigger for the reductive 
environment. The incorporated disulfide bond was weaker compared to the one in DOGSDSO, 
and therefore, it was easily cleaved in presence of 10 mM GSH, releasing more than 50 % of the 
DNA. The overall transfection efficiency was higher than that of its non-disulfide analogue, and 
the cytotoxicity decreased significantly. [136] 
Other carriers such as chitosan (deacetylated chitin [26]) were also stabilized via disulfide bonds. 
For this purpose, the primary amino groups of low molecular weight chitosan were thiolated with 
2-iminothiolane. These modified polymers, i.e. chitosan-thiobutylamidines, were mixed with 
pDNA to form coacervates in the nanometer range. After disulfide crosslinkage, they were stable 
at acidic pH and exhibited increased resistance against salt-induced ion-exchange, which was 
ascribed to the tighter binding of pDNA to the thiolated matrix.[128] In another approach thiols 
were introduced into 33 kDa chitosan with thioglycolic acid and crosslinked afterwards. These 
chitosans exhibited improved physical stability and increased mucoadhesiveness due to better 
cell adhesion as mediated by the disulfides. Moreover, crosslinking resulted in enhanced cellular 
uptake and, thus, reporter gene expression and the subsequent duration were increased 
significantly in in vivo experiments.[137] 
α,β-poly(N-2-hydroxyethyl)-D,L-aspartatamide (PHEA) is another gene carrier that benefits from 
disulfides. This carrier can be functionalized with ethylene diamine to obtain primary amino 
groups that can be further modified to provide a disulfide bond and a positive charge. When 
utilized, this non-viral vector condensed DNA into particles stable towards polyanion exchange. 
The stability of these “thioplexes” was so high that they were capable of circulating in the blood 
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stream without release of the entrapped DNA. Furthermore, the complexes dissociated in 
presence of glutathione, thus liberating their load and providing high transfection levels and low 
toxicity in in vitro experiments with murine B16F10 melanoma cells and murine N2A 
neuroblastoma cells.[125] 
Peptides containing many lysines and histidines were used for the complexation of nucleic acids, 
while cysteines were introduced to obtain stable and reductively degradable carriers. A series of 
different vehicles was built from sequences of many lysines, tryptophan and a variable number 
of cysteines. All obtained peptides were able to condense DNA into particles and exhibited 
increased stability after disulfide formation. The disulfide crosslinked carriers conveyed 5 to 60 
fold higher gene expression as compared to their non-crosslinked analogues. The degree of 
gene expression was dependent on the number of incorporated cysteines, with a maximum for 
terminally inserted cysteines.[138] Since these peptides were quite promising, they were further 
modified with PEG and triantennary peptide for successful liver targeting.[139] A shorter peptide 
sequence, cysteine-histidine-lysine6-histidine-cysteine, was able to condense DNA effectively as 
well.[140] Another approach to condensing pDNA into particles involved a system containing 
cysteine-rich peptides that were coupled to either PEG or the triantennary peptide, a moiety that 
is capable of targeting hepatocytes. Shielding and targeting moieties were coupled to the N-
terminal cysteine, while the internal cysteines were transiently acetamidomethyl-protected. 
Thereafter, the PEG-peptides as well as the glycopeptides were mixed with pDNA and the 
resulting particles were polymerized by disulfide formation of the internal cysteines, thus creating 
stable gene vectors.[141, 141] 
Two similar lysine-rich and cysteine-terminated petides were also used to deliver DNA. They 
were 21 amino acids long and possessed either a transglutaminase substrate site or a NLS. 
These peptides condensed DNA efficiently and could be covalently immobilized into a fibrin 
matrix with the help of the transglutaminase sequence. When the fibrin-matrix was degraded, 
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DNA was released and the cells seeded in the matrix were transfected.[142]  Such a system was 
also employed for the in vivo delivery of an oxygen-insensitive hypoxia-inducible factor-1α 
variant which induces vascular endothelial growth factor (VEGF) expression. Here, the carriers 
embedded in the fibrin matrix were applied to dermal wounds in mice. As a consequence, one 
week after treatment 4 times more mature blood vessels were detected compared to the 
application of VEGF-A165 protein.
[56]  
Plasmid DNA encoding VEGF was also delivered with a reducible disulfide poly(amido 
ethylenediamine (SS-PAED). In this study hypoxia-inducible VEGF expression in a rabbit 
myocardial infarct model was up to 4 times higher than the control showing the usefulness of 
disulfide stabilised carrier systems for the in vivo delivery of growth factors [55] which are usually 
degraded within minutes.[143]  
A very prominent example to enhance the stability of the carrier was shown by Chen et al. They 
used melittin, the main component of bee venom, which is known for its endosomolytic activity. It 
was modified with some additional lysine residues and a terminal cysteine at each end. Since a 
single melittin molecule does not exhibit enough positive charges to bind to DNA, it was 
polymerized via disulfide bonds. The obtained molecule condensed DNA efficiently and 
possessed reduced hemolytic activity when bound to DNA. Cell transfection experiments 
revealed up to ten-fold better results for this system when compared to the control-peptide, 
cysteine-tryptophan-lysine17-cysteine.  Although the hemolytic activity was reduced by this 
modification, it seemed to still be enough for endosomal release and carrier disassembly in the 
reductive environment of the cytosol.[127]  
The modification of the ε-amino groups of pLL with 3-(2-aminoethyldithio)propionyl  residues [144] 
or their crosslinking with DTBP comprises another approach utilizing reductively degradable 
gene carriers.[145] These molecules were able to complex nucleotides into particles that were 
stable under physiological conditions but disintegrated upon treatment with GSH. 
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PEI 25 kDa was also stabilized via disulfide containing linkers, namely, DSP and DTBP. If the 
crosslinking reaction was conducted at low molar ratios (≥ 10:1  linker : PEI 25 kDa), the 
PEI/DNA polyplexes were stable against polyion disruption, while the crosslinking could be 
reversed using 20 mM dithioerythritol.[146] In in vivo experiments, disulfide crosslinked polyplexes 
showed increased blood concentrations and longer circulation times, both of which depended on 
the crosslinking degree.[147]  
Lee et al. used thiolated hyaluronic acid for the encapsulation of oligonucleotides as well. 
Nanogels were formed by crosslinking via disulfide bond formation in presence of siRNA. The 
release of the load from the nanogels was proportional to the amount of glutathione in the buffer 
making this very controllable, while the disulfides were stable in a non-reducing environment. 
The gels were readily taken up by hyaluronic acid receptor positive cells, and the gene encoding 
for green fluorescent protein (GFP) was efficiently silenced, indicating triggered 
erosion/biodegradation in a reductive environment.[148] Thiol groups were also inserted into 
polyacrylic acid. Here, the carboxy groups of the acid reacted with L-cysteine. Thereafter, the 
polymer was gelated by adjusting the ion concentration and crosslinked via disulfides. Due to 
these bonds, particles stable under acidic conditions and with longer residence time in the 
gastrointestinal tract were obtained, seeming to be suitable to deliver therapeutic proteins, genes 
or antigens orally as well as transdermally.[149] 
Zelikin et al. demonstrated that the stability of Layer-by-Layer (LbL ) films can be controlled via 
disulfides.  Polymethacrylic acid was functionalized with cysteamine, and this polymer was 
applied for the fabrication of capsules with polyvinylpyrrolidon (PVP). They were assembled by 
an LbL-technique to form hydrogen-bonded polymer multilayers that were crosslinked by 
disulfide bonds. These deposits were stable at physiological pH, but were amenable to 
degradation in the presence of reducing agents such as DTT.[150] The same degradation 
phenomenon was observed for an LbL-film that consisted of CBA-crosslinked N-tert-
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butoxycarbonyl-1,4-diaminobutane and DNA.[151] The LbL-technique was used to coat a 
stainless-steel mesh. Here, the layers consisted of DNA and reducible hyperbranched 
poly(amidoamine). In vitro these films showed higher levels of transgene expression compared 
to films built of DNA and bPEI 25kDa. Furthermore, the duration of transfection was significantly 
longer in NIH-3T3 cells. The authors speculated that this was due to the mild reducing 
microenvironment of the plasma membrane of the growing cells which reduced the disulfide 
bonds. The authors concluded that the very high levels of alkaline phosphatase that were 
induced by the coated meshes in in vivo experiments were due to the sustained gene 
expression from the LbL-film rather than the persistence in the plasma.[152]  
5.2. Disulfides for the attachment of a shielding moiety 
Polyplexes and lipoplexes do not only interact with target cells, but can also adhere 
nonspecifically to other cells and extracellular components such as serum proteins. Especially 
for cationic polyplexes, interaction with components of the immune system is a major problem. 
This issue can be alleviated by modifying the surface of the particles with hydrophilic or 
uncharged “protein repulsive” molecules, such as polyethylene glycol (PEG) [153] or poly[N-(2-
Hydroxypropyl)methacrylamide] (PHPMA). [154] Such a shielding additionally provides reduced 
toxicity, prevents aggregation and prolongs the half-life of polyplexes. [155]  
One approach to enhance the stability of  so-called polyion micelles (PIC micelles), which are 
micellar structures formed from ionic block copolymers and nucleic acids via disulfides, entails 
mixing thiolated poly(ethylene glycol)-block-poly(L-lysine) (PEG-thiopLL) and 
oligodesoxynucleotides (ODNs). These molecules were seen to spontaneously associate and 
form a crosslinked core. The disulfide provided appreciably increased stability for these micelles 
and allowed the liberation of ODNs and dissociation in the presence of GSH at intracellular 
concentrations.[156] 
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Stable gene vehicles were also attained when a terminally thiol-functionalized branched six-arm 
PEG was used to solubilize DNA. Disulfides crosslinked the DNA/PEG nanocomplexes, resulting 
in DNA/PEG nanogels that were stable in aqueous solutions but able to release DNA in reducing 
environments, as shown by gel retardation assays before and after DTT treatment.[157]  
DOPE and N-[2-ϖ-methoxypoly(ethylene glycol)-α-aminocarbonylethyl-dithiopropionate] formed 
a liposome that was covalently coupled to distearoylphosphatidylethanolamine (mPEG-S-S-
DSPE). The incorporation of the mPEG-S-S-DSPE stabilized these liposomes at low pH, but the 
stabilizing effect was reversed as soon as the carrier was incubated with either DTT or cell-free 
extracts. Under these conditions, the disulfides were reduced, and thus the protecting PEG 
chains were cleaved, and the vehicle became degradable at low pH, releasing its load.[158, 159] 
Disulfides were used for the formation of copolymers consisting of bPEI 25 kDa and PEG of 
20 kDa or 30 kDa.  The connection of PEG via DSP led to a 125 % increase in blood levels and 
decreased hemolysis compared to bPEI 25 kDa.[160] Carlisle et al. showed the stabilization of 
PEI polyplexes with DNA. To this end, thiol groups were inserted at the chain ends of branched 
PEI (bPEI). Next, disulfide bonds were formed with thiol-reactive derivatives of PHPMA, creating 
stable surface-coated nanoparticles that were able to condense pDNA. The disulfides provided 
stability against a 250-fold excess of the counterion poly(aspartic acid) (pAA). After treatment 
with DTT, the disulfides were reduced, leading to complete release of the pDNA. In comparison 
to the thioether analogues, the reducible nanoparticles exhibited 40-100-fold higher transfection 
efficiency. [161] 
Generally, the kind of linker affects the degradation of the disulfide bond and hence the liberation 
of the load. This was nicely demonstrated for a copolymer of PEG and L-lysine, which was 
coupled to the peptide Tat9K(bio)-Cys via a disulfide bond. Either an unsubstituted disulfide or a 
sterically hindered disulfide was used. Both formulations were stable in an oxidative 
environment, but exhibited marked differences when exposed to a reductive milieu. In this case, 
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the polymer with the unhindered disulfide bond exhibited a fairly short half-life of release, 
whereas the sterically hindered disulfide bond released its load about 100 times more slowly.[107] 
The influence of the kind of crosslinkage was also shown for another polyethylene glycol-poly-L-
lysine (PEG-pLL) system. Here, thiol groups were introduced into the block copolymers, either 
with the crosslinker SPDP or with Traut´s reagent. In case of Traut´s reagent, the positive 
charges of pLL´s amino groups were preserved after derivatisation, while for SPDP, the positive 
charges were neutralized due to formation of an amide bond. Both thiolated PEG-pLLs efficiently 
complexed pDNA into disulfide crosslinked polyplexes thatwere more stable than the unmodified 
ones. Moreover, the crosslinking prevented them from dissociation through counterion 
exchange. However, in contrast to the polyplexes treated with Traut´s reagent, the polyplexes 
thiolated with SPDP were able to release pDNA in response to a reductive environment. These 
carriers also showed 50 times higher transfection efficiencies compared to the polyplexes with 
conserved charge and thus, the overall strength of binding was higher.[162] Generally, the 
complexation ability of gene carriers is strongly dependent on the type of linker [163] or the 
resulting charge density, but the degree of thiolation also plays a role. In this context, it was 
shown that a thiolation degree of 28 % balanced the demands of stability and efficient release of 
pDNA in reductive environment in an optimal manner.[162] The stability of these micelles was also 
tested when the model drug pAA was incorporated. These disulfide crosslinked micelles again 
showed enhanced stability.[164]  In another study on the crosslinked PEG-pLL system, a thiolation 
degree of more than 13 % of the lysine residues was needed to freeze-dry the vector without the 
use of any lyoprotectants to make it stable for long-term storage.[165] 
 
5.3. Disulfides for the attachment of a targeting moiety 
For a successful accumulation of the nucleic acid in the target cell, the delivery system requires 
the attachment of a specific “recognition element”.[166, 167] However, since many targeting 
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moieties are rather large, they hamper effective unpacking of the gene vector. Thus, inside cells, 
it is very important to remove them to facilitate the disassembly of the load. Here, disulfides can 
be quite useful, as they can be cleaved at the cell surface during cellular entry or in the cytosol. 
Muratovska et al. successfully demonstrated the attachment of such targeting moieties via 
disulfide bonds. They coupled the membrane permeant peptides (MPP) penetratin and 
transportan to siRNA that was thiol-modified at the 5` ends. In contrast to untargeted siRNAs, 
the MPP-siRNA was able to allow for the cellular uptake of siRNA into many different cells. A 
long-lasting decrease in luciferase activity compared to cells that were treated with siRNAs 
transfected by lipofectamine 2000 was observed. Similar results were obtained when siRNA 
against GFP was used (Figure 5).[168] 
For active targeting, asODNs can also be combined with asialoglycoprotein (ASGP). To this end, 
a thiol-modified oligonucleotide was connected with the glycoprotein via sulfo-LC-SPDP, a 
disulfide containing linker with a long spacer arm providing sufficient conformational stability for 
receptor binding. These conjugated asODNs were directed towards one of the most important 
signal transduction proteins in inflammation. They were more efficient than “naked” antisense 
oligonucleotides in a cell culture model, but they were not able to achieve complete inhibition of 
the protein production. Nevertheless, this approach showed that the number of targeting ligands 
could be controlled by the amount of linker. At the same time, the biological activity of the 
ligands was maintained as shown by transfection experiments.[169] Another targeting ligand is 
mannose-6-phosphate (M6P), which is internalized by membrane lectins, which are sugar 
binding receptors. For enhanced uptake, oligonucleotides were thiol-modified at their 3`end and 
coupled by a covalent disulfide bond to an M6P bovine serum albumine (M6P-BSA) conjugate 
via linkers. Additionally, this molecule was radioiodinated or fluorescently labelled at its 5´-end. 
Consequently, both ends of the oligonulceotide were modified, and nuclease activity was 
abolished. The oligonucleotide as well as the disulfide linkage between the M6P-BSA were 
stable in culture medium as tested by gel electrophoresis. The targeted oligonucleotides 
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mediated increased cellular uptake approximately 20-fold in comparison to free oligonucleotides. 
Within acidic vesicles (endosomes and/or lysosomes), their concentration was increased, and 
  
Figure 5. Silencing of GFP in mouse fibroblast cell lines stably expressing GFP: C166-GFP and 
EOMA-GFP cell lines were treated with 25 nM GFP siRNAs delivered by liposomes or MPP. A–
D: Double fluorescence staining of EOMA-GFP cells treated with siRNAs. The following 
transfectionconditions were used: (A) Lipofectamine, (B) penetratin, (C) transportan, or (D) 
media only as a control. The red fluorophore Cy3 was used to label siRNAs.   The green 
fluorescence from GFP was also visualized using confocal fluorescence microscopy after 3 and 
7 days.[168] 
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thus it was speculated that the amount of oligonucleotides released from the carrier by reduction 
also increased.[170] 
Unfortunately, in all examples, only the differences between targeted and untargeted carriers 
were studied. Thus, the influence of the type of connection, such as triggerable disulfides, is 
hard to determine. Although the exact location of disulfide cleavage inside cells still remains 
unclear, it can be concluded that they do not remain intact within the reductive environment of 
the cytosol.  
5.4. Disulfides for the attachment of endosomolytic agents 
After the delivery system has crossed the cell membrane – which should ideally occur by 
receptor-mediated endocytosis – endosomal escape is a critical barrier for access of the system 
to the cytoplasm or nucleus. In order to enhance endosomal escape, fusogenic peptides can be 
attached to the delivery system [5, 6, 171], or carriers that exhibit intrinsic endosomolytic ability can 
be used.[172] However, since there is no clear evidence whether endosomes or lysosomes 
provide a reductive environment, only few examples are known in which an endosomolytic 
moiety is attached to the carrier via disulfide bonds. 
One approach towards the attachment of endosomolytic components via disulfide bonds is the 
application of LLO, a pore-forming cytolysin that contains a single cysteine residue controlling 
the activity of the whole peptide. As soon as this cysteine forms any disulfide linkage, LLO 
becomes inactive. This characteristic was exploited for the development of a gene carrier 
consisting of LLO and protamine, an arginine-rich cationic polypeptide. The cytolysin was 
covalently coupled to protamine via the thiol group of its cysteine residue. Thus, the hemolytic 
activity was completely annulled, but it could be restored after addition of a reductant such as 
DTT. For pDNA/protamine polyplexes, a degree of substitution of only 1.2 % LLO-S-S-PN was 
sufficient to produce luciferase reporter gene expression nearly three orders of magnitude higher 
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than obtained with pDNA/protamine complexes. Since these results were obtained without 
external addition of a reducing agent, it was concluded that upon cell association, the disulfide 
bonds were cleaved en route to lysosomes. Thus, LLO was separated from the carrier, and at 
the same time, transferred into the activated, pore-forming state, destroying the endosome 
membrane and allowing for the release of its cargo (Figure 6).[81]  
 
Figure 6. GFP gene expression in HEK293 cells mediated by LLO-s-s-PN- at varying PN/pDNA 
weight ratios: LLO-s-s-PN-mediated GFP expression 2 days post-transfection using LLO-s-s-
PN/PN/pDNA complexes incorporating fixed amounts of LLO-s-s-PN (0.06 g) and pDNA (0.5 g) 
and increasing amounts of PN. PN/pDNA weight ratios increased from 0.32 (a) to 2.14 (g). (h) 
shows a typical transmission image of cells 2 days post-transfection.[81] 
While LLO forms pores, melittin, the major component of the bee venom, destabilizes 
membranes by perturbation of their structure. Its lytic activity strongly depends on the number of 
amines available in the peptide. Therefore, amines should not be used for conjugation reactions. 
Instead, disulfides play an important role, since the thiol group of the cysteine on melittin can be 
used for coupling reactions. This approach was pursued when melittin was conjugated to a 
Chapter 1                                           Delivery of nucleic acids via disulfide-based carrier systems 
 
46 
 
modified PEI 25 kDa. The resulting polyplexes exhibited a strong increase in transfection 
activity. Additionally, gene expression started as early as 4 h after transfection, and was also 
high in slowly dividing cells. The early onset of reporter gene expression was thought to be due 
to the endosomolytic activity of melittin.[173] Unfortunately, melittin shows this high lytic activity 
not only at acidic, but also at neutral pH, which consequently leads to toxic side-effects before 
internalization into the cells. In order to circumvent this problem, a melittin derivative was 
synthesized in which the amino groups were masked with an acid-labile protecting group. The 
protected melittin was coupled to pLL via the cysteine residue and showed no cytotoxicity at 
neutral pH, whereas its lytic activity was regained within the acidic milieu of the endosome 
(Figure 7).[174, 175] 
Endosomolysis can not only be achieved with toxins known from nature; some synthetic vectors 
display this feature as well. For example bPEI is not only used for the complexation of 
nucleotides, it is also known to have some inherent endosomolytic ability.[172] This feature was 
exploited when disulfide bonds were employed for the covalent attachment of PEG to asODNs 
that were mixed with bPEI to form PIC micelles. These micelles showed significant antisense 
effect against luciferase gene expression. This was attributed to the fact that bPEI was able to 
mediate successful escape from the endosome.[176] Although the exact site of disulfide cleavage 
is still unclear, these approaches nevertheless show the usefulness of the attachment of 
endosomolytic agents via disulfide bonds. 
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Figure 7. Schematic structure of the pH-responsive endosomolytic polycation-PEG-DMMAn-
Melittin nucleic acid carrier: the pH-drop in the endosome triggers the fast cleavage of the 
dimethylmaleic anhydride protecting groups thereby restoring the lytic activity of melittin.[174] 
5.5. Disulfide bonds to decrease the cytotoxicity 
A dilemma in non-viral nucleic acid delivery is exemplified by considering the polymeric 
transfection agent PEI, which is often referred to as the gold standard for polymer-based gene 
carriers due to the relatively high transfection efficacy of its polyplexes.[6, 21] Unfortunately, 
efficacy and adverse reactions seem to be strongly associated with the use of PEI. A popular 
strategy to reduce the toxicity of polyplexes is to use low MW polycations or cationic monomers 
that are less cytolytic and crosslink them with agents that can be cleaved or activated by the 
intracellular environment.[177] Numerous reports describe the synthesis of carrier systems 
containing disulfide bonds that allow for a compaction and protection of the nucleic acid in the 
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extracellular environment accompanied by reduced toxicity due to intracellular polymer 
degradation. A few selected examples will be presented in the following. 
The group of Park synthesized linear PEI (lPEI) derivatives with disulfide bonds in the backbone. 
The linear poly(ethylene imine disulfide) (l-PEIS) with an amine density similar to PEI showed 
transfection efficiency nearly comparable to ExGen 500, its non-degradable counterpart with a 
MW of 22 kDa, and exhibited very low  toxicity as evaluated in HeLa cells.[178] The kinetics of 
polymer degradation after incubation in 5 mM glutathione buffer were determined by multiple 
angle light scattering (MALS). Total degradation was measured after approximately 100 minutes. 
To observe polymer degradation inside cells, l-PEIS was labelled with BODYPY-FL. In 
fluorescence microscopy pictures, an increase of the fluorescence signal of BODIPY-FL due to 
dequenching indicated intracellular polymer degradation over time, and this effect was not 
observed for ExGen 500. 
In another approach, also a lPEI derivative was used as starting material, but here, the 
components were crosslinked with different amounts of dithiodipropionic acid or cystine 
linkages.[177] In comparison to seven commercial transfection reagents, the resulting polymers 
exhibited outstandingly high transfection efficiencies in seven different cell lines, and at the same 
time, their toxicity was substantially lower (Figure 8). Treatment of CHO-k1 cells with 
duroquinone, an agent that oxidizes NADPH/H+, thereby lowering its intracellular reducing 
potential, reduced the number of transfected cells significantly. 
Gosselin et al. demonstrated that the type of disulfide-based linker may have an influence on the 
toxicity.[179] Low MW bPEI (800 Da) was crosslinked with DSP or DTBP. Conjugates with DSP 
(primary amine:NHS reactive group of 2:1) displayed a higher toxicity in CHO cells, but both 
conjugates were less toxic as compared to bPEI 25 kDa. 
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A series of different poly(disulfide amines) were synthesized by Michael addition of N,N`-
cystamine bisacrylamide (CBA) to different N-protected diamines (N-Boc-1,2-diaminoethane 
(DAE), N-Boc-1,4-diamonobutane (DBA), and N-Boc-1,6-diaminohexane (DAH)).[61] The 
luciferase expression using poly(CBA/DAH) as carrier depended on the side-chain spacer 
length. For three cell lines, the luciferase expression was similar to that observed for 
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Figure 8. Comparison of biodegradable PEIs with commercially available transfection reagents: 
(A and B) EGFP-positive cells expressed as maximal transfection efficiency (A) and 
corresponding cell viability (B) of various biodegradable PEIs and commercially available 
transfection reagents complexed with pEGFP-N1 in (from left to right) CHO-K1 (diagonally 
hatched bars), COS-7 (horizontally hatched bars), NIH/3T3 (black bars), HepG2 (horizontally 
striped bars), HCT116 (white bars), HeLa (diamond-hatched bars), and HEK-293 (gray bars) 
cells as determined by flow cytometry. (C) Transfection efficiency under conditions where cell 
viability is >90%. Statistically significant differences of biodegradable PEIs compared with other 
transfection reagents are denoted by  (P < 0.05) or by ★ (P < 0.01).[177] 
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bPEI 25 kDa, while in C2C12 cells at certain N/P ratios, it was slightly higher. The toxicity of the 
polyplexes was much lower in NIH3T3 cells as compared to PEI 25 kDa. In a similar approach, 
Lin et al. applied various oligoamines for addition to CBA, providing insight into the relationship 
between the structure of the side chain and buffer capacity, transfection efficiency and 
toxicity.[180] Secondary amines in the side chain allowed for a high buffer capacity as along with 
high transfection efficiency and low cytotoxicity. Increasing the alkyl spacer length by switching 
from ethylene to propylene between the amines abolished this effect and resulted in significantly 
higher cytotoxicity. 
The group of Oupicky used high MW polycondensates of the TAT peptide, a protein transduction 
domain from the transcriptional activator protein from HIV-1, to form polyplexes with pDNA.[181] 
The TAT sequence was flanked by terminal cysteines which were oxidatively condensated or 
underwent template polymerization with DNA, thus forming polyplexes (Figure 9). In comparison 
to PEI 25 kDa, the cytotoxicity was reduced in both cases. The transfection efficiency was 
several orders of magnitudes lower, but after addition of chloroquine, it was comparable to bPEI 
25 kDa. The incorporation of histidine residues into the molecule allowed for more effective 
escape from the endosomal compartment. The molecules were not toxic in cell culture testing, 
and the gene transfection efficiency increased manifold.[182] 
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Figure 9.  Schematic representation of the two approaches leading to DNA polyplexes 
containing high-molecular-weight TAT polypeptides. For the template polymerisation the single 
molecules are polymerized through their terminal thiol-groups in presence of the template DNA-
strand. In the oxidative polycondensation the peptides are oxidised in presence of DMSO 
forming the TAT-polypeptides. Thereafter, the polyplexes are formed from the DNA-strand and 
the polypeptides.[181] 
 
5.6. Disulfide bonds to enhance the intracellular release of the nucleic acid 
Efficient nucleic acid condensation is required for the transport of the cargo to the target cell, but 
once there, the delivery system must effectively disassemble in order for the nucleic acid to 
become biologically active. Therefore, the stability of polyplexes and lipoplexes inside cells is 
heavily investigated.[21, 22, 183-188] One approach to facilitate disassembly involves the use of 
materials that degrade inside cells. Here, disulfide bonds possess great potential, as the 
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degradation of the carrier not only reduces the toxicity as described previously, but also allows 
for efficient release of the nucleic acid as a consequence of reduced interaction with degradation 
products (Figure 10.)[189] 
 
Figure 10. This scheme illustrates the concept of DNA condensation and subsequent 
intracellular release: (a) Polyplexes that are built with SS-PAAs and DNA are stable in the 
extracellular environment. (b) The disulfide linkages in the polymer of the polyplex are reduced 
intracellular. (c) DNA dissociates from the degraded polymer. [188] 
To this end, confocal laser scanning microscopy (CLSM) was used to evaluate the intracellular 
distribution and release of fluorescently-labeled siRNA using the following PEI derivatives as 
carriers: lPEI, commercially available bPEI 25 kDa and a PEI derivative that was synthesized by 
crosslinking low MW lPEIs via disulfide bonds (ssPEI) (Figure 11).[187] Discrete green spots seen 
within the cells were interpreted as siRNA associated with the carrier, whereas a homogeneous 
green cell staining indicated that siRNA was released from the polymer and distributed 
throughout the cell. The confocal images supported the hypothesis that degradable PEI 
facilitates the intracellular release of siRNA, as the nucleic acid was homogenously distributed 
inside cells (Figure 11 A). bPEI and especially lPEI seemingly were not able to liberate siRNA to 
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a great extent because specific spots of polyplexes were predominant, and very few cells 
showed a homogeneous faint green fluorescence over the cytosol (Figure 11 B and C, 
respectively).  
 
 
 Figure 11. Confocal laser scanning images of CHO-K1 cells after 5 hours of incubation with 
polyplexes which were fabricated with fluorescently-labeled siRNA (green) and (A) ssPEI, (B) 
bPEI and (C) lPEI at N/P 30. The picture is an overlay of transmitted light and fluorescence 
image (Scale bar: 10µm or 20µm).[187] 
The idea of exploiting disulfide bonds to trigger the release of siRNA in the cytoplasm has also 
been investigated for other polymers.[114, 190, 191] It has been demonstrated that the reducible 
poly(amido ethylenimine) (SS-PAEI) poly(triethylenetetramine/cystamine bisacrylamide) 
(poly(TETA/CBA) is more effective than lPEI 25kDa for VEGF suppression in PC-3 cells.[114] This 
superior gene silencing activity correlated well with the homogenous distribution of siRNA 
throughout the cell (cytoplasm and nucleus) after 5 hours of incubation with polyplexes. In 
contrast, complexes formed with lPEI 25 kDa were distributed as discrete spots within the cell as 
shown by CLSM. The same group applied three different SS-PAEIs that were synthesized from 
Michael addition reactions between CBA and three different ethylene amine monomers, i.e. 
ethylenediamine (EDA), diethylenetriamine (DETA) and triethylenetetramine (TETA), for pDNA 
delivery. The higher transfection efficiency of poly(EDA/CBA) in particular as compared to 
A B C 
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bPEI 25 kDa was signified by the dispersed fluorescence of pDNA inside cells, indicating release 
after just 90 minutes as observed by CLSM.[113] 
Byk et al. nicely showed that the release of pDNA from lipopolyamines can be modulated by the 
location of the linker.[192] The lipopolyamines consisted of 1) a lipid with two fatty acids, 2) a 
cationic entity such as a polyamine, 3) a spacer between these two molecules and 4) a targeting 
side-chain. Figure 12. shows the positions where the disulfide bridges were introduced. The 
expression level of luciferase was used to interpret the disulfide cleavage. If the disulfide bond 
was inserted between the lipid and the polyamine, transfection activity was totally lost, probably 
due to premature release of pDNA during or directly after cell penetration. In contrast, increased 
transfection efficiency was found if the disulfide bridge was inserted between one lipid chain and 
the rest of the molecule. This increase was attributed to disruption of the lipids caused by the 
reducible side-chain entity. Here, additional studies to confirm the interpretation based on 
transfection results are necessary. 
 
Figure 12. Schematic representation of the design of lipopolyamines which bear disulfide 
bridges at different positions within lipopolyamine: blue spheres, polyamine; green boxes, linker; 
red triangles, fatty chains; orange triangles, side chain entity (Arrows indicate the sites where 
disulfide bridges can be introduced in lipopolyamines).[192] 
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5.7. Gene delivery systems with multiple triggerable functionalities 
Although disulfide bonds have proven to be very efficient, especially when used in the carrier 
backbone, it is not enough to address just one step in the process of gene delivery. Moieties that 
are responsive to different incentives must be combined to result in an appropriate set of diverse 
trigger mechanisms at different time points.[193] Such moieties might be cleaved in acidic 
environments, show good buffering capacity, be redoxactive or enzymatically cleavable, or be 
stimulated by some extragenous stimuli such as heat [194], magnetic fields [195] or irradiation.[196] 
A promising example of a triggerable system was created by the synthesis of a liposomal carrier 
that was comprised of a membrane permeable ligand and a reductively detachable PEG-
coating. The surface cover consisted of PEG coupled to DOPE via a thiolytically cleavable linker, 
while the ligand, an ariginine octamer, was immobilized onto cholesteryl hemisuccinate 
(CHEMS). These conjugates were mixed with dipalmitoylphosphatidylcholin (DPPC) and 
unmodified DOPE to form liposomes. The authors expected this formulation to dispose of its 
coating at its destination through a mild reductive trigger such as external L-cysteine. Upon 
activation of the trigger, the arginine octamer would be exposed, causing cellular uptake of the 
liposome. Once in the cytosol, the remaining disulfide bonds would be cleaved, ultimately 
resulting in the destabilization the whole carrier (Figure 13.).[197] 
Other attempts to incorporate multiple triggers in one carrier system to allow for controlled 
nucleic acid delivery have also been made. In one such attempt, polymers were designed to 
possess 1) a targeting moiety for receptor-mediated endocytosis, 2) a pH-responsive element for 
the disruption of endosomal membranes and 3) a disulfide bound biomolecular therapeutic agent 
to be delivered in free form into the cytoplasm. For this purpose, a copolymer of 
dimethylaminoethyl methacrylate (DMAEMA) and hydrophobic alkyl methacrylates (BMA) as 
well as alkylacrylates (BA) were chosen for the formation of the membrane-disruptive backbone. 
PEG was grafted around the polymer for stealth effects. In order to obtain pH sensitivity, acid- 
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Figure 13. Scheme of a stimuli-responsive liposome: the liposomal carrier possesses  
membrane-permeable ligands and a detachable coating which is intended for the intracellular 
delivery of drugs or genes.[197] 
degradable acetal bonds were introduced for the attachment of PEG or PEGylated drugs and 
targeting moieties to the backbone. The acetal linkages readily degraded in the acidic endosome 
and could be tracked by a change in UV absorption. This hydrolysis unmasked the membrane-
disruptive backbone which led to release into the cytosol where the remaining disulfide bonds 
were cleaved allowing the drug to be liberated. This release was followed by fluorescence 
measurements of the labelled peptides (Figure 14).[198] 
A similar approach used DMAEMA, BMA and PEG grafted via an acid-degradable linker. The 
PEG chains in this formulation were further modified. One fraction of PEG was coupled with a 
hexalysine component for complexation of ODNs, while the rest was reacted with lactose in 
order to aid cellular uptake mediated by the asiaglycoprotein receptor.  This gene delivery 
system significantly enhanced endosomal release and cytoplasmic delivery .[199] Another 
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Figure 14. Schematic representation of the encrypted polymer design: The polymers are 
PEGylated and are stable in serum at pH 7.4 and they are able to disrupt the endosomal 
membrane at the acidic pH of the endosome. The polymers contain a membrane-disruptive 
backbone (red line), acid-degradable linkers (purple circle), PEG grafts (aqua ellipsoid), 
conjugated or ionically complexed drug molecules (blue circle), hexalysine peptide (green line), 
and targeting ligands (black arrow). At pH 7.4 the polymers are masked" by the PEG chains. 
After endocytosis the acid-degradable linker is cleaved and the polymer backbone gets rid of its 
PEG- strands (" is unmasked") and becomes at the same time membrane-disruptive. The PEGs 
can be conjugated to the backbone via acid-degradable linkages as well as disulfide bonds. The 
latter are reduced in the cytoplasm  releasing the free drug.[198] 
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polymeric carrier was formed from methacrylic acid (MAAc), BA and pyridyldisulfide acrylate 
(PDSA). This poly(MAAc-co-BA-co-PDSA) was accessorily conjugated with peptides that 
allowed for the electrostatic complexation of oligonucleotides. The terpolymer mediated uptake 
and enhanced cytoplasmic delivery of fluorescein isothiocyanate (FITC)-labelled ODNs in THP-1 
macrophage-like cells.[200] 
The slightly more acidic pH of tumors compared to normal tissue was employed in another 
delivery system.[201] Here, a biodegradable micelle system for tumor-targeted delivery was 
synthesized. It consisted of poly(L-lactic acid)-b-poly(ethylene glycol) (PLLA-b-PEG)  conjugated 
to TAT. This was wrapped in poly(L-cysteine bisamide-g-sulfadiazine)-b-PEG (PCBS-b-PEG), 
which is a shielding, pH-sensitive diblock copolymer. The pH responsive block could also be 
rapidly degraded in the presence of cysteine due to the incorporated disulfide bridges. Not only 
the single blocks were able to degrade; the whole micelle was deshielded at low pH. Moreover, 
this system was able to distinguish between a pH of 7.2 and 7.0, the latter of which is found in 
tumors.[202] This discrimination was demonstrated when the anticancer drug doxorubicin was 
incorporated into the TAT micelles. At the lower pH, cytotoxicity increased due to the larger 
amount of deshielded micelles. Upon partial deshielding, the TAT component was able to guide 
the included drug into the cell. Inside the cells, the remaining PCBS-b-PEG components could 
be degraded by disulfide reduction, thus, liberating the drug load (Figure 15.)  
All of these systems combine multiple trigger mechanisms, making them very potent therapeutic 
agents. With slight variations, for example of the targeting moieties, multiple applications are 
easily possible. Therefore, gene delivery vehicles that are responsive to different changes in the 
environment will be very important for future therapeutic strategies. 
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Figure 15. Schematic model of a pH- and redox-sensitive drug delivery system: The carrier 
system comprises two different building blocks: 1) a PLLA-b-PEG micelle connected with TAT 
and 2) a pH sensitive diblock polymer PCBS-b-PEG. The sulfadiazine is negatively charged at 
normal blood pH ( i.e. pH 7.4). After mixing with the TAT-micelle, the sulfadiazine shields the 
TAT electrostatically. On the surface of the carrier are only PEG chains which provide for long 
circulation times. As soon as there is a drop in pH (e.g. near tumor pH 6.6) the sulfonamide 
becomes uncharged and detaches from the micelles. Then TAT is exposed and can interact with 
tumor cells; while the detached PCBS polymer is degraded rapidly by the native glutathione.[202] 
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6. Conclusion 
Although nucleic acids have revolutionized biomedical research and pharmaceutical 
development, their role as clinically applied drugs is still modest. For future applications it will be 
important to effectively deliver the nucleic acid to its side of action and to adopt nucleic acid 
delivery systems to the disease-specific demands. In this context, disulfides within the carrier will 
hold a unique position. They can stabilize the vehicles for a time scale which may even be long 
enough for tissue repair as well as guarantee for the release of their load in the cytosol of the 
cell while providing for carrier decomposition at the same time - two features that sparely can be 
achieved with other linkages. 
 
 
  
Chapter 1                                           Delivery of nucleic acids via disulfide-based carrier systems 
 
61 
 
7. Reference List 
 [1]  L. De Laporte, L. D. Shea, Matrices and Scaffolds for DNA delivery in tissue engineering. 
Advanced Drug Delivery Reviews (2007) 59, 292-307. 
 [2]  R. Langer, J. P. Vacanti, Tissue Engineering. Science (1993) 260, 920-926. 
 [3]  E. Lavik, R. Langer, Tissue engineering: current state and perspectives. Applied 
Microbiology and Biotechnology (2004) 65, 1-8. 
 [4]  M. D. Brown, A. G. Schaetzlein, I. F. Uchegbu, Gene delivery with synthetic (non viral) 
carriers. International Journal of Pharmaceutics (2001) 229, 1-21. 
 [5]  E. Wagner, J. Kloeckner, Gene Delivery Using Polymer Therapeutics. Advances in 
Polymer Science (2006) 192, 135-173. 
 [6]  U. Lungwitz, M. Breunig, T. Blunk, A. Goepferich, Polyethyleneimine-based non-viral 
gene delivery systems. European Journal of Pharmaceutics and 
Biopharmaceutics (2005) 60, 247-266. 
 [7]  E. Wagner, Application of membrane-active peptides for nonviral gene delivery. 
Advanced Drug Delivery Reviews (1999) 38, 279-289. 
 [8]  A. C. Hunter, Molecular hurdles in polyfection design and mechanistic background to 
polycation induced cytotoxicity. Advanced Drug Delivery Reviews (2006) 58, 
1523-1531. 
 [9]  H. Lv, S. Zhang, B. Wang, S. Cui, J. Yan, Toxicity of cationic lipids and cationic polymers 
in gene delivery. Journal of Controlled Release (2006) 114, 100-109. 
 [10]  D. Fischer, Y. Li, B. Ahlemeyer, J. Krieglstein, T. Kissel, In vitro cytotoxicity testing of 
polycations: influence of polymer structure on cell viability and hemolysis. 
Biomaterials (2003) 24, 1121-1131. 
 [11]  M. A. E. M. van der Aa, E. Mastrobattista, R. S. Oosting, W. E. Hennink, G. A. Koning, D. 
J. A. Crommelin, The Nuclear Pore Complex: The Gateway to Successful 
Nonviral Gene Delivery. Pharmaceutical Research (2006) 23, 447-459. 
 [12]  D. A. Dean, D. D. Strong, W. E. Zimmer, Nuclear entry of nonviral vectors. Gene Therapy 
(2005) 12, 881-890. 
 [13]  C. W. Pouton, K. M. Wagstaff, D. M. Roth, G. W. Moseley, D. A. Jans, Targeted delivery 
to the nucleus. Advanced Drug Delivery Reviews (2007) 59, 698-717. 
 [14]  M. Molas, R. Bartrons, J. C. Perales, Single stranded DNA condensed with poly-L-lysine 
results in nanometric particles that are significantly smaller, more stable in 
physiological ionic strengthfluids and afford higher efficiency of gene delivery than 
their double-stranded counterparts. Biochimica et Biophysica Acta (2002) 1572, 
37-44. 
Chapter 1                                           Delivery of nucleic acids via disulfide-based carrier systems 
 
62 
 
 [15]  Y. H. Choi, F. Liu, J. S. Kim, Y. K. Choi, J. S. Park, S. W. Kim, Polyethylene glycol-
grafted poly-L-lysine as polymeric gene carrier. Journal of Controlled Release 
(1998) 54, 39-48. 
 [16]  G. Liu, M. Molas, G. A. Grossmann, M. Pasumarthy, J. C. Perales, M. J. Cooper, R. W. 
Hanson, Biological properties of Poly-L-lysine-DNA Complexes Generated by 
Cooperative Binding of the Polycation. Journal of Biological Chemistry (2001) 
276, 34379-34387. 
 [17]  J. Wang, H. Q. Mao, K. W. Leong, A Novel Biodegradable Gene Carrier Based on 
Polyphosphoester. Journal of the American Chemical Society (2001) 123, 9480-
9481. 
 [18]  Y. B. Lim, C. H. Kim, K. Kim, S. W. Kim, J. S. Park, Development of  a Safe Gene 
Delivery system Using Biodegradable Polymer, Poly[α-(4-aminobutyl)-L-glycolic 
acid]. Journal of the  American Chemical Society (2000) 122, 6524-6525. 
 [19]  J. S. Remy, B. Abdallah, M. A. Zanta, O. Boussif, J. P. Behr, B. Demeneix, Gene transfer 
with lipospermines and polyethyleneimines. Advanced Drug Delivery Reviews 
(1998) 30, 85-95. 
 [20]  R. Kircheis, L. Wightman, E. Wagner, Design and gene delivery activity of modified 
polyethylenimines. Advanced Drug Delivery Reviews (2001) 53, 341-358. 
 [21]  M. Neu, D. Fischer, T. Kissel, Recent advances in rational gene design based on 
poly(ethylene imine) and its derivatives. Journal of Gene Medicine (2005) 7, 992-
1009. 
 [22]  U. Lungwitz, M. Breunig, R. Liebl, T. Blunk, A. Goepferich, Gene delivery with low 
molecular weight linear polyethylenimines. European Journal of Pharmaceutics 
and Biopharmaceutics (2008) 69, 134-1298. 
 [23]  M. Breunig, U. Lungwitz, R. Liebl, C. Fonatanari, J. Klar, A. Kurtz, T. Blunk, A. 
Goepferich. Gene delivery with low molecular weight linear polyethylenimines, 
Journal of Gene Medicine (2005) 7, 1287-1298. 
 [24]  J. M. Dang, K. W. Leong, Natural polymers for gene delivery and tissue engineering. 
Advanced Drug Delivery Reviews (2006) 58, 487-499. 
 [25]  S. Kommareddy, M. Amiji, Preparation and Evaluation of Thiol-modified Gelatin 
Nanoparticles for Intracellular DNA Delivery in Response to Glutathione. 
Bioconjugate Chemistry (2005) 16, 1423-1432. 
 [26]  A. Bernkop-Schnürch, M. Hornof, D. Guggi, Thiolated chitosans. European Journal of 
Pharmaceutics and Biopharmaceutics (2004) 57, 9-17. 
 [27]  T. Sato, T. Ishii, Y. Okahata, In vitro gene delivery mediated by chitosan. Effect of pH, 
serum and molecular weight on the transfection efficiency. Biomaterials (2001) 
22, 2075-2080. 
Chapter 1                                           Delivery of nucleic acids via disulfide-based carrier systems 
 
63 
 
 [28]  V. L. Truong-Le, S. M. Walsh, E. Schweibert, H. Q. Mao, J. T. Guggino, J. T. August, K. 
W. Leong, Gene Transfer by DNA-Gelatin Nanospheres. Archives of 
Biochemistry and Biophysics (1999) 361, 47-56. 
 [29]  A. Kim, D. M. Checkla, P. Dehazya, W. Chen, Characterization of DNA-hyaluronan 
matrix for sustained gene transfer. Journal of Controlled Release (2003) 90, 81-
95. 
 [30]  Y. H. Yun, D. J. Goetz, P. Yellen, W. Chen, Hyaluronan microspheres for sustained gene 
delivery and site-specific targeting. Biomaterials (2004) 25, 147-157. 
 [31]  R. E. Samuel, C. R. Lee, S. C. Ghivizzani, C. H. Evans, I. V. Yannas, B. R. Olsen, M. 
Spector, Delivery of Plasmid DNA to Articular Chondrocytes via Novel Collagen-
Glycosaminoglycan Matrices. Human Gene Therapy (2002) 13, 791-802. 
 [32]  Y. Tabata, Y. Ikada, Protein release from gelatin matrices. Advanced Drug Delivery 
Reviews (1998) 31, 287-301. 
 [33]  T. C. Laurent, J. Fraser, Hyaluronan. FASEB Journal (1992) 6, 2397-2404. 
 [34]  K. W. Leong, H.-Q. Mao, V. L. Truong-Le, K. Roy, S. M. Walsh, J. T. August, DNA-
polycation nanospheres as non-viral gene delivery vehicles. Journal of Controlled 
Release (1998) 53, 183-193. 
 [35]  W. Friess, Collagen - biomaterial for drug delivery. European Journal of Pharmaceutics 
and Biopharmaceutics (1998) 45, 113-136. 
 [36]  X. Guo, F. C. Szoka, Chemical Approaches to Triggerable Lipid Vesicles for Drug and 
Gene Delivery. Accounts of Chemical Research (2003) 36, 335-341. 
 [37]  M. Voinea, M. Simionescu, Designing of “intelligent” liposomes for efficient delivery of 
drugs. Journal of Cellular and Molecular Medicine (2002) 6, 465-474. 
 [38]  D. D. Lasic, N. S. Templeton, Liposomes in gene therapy. Advanced Drug Delivery 
Reviews (1996) 20, 221-266. 
 [39]  L. P. Brewster, E. M. Brey, H. P. Greisler, Cardiovascular gene delivery: The good road 
is awaiting. Advanced Drug Delivery Reviews (2006) 58, 604-629. 
 [40]  M. D. Kofron, C. T. Laurencin, Bone tissue engineering by gene delivery. Advanced Drug 
Delivery Reviews (2006) 58, 555-576. 
 [41]  B. Nussenbaum, P. H. Krebsbach, The role of gene therapy for craniofacial and dental 
tissue engineering. Advanced Drug Delivery Reviews (2006) 58, 577-591. 
 [42]  A. Saraf, A. G. Mikos, Gene delivery strategies for cartilage tissue engineering. 
Advanced Drug Delivery Reviews (2006) 58, 592-603. 
 [43]  J. Bonadio, Tissue engineering via local gene delivery: Update and future prospects for 
enhancing the technology. Advanced Drug Delivery Reviews (2000) 44, 185-194. 
Chapter 1                                           Delivery of nucleic acids via disulfide-based carrier systems 
 
64 
 
 [44]  J. Bonadio, Tissue engineering via local gene delivery. Journal of Molecular Medicine 
(2000) 78, 303-311. 
 [45]  K. R. Cutroneo, Gene Therapy for Tissue Regeneration. Journal of Cellular Biochemistry 
(2003) 88, 418-425. 
 [46]  L. A. Chandler, D. L. Gu, A. M. Ma, J. Gonzalez, T. Doukas, T. Nguyen, G. F. Pierce, M. 
L. Phililips, Matrix-enabled gene transfer for cutaneous wound repair. Wound 
Repair and Regeneration (2000) 8, 473-479. 
 [47]  J.-H. Jang, T. L. Houchin, L. D. Shea, Gene delivery from polymer scaffolds for tissue 
engineering. Expert Reviews Medical Devices (2004) 1, 127-138. 
 [48]  L. D. Shea, E. Smiley, J. Bonadio, D. J. Mooney, DNA delivery from polymer matrices for 
tissue engineering. Nature Biotechnology (1999) 17, 551-554. 
 [49]  N. Giannoukakis, A. W. Thomson, P. D. Robbins, Gene therapy in transplantation. Gene 
Therapy (1999) 6, 1499-1511. 
 [50]  J. Bonadio, E. Smiley, P. Patil, S. Goldstein, Localized, direct plasmid gene delivery in 
vivo: prolonged therapy results in reproducible tissue regeneration. Nature 
Medicine (1999) 5, 753-759. 
 [51]  M. Egermann, E. Schneider, C. H. Evans, A. W. Baltzer, The potential of gene therapy 
for fracture healing in osteoporosis. Osteoporosis International  (2005) 16, S120-
S128. 
 [52]  J. Fang, Y. Y. Zhu, E. Smiley, J. Bonadio, J. P. Rouleau, S. A. Goldstein, L. K. 
McCauley, B. Davidson, B. J. Roessler, Stimulation of new bone formation by 
direct transfer of osteogenic plasmid genes. Proceedings of the National 
Academy of Sciences of the United States of America (1996) 93, 5753-5758. 
 [53]  J. Bonadio, S. A. Goldstein, R. J. Levy, Gene therapy for tissue repair and regeneration. 
Advanced Drug Delivery Reviews (1998) 33, 53-69. 
 [54]  H. Petite, V. Viateau, W. Bensaid, A. Meunier, C. de Pollak, M. Bourguignon, K. Oudina, 
L. Sedel, G. Guillemin, Tissue-engineered bone regeneration. Nature 
Biotechnology (2000) 18, 959-963. 
 [55]  L. V. Christensen, C. W. Chang, J. W. Yockman, R. Conners, H. Jackson, Z. Zhong, J. 
Feijen, D. A. Bull, S. W. Kim, Reducible poly(amido ethylenediamine) for hypoxia-
inducible VEGF delivery. Journal of Controlled Release (2007) 118, 254-263. 
 [56]  D. Trentin, H. Hall, S. Wechsler, J. A. Hubbell, Peptide-Matrix-mediated gene transfer of 
an oxygen-insensitive hypoxia-inducible factor-1α variant for local induction of 
angiogenesis. Proceedings of the National Academy of Sciences of the United 
States of America (2006) 103, 2506-2511. 
 [57]  A. Napoli, M. Valentini, N. Tirelli, M. Muller, J. A. Hubbell, Oxidation-responsive polymeric 
vesicles. Nature Materials (2004) 3, 183-189. 
Chapter 1                                           Delivery of nucleic acids via disulfide-based carrier systems 
 
65 
 
 [58]  T. Segura, J. A. Hubbell, Synthesis and in Vitro Characterization of an ABC Triblock 
Copolymer for siRNA Delivery. Bioconjugate Chemistry (2007) 18, 736-745. 
 [59]  M. C. Garnett, Targeted drug conjugates: principles and progress. Advanced Drug 
Delivery Reviews (2001) 53, 171-216. 
 [60]  S. Ganta, H. Devalapally, A. Shahiwala, M. Amiji, A review of stimuli-responsive 
nanocarriers for drug and gene delivery. Journal of Controlled Release  (2008) 
126, 187-204. 
 [61]  M. Ou, X. L. Wang, R. Xu, C. W. Chang, D. A. Bull, S. W. Kim, Biodegradable 
Poly(disulfide amine)s for Gene Delivery with High Efficiency and Low 
Cytotoxicity. Bioconjugate Chemistry  (2008) 19, 626-633. 
 [62]  M. Morille, C. Passirani, A. Vonarbourg, A. Clavreul, J. P. Benoit, Progress in developing 
cationic vectors for non-viral systemic gene therapy against cancer. Biomaterials 
(2008) 29, 3477-3496. 
 [63]  D. Lechardeur, A. S. Verkman, G. L. Lukacs, Intracellular routing of plasmid DNA during 
non-viral gene transfer. Advanced Drug Delivery Reviews (2005) 57, 755-767. 
 [64]  R. Bausinger, K. von Gersdorff, K. Braeckmans, M. Ogris, E. Wagner, C. Bräuchle, A. 
Zumbusch, The Transport of Nanosized Gene Carriers Unraveled by Live-Cell 
Imaging. Angewandte Chemie International Edition English (2006) 45, 1568-
1572. 
 [65]  C. S. Pillay, E. Elliott, C. Dennison, Endolysosomal proteolysis and its regulation. 
Biochemistry Journal (2002) 363, 417-429. 
 [66]  T. Tagami, J. M. Barichello, H. Kikuchi, T. Ishida, H. Kiwada, The gene-silencing effect of 
siRNA in cationic lipoplexes is enhanced by incorporating pDNA in the complex. 
International Journal of Pharmaceutics (2007) 333, 62-69. 
 [67]  A. W. Wong, S. J. Scales, D. E. Reilly, DNA Internalized via Caveolae Requires 
Microtubule-dependent, Rab7-independent Transport to the Late Endocytic 
Pathway for Delivery to the Nucleus. Journal of  Biological Chemistry (2007) 282, 
22953-22963. 
 [68]  A. Akinc, R. Langer, Measuring the pH environment of DNA delivered using nonviral 
vectors: Implications for lysosomal trafficking. Biotechnology and Bioengineering 
(2002) 78, 503-508. 
 [69]  W. C. Shen, H. J. Ryser, L. LaManna, Disulfide spacer between methotrexate and 
poly(D-lysine). A probe for exploring the reductive process in endocytosis. Journal 
of Biological Chemistry (1985) 260, 10905-10908. 
 [70]  G. Saito, J. A. Swanson, K. D. Lee, Drug delivery strategy utilizing conjugation via 
reversible disulfide linkages: role and site of cellular reducing activities. Advanced 
Drug Delivery Reviews (2003) 55, 199-215. 
 [71]  S. Takae, K. Miyata, M. Oba, T. Ishii, N. Nishiyama, K. Itaka, Y. Yamasaki, H. Koyama, 
K. Kataoka, PEG-Detachable Polyplex Micelles Based on Disulfide-Linked Block 
Chapter 1                                           Delivery of nucleic acids via disulfide-based carrier systems 
 
66 
 
Catiomers as Bioresponsive Nonviral Gene Vectors. Journal of the American 
Chemical Society (2008) 130, 6001-6009. 
 [72]  C. D. Austin, X. Wen, L. Gazzard, C. Nelson, R. H. Scheller, S. J. Scales, Oxidizing 
potential of endosomes and lysosomes limits intracellular cleavage of disulfide-
based antibody-drug conjugates. Proceedings of the National Academy of 
Sciences of the United States of America (2005) 102, 17987-17992. 
 [73]  E. P. Feener, W. C. Shen, H. J. Ryser, Cleavage of disulfide bonds in endocytosed 
macromolecules. A processing not associated with lysosomes or endosomes. 
Journal of Biological Chemistry (1990) 265, 18780-18785. 
 [74]  F. Q. Schafer, G. R. Buettner, Redox environment of the cell as viewed through the 
redox state of the glutathione disulfide/glutathione couple. Free Radical Biology 
and Medicine (2001) 30, 1191-1212. 
 [75]  J. Yang, H. Chen, I. R. Vlahov, J. X. Cheng, P. S. Low, Evaluation of disulfide reduction 
during receptor-mediated endocytosis by using FRET imaging. Proceedings of 
the National Academy of Sciences of the United States of America (2006) 103, 
13872-13877. 
 [76]  D. S. Manickam, D. Oupicky, Polyplex gene delivery modulated by redox potential 
gradients. Journal of Drug Targeting (2006) 14, 519-526. 
 [77]  H. R. López-Mirabal, J. R. Winther, Redox characteristics of the eukaryotic cytosol. 
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2008) 1783, 
629-640. 
 [78]  D. S. Manickam, A. Hirata, D. A. Putt, L. H. Lash, F. Hirata, D. Oupicky, Overexpression 
of Bcl-2 as a proxy redox stimulus to enhance activity of non-viral redox-
responsive delivery vectors. Biomaterials (2008) 29, 2680-2688. 
 [79]  J. Sastre, F. V. Pallardo, J. Viña, Glutathione, in Reactions, Processes, Springer, 
Berlin/Heidelberg (2005) 91-108. 
 [80]  E. Fenouillet, R. Barbouche, I. M. Jones, Cell Entry by Enveloped Viruses: Redox 
Considerations for HIV and SARS-Coronavirus. Antioxidants & Redox Signaling 
(2007) 9, 1009-1034. 
 [81]  G. Saito, G. L. Amidon, K. D. Lee, Enhanced cytosolic delivery of plasmid DNA by a 
sulfhydryl-activatable listeriolysin O/protamine conjugate utilizing cellular reducing 
potential. Gene Therapy (2003) 10, 72-83. 
 [82]  D. S. Collins, E. R. Unanue, C. V. Harding, Reduction of disulfide bonds within 
lysosomes is a key step in antigen processing. Journal of Immunology (1991) 
147, 4054-4059. 
 [83]  U. T. Phan, B. Arunachalam, P. Cresswell, Gamma-Interferon-inducible Lysosomal Thiol 
Reductase (GILT). MATURATION, ACTIVITY, AND MECHANISM OF ACTION, 
Journal of Biological Chemistry (2000) 275, 25907-25914. 
Chapter 1                                           Delivery of nucleic acids via disulfide-based carrier systems 
 
67 
 
 [84]  D. Gainey, S. Short, K. L. McCoy, Intracellular location of cysteine transport activity 
correlates with productive processing of antigen disulfide. Journal of Cellular 
Physiology (1996) 168, 248-254. 
 [85]  B. Arunachalam, U. T. Phan, H. J. Geuze, P. Cresswell, Enzymatic reduction of disulfide 
bonds in lysosomes: Characterization of a Gamma-interferon-inducible lysosomal 
thiol reductase (GILT). Proceedings of the National Academy of Sciences of the 
United States of America (2000) 97, 745-750. 
 [86]  J. Yang, H. Chen, I. R. Vlahov, J. X. Cheng, P. S. Low, Characterization of the pH of 
Folate Receptor-Containing Endosomes and the Rate of Hydrolysis of 
Internalized Acid-Labile Folate-Drug Conjugates. Journal of Pharmacoogy and. 
Experimental Therapeutics (2007) 321, 462-468. 
 [87]  S. K. Lai, K. Hida, S. T. Man, C. Chen, C. Machamer, T. A. Schroer, J. Hanes, Privileged 
delivery of polymer nanoparticles to the perinuclear region of live cells via a non-
clathrin, non-degradative pathway. Biomaterials (2007) 28, 2876-2884. 
 [88]  J. P. Tam, C.-R. Wu, W. liu, J.-W. Zhang, Disulfide Bond Formation in Peptides by 
Dimethyl sulfoxide. Scope and Applications. Journal of the American Chemical 
Society (1991) 113, 6657-6662. 
 [89]  D. Oupicky, A. L. Parker, L. W. Seymour, Laterally Stabilized Complexes of DNA with 
Linear Reducible Polycations: Strategy for Triggered Intracellular Activation of 
DNA Delivery Vectors. Journal of the American Chemical Society (2002) 124, 8-9. 
 [90]  Y. Lee, H. Koo, G. Jin, H. Mo, M. Y. Cho, J. Y. Park, J. S. Choi, J. S. Park, Poly(ethylene 
oxide sulphide): New Poly(ethylene glycol) Derivatives Degradable in Reductive 
Conditions. Biomacromolecules (2005) 6, 24-26. 
 [91]  K. H. Sun, Y. S. Sohn, B. Jeong, Thermogelling poly(ethylene oxide-b-propylene oxide-b-
ethylene oxide) Disulfide Multiblock Copolymer as a Thiol-Sensitive Degradable 
Polymer. Biomacromolecules (2006) 7, 2871-2877. 
 [92]  A. Napoli, N. Tirelli, G. Kilcher, A. Hubbell, New Synthetic Methodologies for Amphiphilic 
Multiblock Copolymers of Ethylene Glycol and Propylene Sulfide. 
Macromolecules (2001) 34, 8913-8917. 
 [93]  C. Woghiren, B. Sharma, S. Stein, Protected Thiol-Polyethylene Glycol: A New Activated 
Polymer for Reversible Protein modifications, Bioconjugate Chemistry (1993) 4, 
314-318. 
 [94]  V. Ghetie, E. Vitetta, Chemical Construction of Immunotoxins. Molecular Biotechnology, 
(2001) 18, 251-268. 
 [95]  G. T. Hermanson, Bioconjugate Techniques, Academic Press, San Diego (2005). 
 [96]  T. P. King, Y. Li, L. Kochoumian, Preparation of Protein Conjugates via Intramolecular 
Disulfide Bond Formation. Biochemistry (1978) 17, 1499-1506. 
Chapter 1                                           Delivery of nucleic acids via disulfide-based carrier systems 
 
68 
 
 [97]  T. Masuko, A. Minami, N. Iwasaki, T. Majima, S.-I. Nishimura, Lee Y.C, Thiolation of 
Chitosan: Attachment of Proteins via Thioether Formation. Biomacromolecules 
(2005) 6, 880-884. 
 [98]  R. R. Traut, A. Bollen, T.-T. Sun, J. W. B. Hershey, J. Sundberg, L. R. Pierce, Methyl 4-
Mercaptobutyrimidate as a Cleavable Cross-Linking Reagent and its Application 
to the Escherichia coli 30S Ribosome. Biochemistry (1973) 12, 3266-3273. 
 [99]  D. A. Goff, S. F. Carroll, Substituted 2-Iminothiolanes: Reagents for the Preparation of 
Disulfide Cross-Linked Conjugates with Increased Stability. Bioconjugate 
Chemistry (1990) 1, 381-386. 
 [100]  S. F. Carroll, S. L. Bernhard, D. A. Goff, R. J. Bauer, W. Leach, A. H. C. Kung, Enhanced 
Stability in Vitro and in Vivo of Immunoconjugates Prepared with 5-Methyl-2-
iminothiolane. Bioconjugate Chemistry (1994) 5, 248-258. 
 [101]  R. Benesch, R. E. Benesch, Formation of Peptide Bonds by Aminolysis of Homocysteine 
Thiolactones. Proceedings of the National Academy of Sciences of the United 
States of America (1958) 44, 848-853. 
 [102]  R. Benesch, R. E. Benesch, Thiolation of Proteins. Journal of the American Chemical 
Society (1956) 78, 1597-853. 
 [103]  Q. Peng, Z. Zhong, R. Zhuo, Disulfide Cross-Linked Polyethylenimines (PEI) Prepared 
via Thiolation of Low Molecular Weight PEI as Highly Efficient Gene Vectors. 
Bioconjugate Chemistry (2008) 19, 499-506. 
 [104]  I. M. Klotz, R. E. Heiney, Introduction of Sulfhydryl Groups into Proteins Using 
Acetylmercaptosuccinic Anhydride. Archives of  Biochemistry and Biophysics 
(1962) 96, 605-612. 
 [105]  R. J. Duncan, P. D. Weston, R. Wrigglesworth, A New reagent Which May Be Used to 
Introduce Sulfhydryl Groups into Proteins, and Its Use in the Preparation of 
Conjugates for Immunoassay. Anaytical. Biochemistry (1983) 132, 68-73. 
 [106]  L. L. Chen, J. J. Rosa, S. Turner, R. B. Pepinsky, Production of Multimeric Forms of CD4 
Through a Sugar-based Cross-linking Strategy. Journal of Bioogical Chemistry  
(1991) 266, 18237-18243. 
 [107]  S. Y. Huang, S. Pooyan, J. Wang, I. Choudhury, M. J. Leibowitz, S. Stein, Polyethylene 
Glycol Copolymer for Carrying and Releasing Multiple Copies of Cysteine-
Containing Peptides. Bioconjugate Chemistry (1998) 9, 612-617. 
 [108]  W. K. Miskimins, N. Shimizu, Synthesis of a cytotoxic insulin cross-linked to diphtheria 
toxin fragment A capable of recognizing insulin receptors. Biochemical and  
Biophysical Research Commununications (1979) 91, 143-151. 
 [109]  N. Shimizu, W. K. Miskimins, Y. Shimizu, A cytotoxic epidermal growth factor cross-
linked to diphtheria toxin-A fragment. FEBS Letters (1980) 118, 274-278. 
 [110]  D. G. Gilliland, R. J. Collier, J. M. Moehring, T. J. Moehring, Chimeric toxins: Toxic, 
disulfide-linked conjugate of concanavalin A with fragment A from diphtheria 
Chapter 1                                           Delivery of nucleic acids via disulfide-based carrier systems 
 
69 
 
toxin. Proceedings of the National Academy of Sciences of the United States of 
America (1978) 75, 5319-5323. 
 [111]  A. J. Lomant, G. Fairbanks, Chemical Probes of Extended Biological Structures: 
Synthesis and Properties of the Cleavable Preotein Cross-linking Reagent [35S] 
Dithiobis(succinimidyl propionate). Journal of Molecular Biology (1976) 104, 234-
261. 
 [112]  K. Wang, F. M. Richards, An Approach to Nearest Neighbor Analysis of Membrane 
Proteins, Journal of Biological Chemistry (1974) 249, 8005-8018. 
 [113]  L. V. Christensen, C. W. Chang, W. J. Kim, S. W. Kim, Z. Zhong, C. Lin, J. F. J. 
Engbersen, J. Feijen, Reducibel Poly(amido amine)s Designed for Triggered 
Intracellular Gene Delivery. Bioconjugate Chemistry (2006) 17, 1233-1240. 
 [114]  J. Hoon Jeong, L. V. Christensen, J. W. Yockman, Z. Zhong, J. F. J. Engbersen, W. Jong 
Kim, J. Feijen, S. Wan Kim, Reducible Poly(amido amine) directed to enhance 
RNA interference. Biomaterials (2007) 28, 1912-1917. 
 [115]  G. Mattson, E. Conklin, S. Desai, G. Nielander, M. D. Savage, S. Morgensen, A practical 
approach to crosslinking. Molecular Biology Reports (1993) 17, 167-183. 
 [116]  J. Carlsson, H. Drevin, R. Axen, Protein Thiolation and Reversible Protein-Protein 
Conjugation N-Succinimidyl 3-(2-Pyridyldithio)propionate, a new 
heterobifunctional reagent. Biochemical Journal (1978) 173, 723-737. 
 [117]  P. E. Thorpe, A. N. F. Brown, W. C. J. Ross, A. J. Cumber, S. I. Detre, D. C. Edwards, A. 
J. S. Davies, F. Stirpe, Cytotoxicity Acquired by Conjugation of an Anti-Thy1.1 
monoclonal Antibody and the Ribosome-Inactivating Protein, Gelonin. European 
Journal of Biochemistry (1981) 116, 447-454. 
 [118]  P. E. Thorpe, P. M. Wallace, P. P. Knowles, M. G. Relf, A. N. F. Brown, G. J. Watson, R. 
E. Knyba, E. J. Wawrzynczak, D. C. Blakey, New Coupling Agents for the 
Synthesis of immunotxins Containing a Hindered Disulfide Bond with Improved 
Stability in Vivo. Cancer Research (1987) 47, 5924-5931. 
 [119]  S. Arpicco, F. Dosio, P. Brusa, P. Crosasso, L. Cattel, New Coupling Reagents for the 
Preparation of Disulfide Cross-Linked Conjugates with Increased Stability. 
Bioconjugate Chemistry (1997) 8, 327-337. 
 [120]  L. Delprino, M. Giacomotti, F. Dosio, P. Brusa, M. Ceruti, G. Grosa, L. Cattel, Toxin-
Targeted Design for Anticancer Therapy. I: Synthesis and Biological Evaluation of 
New Thioimidate Heterobifunctional Reagebts. Journal of  Pharmaceutical 
Sciebces (1993) 82, 506-512. 
 [121]  L. Greenfield, W. Bloch, M. Moreland, Thiol-Containing Cross-Linking Agent with 
Enhanced Steric Hindrance. Bioconjugate Chemistry (1990) 1, 400-410. 
 [122]  J. J. Zara, R. D. Wood, P. Boon, C. H. Kim, N. Pomato, R. Bredehorst, C. W. Vogel, A 
Carbohydrate-Directed Heterobifunctional Cross-Linking Reagent for te Synthesis 
of Immunoconjugates. Analytical Biochemistry (1991) 194, 156-162. 
Chapter 1                                           Delivery of nucleic acids via disulfide-based carrier systems 
 
70 
 
 [123]  A.-G. Gao, W. A. Frazier, Identification of a Receptor Candidate fort he Carboxyl-terminal 
Cell Binding Domain of Thrombospondins. Journal of Biological Chemistry (1994) 
269, 29650-29657. 
 [124]  D. Dey, D. E. Bochkariov, G. G. Jokhadze, R. R. Traut, Cross-linking of Selected 
Residues in the N- and C-terminal Domains of Escherichia coli Protein L7/L12 to 
Other Ribosomal Proteins and the Effect of Elongation Factor Tu. Journal of 
Biological Chemistry (1998) 273, 1670-1676. 
 [125]  G. Cavallaro, M. Campisi, M. Licciardi, M. Ogris, G. Giammona, Reversibly stable 
thiopolyplexes for intracellular delivery of genes. Journal of Controlled Release 
(2006) 115, 322-334. 
 [126]  M. Neu, J. Sitterberg, U. Bakowsky, T. Kissel, Stabilized Nanocarriers for Plasmids 
Based Upon Cross-Linked Poly(ethylene imine). Biomacromolecules (2006) 7, 
3428-3438. 
 [127]  C. P. Chen, J. Kim, E. Steenblock, D. Liu, K. G. Rice, Gene Transfer with Poly-Melittin 
Peptides. Bioconjugate Chemistry (2006) 17, 1057-1062. 
 [128]  T. Schmitz, I. Bravo-Osuna, C. Vauthier, G. Ponchel, B. Loretz, A. Bernkop-Schnürch, 
Development and in vitro evaluation of a thiomer-based nanoparticulate gene 
delivery system. Biomaterials (2007) 28, 524-531. 
 [129]  R. C. Adami, K. G. Rice, Metabolic Stability of Glutaraldehyde Cross-Linked Peptide 
DNA Condensates. Journal of Pharmaceutical Sciences (1999) 88, 739-746. 
 [130]  C. Chittimalla, L. Zammut-Italiano, G. Zuber, J. P. Behr, Monomolecular DNA 
Nanoparticles for Intravenous Delivery of Genes. Journal of the American 
Chemical Society (2005) 127, 11436-11441. 
 [131]  T. Blessing, J. S. Remy, J. P. Behr, Monomolecular collapse of plasmid DNA into stable 
virus-like Particles. Proceedings of the National Academy of Sciences of the 
United States of America (1998) 95, 1427-1431. 
 [132]  V. S. Trubetskoy, V. G. Budker, L. J. Hanson, P. M. Slattum, J. A. Wolff, J. E. Hagstrom, 
Self-assembly of DNA-polymer complexes using template polymerization. Nucleic 
Acids Research (1998) 26, 4178-4185. 
 [133]  V. S. Trubetskoy, A. Loomis, P. M. Slattum, J. E. Hagstrom, V. G. Budker, J. A. Wolff. 
Caged DNA does not aggregate under high ionic strength solutions, Bioconjugate 
Chemistry (1999) 10, 624-628. 
 [134]  F. Tang, J. A. Hughes, Introduction of a Disulfide Bond into a Cationic Lipid Enhances 
Transgene Expression of Plasmid DNA. Biochemical and Biophysical Research 
Communications (1998) 242, 141-145. 
 [135]  P. S. Ajmani, F. Tang, S. Krishnaswami, E. M. Meyer, C. Sumners, J. A. Hughes, 
Enhanced transgene expression in rat brain cell cultures with a disulfide-
containing cationic lipid. Neuroscience Letters (1999) 277, 141-144. 
Chapter 1                                           Delivery of nucleic acids via disulfide-based carrier systems 
 
71 
 
 [136]  F. Tang, J. A. Hughes, Use of Dithioglycolic Acid as a Tether for Cationic Lipids 
Decreases the Cytotoxiciy and Increases Transgene Expression of Plasmid DNA 
in Vitro. Bioconjugate Chemistry (1999) 10, 791-796. 
 [137]  D. Lee, W. Zhang, S. Shirley, X. Kong, G. Hellermann, R. Lockey, S. Mohapatra, 
Thiolated Chitosan/DNA Nanoparticles Exhibit Enhanced and Sustained Gene 
Delivery. Pharmaceutical Research (2007) 24, 157-167. 
 [138]  D. L. McKenzie, K. Y. Kwok, K. G. Rice, A potent New Class of Reductively Activated 
Peptide Gene Delivery Agents. Journal of  Biological Chemistry  (2000) 275, 
9970-9977. 
 [139]  K. Y. Kwok, Y. Park, Y. Yang, D. L. McKenzie, Y. Liu, K. G. Rice, In Vivo Gene Transfer 
Using Sulfhydryl Cross-Linked PEG/Glycopeptide DNA Co-Condensates. Journal 
of  Pharmaceutical Sciences (2003) 92, 1174-1185. 
 [140]  D. L. McKenzie, E. Smiley, K. Y. Kwok, K. G. Rice, Low Molecular Weight Cross Linking 
Peptides as Nonviral Gene Delivery Carriers. Bioconjugate Chemistry (2000) 11, 
901-909. 
 [141]  Y. Park, K. Y. Kwok, C. Boukarim, K. G. Rice, Synthesis of Sulfhydryl Cross-linking 
Poly(Ethylene Glycol)-Peptides and Glycopeptides as Carriers for Gene Delivery. 
Bioconjugate Chemistry (2002) 13, 232-239. 
 [142]  D. Trentin, J. Hubbell, H. Hall, Non-viral gene delivery for local and controlled DNA 
release. Journal of Controlled Release (2005) 102, 263-275. 
 [143]  S. J. Lee, Cytokine Delivery and Tissue Engineering. Yonsei Medical Journal (2000) 41, 
704-719. 
 [144]  C. Pichon, E. LeCam, B. Guerin, D. Coulaud, E. Delain, P. Midoux, Poly[Lys-(AEDTP)]: A 
Cationic Polymer That Allows Dissociation of pDNA/Cationic Polymer Complexes 
in a Reductive Medium and Enhances Polyfection. Bioconjugate Chemistry 
(2002) 13, 76-82. 
 [145]  D. Oupicky, R. C. Carlisle, L. W. Seymour, Triggered intracellular activation of disulfide 
crosslinked polyelectrolyte gene delivery complexes with extended systemic 
circulation in vivo. Gene Therapy (2001) 8, 713-724. 
 [146]  M. A. Gosselin, W. Guo, R. J. Lee, Incorporation of Reversibly Cross-Linked Polyplexes 
into LPDH Vectors for Gene Delivery. Bioconjugate Chemistry (2002) 13, 1044-
1053. 
 [147]  M. Neu, O. Germershaus, S. Mao, K. H. Voigt, M. Behe, T. Kissel, Crosslinked 
nanocarriers based upon poly (ethylene imine) for systemic plasmid delivery: In 
vitro characterization and in vivo studies in mice. Journal of Controlled Release 
(2007) 118, 370-380. 
 [148]  H. Lee, H. Mok, S. Lee, Y. K. Oh, T. G. Park, Target-specific intracellular delivery of 
siRNA using degradable hyaluronic acid nanogels. Journal of Controlled Release 
(2007) 119, 245-252. 
Chapter 1                                           Delivery of nucleic acids via disulfide-based carrier systems 
 
72 
 
 [149]  M. Greindl, A. Bernkop-Schnürch, Development of a Novel Method for the Preparation of 
Thiolated Polyacrylic Acid Nanoparticles. Pharmaceutical Research (2006) 23, 
2183-2189. 
 [150]  A. N. Zelikin, J. F. Quinn, F. Caruso, Disulfide Cross-Linked Polymer Capsules: En Route 
to Biodeconstructible Systems. Biomacromolecules (2006) 7, 27-30. 
 [151]  J. Chen, S.-W. Huang, W.-H. Lin, R.-X. Zhuo, Tunable Film Degradation and Sustained 
Release of Plasmid DNA from Cleavable Polycation/Plasmid DNA Multilayers 
under Reductive Conditions. Small (2007) 3, 636-643. 
 [152]  J. Blacklock, Y. Z. You, Q. H. Zhou, G. Mao, D. Oupicky, Gene delivery in vitro and in 
vivo from bioreducible multi-layered polyelectrolyte films of plasmid DNA. 
Biomaterials (2009) 30, 939-950. 
 [153]  M. Ogris, S. Brunner, S. Schuller, R. Kircheis, E. Wagner, PEGylated DNA/transferrin-
PEI complexes: reduced interaction with blood components, extended circulation 
in blood and potential for systemic gene delivery. Gene Therapy (1999) 6, 595-
605. 
 [154]  D. Oupicky, K. A. Howard, C. Konak, P. R. Dash, K. Ulbrich, L. W. Seymour, Steric 
Stabilization of poly-L-Lysine/DNA Complexes by the Covalent Attachment of 
Semitelechelic poly[N-(2-Hydroxypropyl)methacrylamide]. Bioconjugate 
Chemistry (2000) 11, 492-501. 
 [155]  M. Lee, S. W. Kim, Polyethylene Glycol-Conjugated Copolymers for Plasmid DNA 
Delivery. Pharmaceutical Research (2005) 22, 1-10. 
 [156]  Y. Kakizawa, A. Harada, K. Kataoka, Glutathione-Sensitive Stabilization of Block 
Copolymer Micelles Composed of Antisense DNA and Thiolated Poly(ethylene 
glycol)-block-poly(L-Lysine): A Potential Carrier for Systemic Delivery of 
Antisense DNA. Biomacromolecules (2001) 2, 491-497.  
 [157]  H. Mok, T. G. Park, PEG-Assisted DNA Solubilization in Organic Solvents for Preparing 
Cytosol Specifically Degradable PEG/DNA Nanogels. Bioconjugate Chemistry 
(2006) 17, 1369-1372. 
 [158]  T. Ishida, M. J. Kirchmeier, E. H. Moase, S. Zalipsky, T. M. Allen, Targeted delivery and 
triggered release of liposomal doxorubicin enhances cytotoxicity against human B 
lymphoma cells. Biochimica et Biophysica  Acta (2001) 1515, 144-158. 
 [159]  D. Kirpotin, K. Hong, N. Mullah, D. Papahadjopoulos, S. Zalipsky, Liposome with 
detachable polymer coating: destabilization and fusion of 
dioleoylphosphatidylethanolamine vesicles triggered by cleavage of surface-
grafted poly(ethylene glycol). FEBS Letters (1996) 388, 115-118. 
 [160]  M. Neu, O. Germershaus, M. Behe, T. Kissel, Bioreversibly crosslinked of PEI and high 
molecular weight PEG show extended circulation times in vivo. Journal of 
Controlled Release (2007) 124, 69-80. 
Chapter 1                                           Delivery of nucleic acids via disulfide-based carrier systems 
 
73 
 
 [161]  R. C. Carlisle, T. Etrych, S. S. Briggs, J. A. Preece, K. Ulbrich, L. W. Seymour, Polymer-
coated polyethylenimine/DNA complexes designed for triggered activation by 
intracellular reduction. Journal of Gene Medicine (2004) 6, 33-344. 
 [162]  K. Miyata, Y. Kakizawa, N. Nishiyama, A. Harada, Y. Yamasaki, H. Koyama, K. Kataoka, 
Block Catiomer polyplexes with Regulated Densities of Charge and Disulfide 
Cross-Linking Directed To Enhance Gene Expression. Journal of the American 
Chemical Society (2004) 126, 2355-2361. 
 [163]  J. Kloeckner, E. Wagner, M. Ogris, Degradable gene carriers based on oligomerized 
polyamines, European Journal of Pharmaceutical Sciences (2006) 29, 414-425. 
 [164]  Y. Kakizawa, A. Harada, K. Kataoka, Environment-Sensitive Stabilization of Core-Shell 
Structured Polyion Complex Micelle by Reversible Cross-Linking of the Core 
through Disulfide Bond. Journal of the American Chemical Society (1999) 121, 
11247-11248. 
 [165]  K. Miyata, Y. Kakizawa, N. Nishiyama, Y. Yamasaki, T. Watanabe, M. Kohara, K. 
Kataoka, Freeze-dried formulations for in vivo gene delivery of PEGylated 
polyplex micelles with disulfide crosslinked cores to the liver. Journal of 
Controlled Release (2005) 109, 15-23. 
 [166]  A. G. Schatzlein, Non-viral vectors in cancer gene therapy: principles and progress, 
Journal of Biomedicine and Biotechnology (2003) 149-158. 
 [167]  V. Russ, E. Wagner, Cell and Tissue Targeting of Nucleic Acids for Cancer Gene 
Therapy. Pharmaceutical Research (2007) 24, 1047-1057. 
 [168]  A. Muratovska, M. R. Eccles, Conjugates for efficient delivery of short interfering RNA 
(siRNA) into mammalian cells, FEBS Letters (2004) 558, 63-68. 
 [169]  S. B. Rajur, C. M. Roth, J. R. Morgan, M. L. Yarmush, Covalent Protein-Oligonucleotide 
Conjugates for Efficient Delivery of Antisense Molecules, Bioconjugate Chemistry 
(1997) 8, 935-940. 
 [170]  E. Bonfils, C. Depierreux, P. Midoux, N. T. Thuong, M. Monsigny, A. C. Roche, Drug 
targeting: synthesis and endocytosis of oligonucleotide-neoglycoprotein 
conjugates, Nucleic Acids Research (1992) 20, 4621-4629. 
 [171]  E. Wagner, Application of membrane-active peptides for nonviral gene delivery, 
Advanced Drug Delivery Reviews (1999) 38, 279-289. 
 [172]  J.-P. Behr, The Proton Sponge: a Trick to enter Cells the Viruses did not exploit. Chimia 
(1997) 51, 34-38. 
 [173]  M. Ogris, R. C. Carlisle, T. Bettinger, L. W. Seymour, Melittin Enables Efficient Vesicular 
Escape and Enhanced Nuclear Access of Nonviral Gene Delivery Vectors. 
Journal of Biological Chemistry (2001) 276, 47550-47556. 
 [174]  M. Meyer, A. Philipp, R. Oskuee, C. Schmidt, E. Wagner, Breathing Life into Polycations: 
Functionalization with pH-Responsive Endosomolytic Peptides and Polyethylene 
Chapter 1                                           Delivery of nucleic acids via disulfide-based carrier systems 
 
74 
 
Glycol Enables siRNA Delivery. Journal of the American Chemical Society (2008) 
130, 3272-3273. 
 [175]  M. Meyer, A. Zintchenko, M. Ogris, E. Wagner, A dimethylmaleic acid-melittin-polylysine 
conjugate with reduced toxicity, pH-triggered endosomolytic activity and 
enhanced gene transfer potential. Journal of Gene Medicine (2007) 797-805. 
 [176]  M. Oishi, T. Hayama, Y. Akiyama, S. Takae, A. Harada, Y. Yamasaki, F. Nagatsugi, S. 
Sasaki, Y. Nagasaki, K. Kataoka, Supramolecular Assemblies for the 
Cytoplasmatic Delivery of Antisense Oligodeoxynucleotides: Polyion Complex 
(PIC) Micelles Based on Poly(ethylene glycol)-SS-Oligodeoxynucleotide 
Conjugate. Biomacromolecules (2005) 6, 2449-2454. 
 [177]  M. Breunig, U. Lungwitz, R. Liebl, A. Goepferich, Breaking up the correlation between 
efficacy and toxicity for nonviral gene delivery. Proceedings of the National 
Academy of Sciences of the United States of America (2007) 104, 14454-14459. 
 [178]  Y. Lee, H. Mo, H. Koo, J. Y. Park, M. Y. Cho, G. Jin, J. S. Park, Visualization of the 
Degradation of a Disulfide Polymer, Linear Poly(ethylenimine sulfide), for Gene 
Delivery. Bioconjugate Chemistry (2007) 18, 13-18. 
 [179]  M. A. Gosselin, W. Guo, R. J. Lee, Efficient Gene Transfer Using Reversibly Cross-
Linked Low Molecular Weight Polyethylenimine. Bioconjugate Chemistry (2001) 
12, 989-994. 
 [180]  C. Lin, C. J. Blaauboer, M. M. Timoneda, M. C. Lok, M. van Steenbergen, W. E. Hennink, 
Z. Zhong, J. Feijen, J. F. J. Engbersen, Bioreducible poly(amido amine)s with 
oligoamine side chains: Synthesis, characterization, and structural effects on 
gene delivery. Journal of Controlled Release (2008) 126, 166-174. 
 [181]  D. Soundara Manickam, H. S. Bisht, L. Wan, G. Mao, D. Oupicky, Influence of TAT 
peptide polymerization on properties and transfection activity of TAT/DNA 
polyplexes. Journal of Controlled Release, (2005) 102, 293-306. 
 [182]  S. L. Lo, S. Wang, An endosomolytic TAT peptide produced by incorporation of histidine 
and cysteine as a nonviral vector for DNA transfection. Biomaterials (2008) 29, 
2408-2414. 
 [183]  S. Huth, F. Hoffmann, K. von Gersdorff, A. Laner, D. Reinhardt, J. Rosenecker, C. 
Rudolph, Interaction of polyamine gene vectors with RNA leads to the 
dissociation of plasmid DNA-carrier complexes. Journal of Gene Medicine (2006) 
8, 1416-1424. 
 [184]  B. Lucas, K. Remaut, N. N. Sanders, K. Braeckmans, S. C. DeSmedt, J. Demeester, 
Studying the Intracellular Dissociation of Polymer-Oligonucleotide Complexes by 
Dual Color Fluorescence Fluctuation Spectroscopy and Confocal Imaging. 
Biochemistry (2005) 44, 9905-9912. 
 [185]  M. Bertschinger, G. Backliwal, A. Schertenleib, M. Jordan, D. L. Hacker, F. M. Wurm, 
Disassembly of polyethylenimine-DNA particles in vitro: Implications for 
polyethylenimine-mediated DNA delivery. Journal of Controlled Release (2006) 
116, 96-104. 
Chapter 1                                           Delivery of nucleic acids via disulfide-based carrier systems 
 
75 
 
 [186]  J. P. Clamme, J. Azoulay, Y. Mely, Monitoring of the Formation and Dissociation of 
Polyethylenimine/DNA Complexes by Two Photon Fluorescence Correlation 
Spectroscopy. Biophysical Journal (2003) 84, 1960-1968. 
 [187]  M. Breunig, C. Hozsa, U. Lungwitz, K. Watanabe, I. Umeda, H. Kato, A. Goepferich, 
Mechanistic investigation of poly(ethylene imine)-based siRNA delivery: Disulfide 
bonds boost intracellular release of the cargo. Journal of Controlled Release 
(2008) 130, 57-63. 
 [188]  C. Lin, Z. Zhong, M. C. Lok, X. Jiang, W. E. Hennink, J. Feijen, J. F. J. Engbersen, Novel 
Bioreducible Poly(amido amine)s for Highly efficient Gene Delivery. Bioconjugate 
Chemistry (2007) 18, 138-145. 
 [189]  T. Reschel, C. Konak, D. Oupicky, L. W. Seymour, K. Ulbrich, Physical properties and in 
vitro transfection efficiency of gene delivery vectors based on complexes of DNA 
with synthetic polycations. Journal of Controlled Release (2002) 81, 201-217. 
 [190]  X. L. Wang, R. Jensen, Z. R. Lu, A novel environment-sensitive biodegradable 
polydisulfide with protonatable pendants for nucleic acid delivery. Journal of 
Controlled Release (2007) 120, 250-258. 
 [191]  M. L. Read, S. Singh, Z. Ahmed, M. Stevenson, S. S. Briggs, D. Oupicky, L. B. Barrett, 
R. Spice, M. Kendall, M. Berry, J. A. Preece, A. Logan, L. W. Seymour, A 
versatile reducible polycation-based system for efficient delivery of a broad range 
of nucleic acids. Nucleic Acids Research (2005) 33, e86, 1-16. 
 [192]  G. Byk, B. Wetzer, M. Frederic, C. Dubertret, B. Pitard, G. Jaslin, D. Scherman, 
Reduction Sensitive Lipopolyamines as a Novel Nonviral Gene Delivery System 
for Modulated Release of DNA with Improved Transgene Expression. Journal of 
Medicinal Chemistry (2000) 43, 4377-4387. 
 [193]  V. P. Torchilin, Multifunctional nanocarriers. Advanced Drug Delivery Reviews (2006) 58, 
1532-1555. 
 [194]  S. Ganta, H. Devalapally, A. Shahiwala, M. Amiji, A review of stimuli-responsive 
nanocarriers for drug and gene delivery. Journal of Controlled Release (2008) 
126, 187-204. 
 [195]  W. Li, C. Nesselmann, Z. Zhou, L.-L. Ong, F. Öri, G. Tang, A. Kaminski, K. Lützow, A. 
Lendlein, A. Liebhold, C. Stamm, J. Wang, N. Ma, Gene delivery to the heart by 
magnetic nanobeads. Journal of Magnetism and Magnetic Materials (2007) 311, 
336-341. 
 [196]  C. Alexander, K. M. Shakesheff, Responsive Polymers at the Biology/Materials Science 
Interface, Advanced Materials (2006) 18, 3321-3328. 
 [197]  T. Maeda, K. Fujimoto, A reduction-triggered delivery by a liposomal carrier possessing 
membrane-permeable ligands and a detachable coating. Colloids and Surfaces 
B: Biointerfaces (2006) 49, 15-21. 
Chapter 1                                           Delivery of nucleic acids via disulfide-based carrier systems 
 
76 
 
 [198]  N. Murthy, J. Campbell, N. Fausto, A. S. Hoffman, P. S. Stayton, Bioinspired pH-
Responsive Polymers for the Introcellular Delivery of Biomolecular Drugs. 
Bioconjugate Chemistry, 2003, 14, 412-418. 
 [199]  N. Murthy, J. Campbell, N. Fausto, A. S. Hoffman, P. S. Stayton, Design and Synthesis 
of pH-responsive polymeric carriers that target uptake and enhance the 
intracellular delivery of oligonucleotides. Journal of Controlled Release, 2003, 89, 
365-374. 
 [200]  V. Bulmus, M. Woodward, L. Lin, N. Murthy, P. Stayton, A. Hoffman, A new pH-
responsive and glutathione-reactive, endosomal membrane-disruptive polymeric 
carrier for intracellular delivery of biomolecular drugs. Journal of Controlled 
Release (2003) 93, 105-120. 
 [201]  N. Raghunand, R. A. Gatenby, R. J. Gillies, Microenvironmental and cellular 
consequences of altered blood flow in tumours. British Journal of Radiology 
(2003) 76, 11-22. 
 [202]  V. Sethuraman, M. Lee, Y. Bae, A Biodegradable pH-sensitive Micelle System for 
Targeting Acidic Solid Tumors. Pharmaceutical Research (2008) 25, 657-666. 
 
 
 
 
 
 
 77 
 
Chapter 2 
 
Goals of the thesis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2  Goals of the thesis 
78 
 
The delivery of nucleic acids is a promising strategy for the modulation of gene expression inside 
cells. It offers both, the opportunity to insert therapeutic genes by the application of DNA and the 
chance to inhibit the expression of non-functional or harmful proteins by the use of therapeutic 
RNA. These two approaches each pave the way for the treatment of inherited or acquired 
diseases as well as the regeneration of defective tissue. But safe and efficient carrier systems 
for these therapies are still needed. While viral carriers are generally considered to be most 
efficient, they bear considerable risks such as infectiousness and insertional oncogenesis. Thus, 
scientists focused on the development of non-viral, polymeric carrier systems. The most 
prominent polymer among these systems is poly(ethylene imine) (PEI). It masters the most 
important steps in the delivery of nucleic acids: it condenses its payload into small particles, 
protects it from degradation and facilitates endosomal uptake. In the endosome it achieves 
endosomolysis and thereafter releases its cargo. Despite these advantages its broad use is 
hampered by the tendency of PEI particles to agglomerate and the strong correlation between 
transfection efficiency and toxicity. Thus, the first aim of the thesis was the development of new 
strictly linear PEI copolymers with lower toxicity and enhanced stability in the extracellular 
environment due to the attachment of a shielding moiety. In a second step copolymers 
responsive to a specific trigger -the change in redox potential upon cell entry- were developed 
and investigated.  
First of all the delivery of nucleic acids via disulfide based carrier systems is reviewed. 
Therefore, the biological rationale for the exploitation of the large intra-/extracellular redox 
gradient was explained. Thereafter examples for the generation of disulfides were given, 
followed by a section which dealt with examples for carrier systems bearing disulfides. Finally, 
examples for redox active systems in the field of tissue engineering were given (Chapter 1). 
Chapter 3 deals with the synthesis and modification of PEI. Compared to the standard synthesis 
for linear PEI, an attempt was taken to insert a thiol group at the chain end instead of the 
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common hydroxy group. This thiol group was introduced to selectively build a bridge between 
the chain end of PEI and the chain end of a second polymer resulting in strictly linear 
copolymers. For this modification different reaction conditions were tested. Furthermore, since 
the resulting thiol group is known to be unstable, different methods for its reactivation and 
storage were examined. Afterwards it was tested via an ethidium bromide exclusion assay 
whether the 13 obtained thiol-modified polymers with a molecular weight ranging from 1.5 kDa to 
10.8 kDa were able to form particles with pDNA. Moreover, the hydrodynamic diameters and 
zeta potentials were determined. 
After the synthesis of 13 different thiol-modified PEIs two attempts were taken towards the 
formation of strictly linear copolymers made from PEI and the shielding moiety poly(ethylene 
glycol) (PEG). The first copolymer series aimed at the formation of noncleavable thioether-
connected copolymers with different molecular weights of both PEI and PEG for an analysis of 
structure-activity-relationships later on. But first these copolymers were examined for their 
complexation ability for such different nucleic acids as pDNA and siRNA by an ethidium bromide 
exclusion assay and size measurement of the particles made from the polymers and nucleic 
acids (polyplexes). The second copolymer series was intended for the triggered degradation of 
the disulfide bond which connected PEI with PEG (PEI-SS-PEG). Therefore, a thioacetate-
modified PEG was synthesized, the conditions for its cleavage were examined and PEI-SS-PEG 
copolymers were synthesized (Chapter 4). 
Chapter 5 aims at the performance of structure-function-relationships for the library of thioether 
connected copolymers. It was hypothesized that this library would allow a systematic study of 
the influence of the PEG moiety on the physicochemical properties and the biological activity of 
the polyplexes formed with pDNA. Thus, sizes and zeta potentials were measured under 
different conditions in order to obtain information about the compactness of the polyplexes, the 
extent of the PEG shielding and the influence of different pH values. The size measurements 
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were further supported by electron micrographs. Furthermore, a quenching assay was 
introduced for the determination of the strength of interaction between the nucleic acids and the 
PEI homo- or copolymers. In order to study the effects of different copolymer compositions in 
cell culture transfection experiments were performed as well as uptake studies. The polyplex 
uptake was also observed with the confocal microscope. The results of all these experiments 
were used to draw structure-activity-relationships. 
Last, but not least, the series of thiol-connected copolymers was tested for its physicochemical 
and transfection characteristics. The cleavage of the disulfide bond connecting the PEI and the 
PEG chain is very important because the detachment of the PEG part is thought to be needed 
for the restoration of PEIs transfection efficiency which is generally reduced after the addition of 
a shielding moiety. Thus, the special focus of Chapter 6 lay on the reductive cleavage of the 
connecting disulfide bond which was examined in detail. Size and zeta potential measurements 
were performed under non-reductive and reductive conditions in order to work out the influence 
of the molecular weights of both, PEG and PEI, on the cleavability. In order to support these 
experiments cellular uptake and transfection studies were also performed. The second main 
point of this chapter was the determination of the influence of the PEG shielding on the mobility 
of the polyplexes in a model matrix. This was investigated with the help of FRAP (fluorescence 
recovery after photobleaching) experiments. Since this method needed special fluorescently 
labeled copolymers, a synthesis route for fluoresceine labeled copolymers was developed and 
FRAP experiments were performed with these copolymers. 
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Abstract 
Poly(ethylene imine) 25 kDa (PEI 25k) is the gold standard in nonviral gene delivery. This high 
molecular weight polymer efficiently transfects cells but it is also rather toxic. Generally, 
transfection efficiency and toxicity of PEI strongly correlate. Thus, it is not astounding that linear 
PEI with low molecular weight appeared to be a promising gene carrier which transfects cells 
and is rather nontoxic. Here we report on the synthesis of linear low molecular weight PEI with a 
thiol group at the chain end. This thiol group is intended for further modifications. We 
synthesized a library of 13 different PEIs with a molecular weight ranging from 1.5 to 10.8 kDa 
and introduced a sophisticated synthesis route leading to activated and at the same time 
storable PEI thiol derivatives. This multistep synthesis was investigated in detail. After 
successful synthesis the resulting carriers were tested for their ability to condense plasmid DNA 
into particles and to exclude ethidium bromide from the intercalation with the nucleic acid. Thus, 
the resulting polymers seem to be ideally suited for the attachment of further moieties such as a 
shielding polyethylene glycol chain for further improvement of the gene carrier. 
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Introduction 
The decoding of the human genome in 2001 was a milestone [1] and greatly improved the 
understanding of hereditary diseases. It seemed to be possible to replace defective genes and 
cure diseases which were untreatable by state-of-the-art medicine. Unfortunately, applying 
naked genes is impossible mostly because they are not effectively taken up by cells due to their 
large size, which exceeds the upper uptake limit by far. Moreover, they carry negative charges 
and are prone to degradation by nucleases. Thus, carrier systems are needed, which condense 
nucleic acids into small particles. In nature basic polyamines such as spermine or spermidine 
interact with the DNA within a cell [2,3] and pack this DNA into small particles arranged next to 
each other like pearls in a necklace. These aliphatic polyamines are important for gene 
expression, enzyme activity and cell proliferation as well as differentiation [4,5]. But most 
importantly, they protect DNA from external agents. Having this in mind researchers examined 
these natural polycations in detail [6-8], used them as guideline and looked for other basic 
polymers as DNA condensing agents. The most prominent representative of these polycations is 
poly(ethylene imine) (PEI) [9]. It exists in two different forms, branched and linear, and both of 
them contain a high number of basic amines. These amines account for typical properties such 
as high buffering capacity, the ability to escape from endosomes and high protonation level at 
physiologic pH [10,11]. Due to its high efficiency branched PEI 25 kDa (bPEI 25k) has become the 
gold standard in gene delivery efficiency, the so called transfection. Unfortunately, the polymer 
exhibits at the same time cytotoxicity which correlates especially with the molecular weight and 
the branching degree [12,13]. Thus, linear PEI (lPEI) appeared to be an alternative to bPEI. In in 
vitro and in in vivo experiments long chain lPEI (22 kDa and 25 kDa) outperformed bPEI 25k 
concerning its transfection [14,15]. But toxicity of high molecular weight PEI was still an issue. This 
inspired our group to investigate the performance of lPEIs with lower molecular weight. In a 
series of 12 different lPEIs with a molecular weight ranging from 1 to 10 kDa we could show that 
the toxicity and transfection efficiency correlated with the molecular weight of the polymer [16]. 
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This finding encouraged us to keep the approach of low molecular weight PEIs.  We synthesized 
a library of low molecular weight PEIs with a thiol group at the end of the polymer chain because 
we wanted to further improve these gene vectors by attaching additional moieties such as 
shielding components or targeting ligands either stably by thioethers or degradably via 
disulfides. For this purpose we synthesized and tested a library of 13 different PEIs. But we 
varied the underlying synthesis scheme compared to the known synthesis which yielded a 
hydroxyl group at the chain end. We sticked to the living polymerization of 2-ethyl-2-oxazoline by 
methyl toluenesulfonate (Figure 1, 1) but we inserted a substitution step in order to gain a 
thioacetate group as thiol precursor (2) which in turn had to be cleaved (3) and activated (4) 
before use. Thus, the synthesis was a multistep procedure according to Figure 1 resulting in 
polymers that were on the one hand suited for the formation of polyplexes (the complexes made  
 
Figure 1. Schematic drawing of the multistep synthesis yielding activated lPEI-SH. 
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from nucleic acids and polymeric carriers) from the homopolymers and on the other hand suited 
for the attachment of a second moiety. 
Materials and methods 
All chemicals and materials were from Merck KGaA (Germany), Acros Organics (Belgium), 
Sigma-Aldrich Chemie GmbH (Germany), J.T. Baker (The Netherlands) or IRIS Biotech 
(Germany). Acetonitrile, dimethylformamide (DMF) and 2-ethyl-2-oxazoline were distilled over 
calciumhydride. Methyl-p-toluene sulfonate was dried in vacuo before use. All other chemicals 
were used as received.  
The plasmid DNA encoding enhanced green fluorescent protein (EGFP) (pEGFP-N1, Clontech, 
Germany) was used as reporter gene and isolated from E. coli JM 109 strain using a Qiagen 
Plasmid Maxi Kit (Qiagen, Germany).  
Polymer synthesis poly(2-ethyl-2-oxazoline)-thioacetate/ linear poly(ethylene imine) thiol 
poly(2-ethyl-2-oxazoline) (pEtOXZ) was synthesized by cationic ring opening polymerization of 
2-ethyl-2-oxazoline in acetonitrile  at 90°C. The polymerization was conducted in dried glass 
ware in which dry acetonitrile, 2-ethyl-2-oxazoline and varying amounts of methyl-p-toluene 
sulfonate were converted. The amounts of methyl-p-toluene sulfonate were chosen depending 
on the desired molecular weight (MW) of PEI (typical amounts are listed in Table 1). The 
reaction apparatus was set under a nitrogen atmosphere and was heated to 90°C for several 
days (3 to 6 days, depending on the calculated MW of PEI). Afterwards the reaction was cooled 
down to rt and the MW of the resulting polymer was determined by 1H-NMR. Then, 7.5 equi-
valents (eq., corresponding to the MW of PEI) of sodium thioacetate in DMF were added and the 
reaction mixture was stirred for 4 hours (h). After this the solvent was removed, the residue was 
dissolved in chloroform and the solution was washed 3 times with water. The raw product, 
poly(2-ethyl-2-oxazoline)-thioacetate (pEtOXZ-SAc) , was precipitated in ice cooled diethyl ether, 
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filtrated and dried in vacuo. In the next step, pEtOXZ-SAc was hydrolyzed in fuming HCl at 95°C 
for one day. After distilling off  the HCl, the product PEI-SH was dissolved in water, precipitated 
with NaOH, washed with water until the supernatant became neutral and dried in vacuo. 
Table 1. Overview of the reaction educts for the polymerization. 
MW 
(pEtOXZ) 
MW  
(lPEI) 
V (OXZ) 
[ml] 
n (Tos) 
[mmol] 
m (Tos)  
[mg] 
n (SAc) 
[mmol] 
m (SAc) 
[mg] 
22790 10000 6.25 0.266 50 2.00 228 
19372 8500 6.25 0.313 58 2.35 268 
15953 7000 6.25 0.380 71 2.85 325 
13622 5977 6.25 0.445 83 3.34 381 
11395 5000 6.25 0.532 99 3.99 456 
10256 4500 6.25 0.592 110 4.44 507 
9114 3999 6.25 0.666 124 5.00 570 
8415 3655 6.25 0.731 136 5.48 626 
7938 3483 6.25 0.764 142 5.73 654 
6860 3010 6.25 0.884 165 6.63 757 
5684 2494 6.25 1.067 199 8.00 914 
4606 2021 6.25 1.317 245 9.88 1128 
3465 1500 6.25 1.751 326 13.13 1500 
 
The third step was the activation of the PEI derivative with 30 eq. NaBH4 at pH 8.5 for 20 
minutes (min), then the reaction mixture was acidified to pH 1 in order to destroy unreacted 
NaBH4. This was followed by the adjustment of the pH to 4, the addition of 2.5 eq. 2,2`-dithio 
dipyridine (DTDP) and stirring overnight. On the next day the reaction mixture was slightly 
concentrated and dialysed against water excessively. Then the product was dried in vacuo.  
Successful conversion was monitored by 1H-NMR. 1H-NMRs were recorded on an Avance 300 
spectrometer (300 MHz, Bruker BioSpin GmbH, Germany). Afterwards the polymers were 
dissolved in 150 mM NaCl, and the pH was adjusted to 7.0. 
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NMR analysis 
Estimation of the molecular weight of the polymer pEtOXZ 
In order to estimate the molecular weight of the polymer NMRs were recorded of the oxazolinium 
salt species (Figure 2, 3). The peaks assigned to the aromatic protons of the tosylate starter 
were set to 2 and the protons of the backbone peaks were calculated according to this first 
setting. These peaks corresponded to the propionyl side chains (0.81-1.41 ppm and 2.18-2.64 
ppm) and to the methylene groups of the polymer backbone (3.13-3.92 ppm) and accounted for 
3, 2 or 4 protons, respectively. 
Conversion into pEtOXZ-thioacetate 
The backbone peaks of the polymer (Figure 2, 4) were set to the number of protons calculated 
from the precursor NMR of the oxazolinium salt polymer (Figure 2, 3). The area of the only 
visible peak for the thioacetate at 2.92-2.97 ppm was used for the calculation of the conversion 
rate. The ratio of the resulting peak area to the theoretical area of 2 protons was the basis for the 
calculation of the conversion. 
Conversion of lPEI-SH into lPEI-SS-pyr 
In the 1H-NMRs one backbone peak for lPEI can be seen as well as the aromatic peaks for the 
pyridyl conjugate. The area of the backbone peak was set to the expected value calculated from 
the molecular weight estimation after the first synthesis step. All other peaks resulted from this 
setting. The ratio of the obtained peak areas compared to the theoretical value of 1 gave the 
conversion into PEI-SS-pyr. 
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Investigation of the influence of reaction conditions on the polymer conversion 
In order to determine the best reaction conditions for the conversion of the pEtOXZ intermediate 
into the thioacetate a series of different reaction conditions was tested. One series investigated 
the influence of reaction temperature and reaction time while the other series concentrated on 
reaction time and amount of added potassium thioacetate. 
In both cases the polymerization was performed as described in the former section. 
For the examination of the influence of time and temperature the reaction was divided into 3 
parts after a reaction time of 4 days. One part was cooled down to 0°C, the other one was 
cooled down to rt while the third part was kept at 95°C. To each part 10 equ. of potassium 
thioacetate were added. After 1, 3 and 5 days samples were taken, the solvent was removed 
and the residue was dissolved in chloroform. This solution was washed three times with water 
and the resulting raw product was precipitated in diethyl ether. After filtration the product was 
dried in vacuo and the conversion degree was determined by 1H-NMR as described before. 
The investigation of the influence of time and excess of potassium thioacetate on the conversion 
rate followed the same scheme. First the polymerization was started. After 4 days reaction time 
the reaction was cooled down to room temperature, split into 4 parts and different amounts of 
potassium thioacetate (corresponding to 5 eq., 7.5 eq., 10 eq. and 15 eq.) were added. Again 
samples were taken at different time points (1h, 3h, 5h and 1day) and were worked up as 
described above. Also the conversion degree was calculated by 1H-NMR as described above. 
Determination of reduction/activation conditions 
The determination of the best reaction conditions focused on the pH and reaction time during the 
reduction step on the one hand and on the same parameters during the activation step with 
2,2`dithio dipyridine (DTDP). 
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Three different samples were prepared. For these samples three different starting pH´s were 
chosen (pH 7.5, pH 8 and pH 9). Each sample contained 0.545 mmol of the obtained lPEI- 
derivative dissolved in water and 0.48 ml alkaline  NaBH4 solution  pH 7.5 ( 70% w/V) were 
added to every reaction vessel. The mixtures were stirred at rt. After 5 different time points (15 
min, 30 min, 60 min, 90 min and 120 min) samples were taken. These samples were treated 
with 0.1 ml hexanol and 0.75 ml 6M HCl for 2 min and then further split in 3 parts. Part 1 had a 
pH of 4; part 2 was adjusted to pH 6 and part 3 was adjusted to pH 7. After this adjustment 
0.0045 mmol DTDP were added and all samples were stirred. After different time points (15 min, 
30 min, 60 min and overnight) samples were taken which were measured on a TitertekPlus 
Microplate Reader (Bartolomey Labortechnik, Germany) at 343 nm.  This resulted in 180 
different reaction conditions which were all measured in sextuplets. The concentrations were 
determined using cysteine standards reacted with DTDP. The outcome was visualized with 
MODDE (Umetrix, Umea, Sweden). 
NTSB-Assay 
The NTSB assay was adopted from [17]. The assay stock solution was prepared by dissolving  
0.1 g 5,5`-dithio-bis-(2-nitrobenzoic acid) (DTNB) in 10 ml 1M Na2SO3 solution. This mixture was 
then heated to 38°C and oxygen was bubbled through the solution for 45 min. For the 
preparation of the assay solution the stock solution was further diluted 1:100 with a solution 
containing 0.605 g tris(hydroxymethyl)aminomethane (TRIS), 0.315 g  Na2SO3  and 28 mg 
ethylene diamine tetra acetate (EDTA) pH 9,5. 300 µl assay solution were then mixed with 10 µl 
sample, pipetted into a 96 well plate and incubated for 10 min. Thereafter the absorbance was 
detected on a TitertekPlus Microplate Reader (Bartolomey Labortechnik, Germany) at 412 nm. 
All samples were measured three times. The concentration was determined using cysteine 
solutions as standards. 
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Ellman assay 
For the Ellman assay the supplier´s instruction was transferred to a 96 well plate protocol. In 
brief, a pH 8 reaction buffer consisting of 0.1 M sodium phosphate and 1 mM EDTA was 
prepared. The Ellman reagent solution was made by mixing 4 mg Ellman´s reagent  (5,5`-dithio-
bis-(2-nitrobenzoic acid)) with 1 ml reaction buffer. All samples were reduced to thiols before 
analysis. Therefore, the pH of the PEI solutions was adjusted to pH 8-9, 5 eq. of NaBH4 were 
added and the reaction mixtures were stirred at rt. After 20 min pH 1 was adjusted using 6M HCl 
and the solution was again stirred for 2 min. Then the pH was again adjusted, this time to pH 7. 
25 µl of these solutions were mixed with 250 µl reaction buffer and 5 µl Ellman´s reagent. After 
incubation for 15 min at rt the absorbance was measured on a TitertekPlus Microplate Reader 
(Bartolomey Labortechnik, Germany) at 412 nm. All samples were measured 3 times and the 
concentration was determined using cysteine standards. 
DTDP assay 
The assay of Riener et al. [18] was modified for the use in a well plate format. The buffer for the 
DTDP-Assay (2,2`-dithio-dipyridine assay) consisted of 100 mM NaH2PO4 and 0.2 mM EDTA at 
pH 7. The assay solution was prepared by dissolving 88 mg DTDP in 100 µl fuming HCl and 3 
ml water. This solution was diluted to 100 ml with DTDP buffer. All samples were reduced to 
thiols before analysis. Therefore, the pH of the PEI solutions was adjusted to pH 8-9, 5 eq. of 
NaBH4 were added and the reaction mixtures were stirred at rt. After 20 min pH 1 was adjusted 
using 6M HCl and the solution was again stirred for 2 min. Then the pH was again adjusted, this 
time to pH 7. 4 µl samples were taken and mixed with 300 µl reaction buffer and 12.5 µl assay 
solution. After incubation at rt for 5 min the absorbance was measured on a TitertekPlus 
Microplate Reader (Bartolomey Labortechnik, Germany) at 343 nm. All samples were measured 
in triplicate and the concentrations were determined relative to cysteine standards. 
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Formation of polyplexes 
The polyplexes of plasmid DNA and polymer were prepared at different N/P ratios (ratio of 
nitrogens in polymer to phosphates in DNA). The polymer and plasmid DNA were each diluted in 
equal volumes of 150 mM NaCl. The polymer solution was added to the DNA solution, the 
mixture was vortexed for 20 seconds and then incubated for 20 min before use. The amount of 
plasmid DNA and the total volume of the polyplex solution are given in each section. 
Ethidium bromide quenching assay 
The polyplexes were prepared at different N/P ratios ranging from 0.5 to 3 by diluting 1 µg of 
plasmid DNA in a final volume of 100 µl. After incubation for 20 min the polyplexes were pipetted 
in a 96-well plate and mixed with 2.5 µl of a 0.1 µg/µl ethidium bromide (EtBr) solution. The 
fluorescence of EtBr was excited at 518 nm and recorded at 605 nm using a LS 55 fluorescence 
spectrometer (Perkin Elmer, Germany) and expressed as relative fluorescence compared to 
uncomplexed plasmid DNA. Measurements were performed in quadruplet. The relative 
fluorescence loss was calculated as follows:  
relative fluorescence loss = relative fluoresencePEG-PEI-polyplexes/relative fluorescencePEI-polyplexes. 
 
Hydrodynamic diameter and zeta potential measurements 
The hydrodynamic diameter was measured using a Zetasizer Nano-ZS from Malvern 
Instruments (Malvern, Germany) at 25°C. A 4 mW He-Ne laser at a wavelength of 633 nm was 
used as the light source. The measurement position was at 4.65 mm with automated laser 
attenuation. Scattered light was detected at an angle of 173° backscatter. The viscosity and 
refractive index of the dispersant were used as follows: 150 mM NaCl: 0.90 mm2/s and 1.33, 
respectively. Three measurements with 10 sub-runs were performed for each sample. Data were 
analyzed by the general purpose mode and expressed as mean ± standard deviation (SD). 
Chapter 3 Synthesis and characterization of thiol-modified low molecular weight lPEI 
92 
 
Polyplexes were formed by mixing 2 µg DNA and varying amounts of polymer to achieve 
different N/P ratios in a final volume of 500 µl. 
Statistics 
Results are shown as mean (± SD). Experiments were performed in triplicate if not otherwise 
indicated. Significance between the mean values of the pDNA and different polyplexes was 
calculated using one-way ANOVA analysis followed by Bonferroni t-test. A p-value of 0.05 was 
considered to be significant. Analysis was performed with Sigma Plot (Version 12.2, Systat 
Software, Chicago, IL, USA). 
 
Results and discussion  
Synthesis of pEtOXZ-SAc 
The synthesis was a multistep procedure according to Figure 2. The first step comprised the 
polymerization of 2-ethyl-2-oxazoline (1), which was started by methyl-p-toluenesulfonate (2) 
and terminated by potassium thioacetate. The resulting poly-2-ethyl-2-oxazoline thioacetate 
(pEtOXZ-SAc, 4) was cleaved yielding linear polyethylene imine thiol (lPEI-SH, 5). This was 
further modified resulting in lPEI pyridyl disulfide (lPEI-SS-pyr, 6). 
We applied this polymerization reaction because of its living character where one monomer after 
the other is added to the growing polymer chain [19-21]. The growth is much slower than the 
increase in molecular weight gained by a radical polymerization. Thus, the addition is much 
more uniform and the size distribution is very narrow. This narrow size distribution was needed 
in order to properly characterize the resulting polymers and draw correlations between their 
molecular weight and their physicochemical and transfection characteristics. We chose 2-ethyl-
2-oxazoline (1) as starting material for the formation of poly-2-ethyl-2-oxazoline (pEtOXZ) among 
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Figure 2. Overview over the synthesis route of lPEI-SS-pyr. 
a lot of possible different cyclic imino ethers [22-24] because this 5-membered cyclic imino ether 
possesses high polymerizability. This is caused by both the thermodynamically favorable 
isomerization of the imino ether group to the amide and factors concerning ring strain [25]. In the 
case of the polymerization of 2-ethyl-2-oxazoline methyl-p-toluenesulfonate (2) has been shown 
to be perfectly suited as a starter since it decomposes fast when heated and, thus, the 
polymerization of each polymer strand is initiated at nearly the same time [26]. Furthermore, 
according to literature acetonitrile was used as solvent [26-29] and the reaction times were set to  
Chapter 3 Synthesis and characterization of thiol-modified low molecular weight lPEI 
94 
 
 
Figure 2. 1H-NMR of the intermediate oxazolinium tosylate recorded in CDCl3. The molecular 
weight of the polymer was estimated from the ratio of peaks (a), (b) and (c) to peaks (d) and (e). 
Peaks (d) and (e) were both set to 2 and peaks (a), (b) and (c) were calculated according to this 
setting.  
4-6 days which guaranteed for complete conversion [26,30]. After this polymerization time samples 
were taken and the molecular weight of the resulting polymers was analyzed by 1H-NMR 
according to [26]. The ratios of the calculated number of protons to the protons per molecule part 
allowed for an estimation of the molecular weight. This procedure was also possible because of 
the living nature of the polymerization [20,31] where all growing pEtOXZ-chains are terminated by 
a oxazolinium tosylate end (3). As seen from Table 2 the calculated molecular weights of the 
obtained polymers were in good agreement with the theoretical values. 
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Table 2. Overview of the theoretical and calculated molecular weight (MW) of the synthesized 
polymers. 
Polymer 
MW 
 pEtOXZ 
theory 
MW pEtOXZ  
calculated 
MW lPEI  
theory 
MW  
lPEI  
calculated designated 
    [g/mol] [g/mol] [g/mol] [g/mol]   
PEI 1 3456 3456 1501 1501 PEI 1.5 
PEI 2 4606 4752 2001 2064 PEI 2.1 
PEI 3 5648 5346 2453 2322 PEI 2.3 
PEI 4 6860 6831 2980 2967 PEI 3.0 
PEI 5 7938 8019 3448 3483 PEI 3.5 
PEI 6 8415 8811 3655 3827 PEI 3.8 
PEI 7 9114 9108 3959 3956 PEI 4.0 
PEI 8 10256 9405 4455 4085 PEI 4.1 
PEI 9 11389 11385 4947 4945 PEI 4.9 
PEI 10 13622 15518 5917 6740 PEI 6.7 
PEI 11 19372 18612 8414 8084 PEI 8.1 
PEI 12 21285 20790 9245 9030 PEI 9.0  
PEI 13 22790 24849 9899 10793 PEI 10.8 
 
After analyzing polymer 3 (Figure 2), the oxazolinium salt species was used as activated 
intermediate for the attachment of a new functional group [21]. In this case potassium thioacetate 
was used to insert the precursor of the thiol group at the polymer chain end. This one step 
procedure proved to be faster and yielded higher conversion rates than the classical activation of 
hydroxyl groups with tosylates and their further substitution with thioacetates. High conversion 
rates are indispensable for further reactions because purification of polymers which differ only in 
their functional end group is very difficult. This is due to the fact that the polymer backbone is 
mainly responsible for the behavior of the molecule while the end group has just a minor 
influence. Thus, the optimization of the reaction yield was highly important and the 1-step  
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Figure 3. 1H-NMR of pEtOXZ-SAc recorded in CDCl3. The backbone peaks (a), (b) and (c) were 
set to the number of protons calculated from the precursor NMR of the oxazolinium salt polymer. 
The area of peak (d) was used for the calculation of the conversion rate. The conversion was 
calculated from the ratio of the resulting peak area to the theoretical area of 2 protons. 
approach needed to be examined in detail concerning the reaction temperature, the excess of 
thioacetate as well as the reaction time. After different times samples were taken and all of them 
were analyzed by 1H-NMR in order to determine the conversion into the thioacetate. It can be 
seen from Figure 4 that the differences between the conditions were not huge, just for a reaction 
at 95°C for 3 days higher yields were obtained. But further prolonging the reaction time had 
adverse effects and the reaction was never brought to completeness.  
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Figure 4. Investigation of the influence of reaction time and reaction temperature on the 
conversion rate. The reaction time is given on the x-axis and the reaction temperature on the z-
axis. The y-axis corresponds to the conversion rate. 
Thus, in a second approach the influence of the amount of thioacetate was investigated. Since 
the conversion differences obtained in the first assay were not high and reactions at rt are easier 
to handle this investigation was conducted at rt and the amounts of thioacetate were varied. This 
time also the reaction times were shortened since the thioacetate seemed to be cleaved if the 
reaction lasted too long. The samples were analyzed by 1H-NMR again. 
Interestingly, best results were obtained when 7.5 eq. thioacetate were used and when the 
reaction time was rather short. Hence reaction conditions were chosen according to these 
results. 
 
Chapter 3 Synthesis and characterization of thiol-modified low molecular weight lPEI 
98 
 
 
Figure 5. Investigation of the influence of reaction time and thioacetate excess on the 
conversion rate. The reaction time is given on the x-axis. The thioacetate excess is on the z-axis 
and the y-axis accounts for the conversion rate. 
 
Synthesis and activation of lPEI-SH 
The second synthesis step comprised the acidic cleavage of pEtOXZ-SAc (Figure 2, 4) and the 
subsequent activation with 2,2´-dithio-dipyridine (DTDP). According to literature [26,27,32] the 
pEtOXZ-SAc was cleaved by acidic hydrolysis yielding the corresponding low molecular weight 
lPEI-SH (Figure 2, 5). Fuming HCl and reflux for 1 d were chosen to guarantee for complete 
cleavage of the amide bonds [27]. The subsequent purification comprised a very basic work-up 
step. This proved to be rather problematic since thiols were instable at this basic pH and formed 
disulfides fast. In consequence a reduction procedure after this work up had to be established as 
well as a step that generates stable thiol forms for storage. Thus, downstream the work up 
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another 2-step reaction had to be introduced which eliminated the problem of disulfide formation 
during work-up and storage by reduction and subsequent thiol modification. 
For the reduction a lot of different agents are known. The most important ones are tris(2-
carboxyethyl)phosphine (TCEP) [33-37] dithiothreitol (DTT) [34,38,39], mercaptoethanol [40,41] and 
NaBH4 
[42-44]. Their features are summarized in Table 3. 
Table 3. Characteristics of the most common disulfide reductants. 
Reductant Tris(2-carboxy 
ethyl)phos-
phine 
Cleland´s 
reagent 
(dithiothreitol) 
 
β-Mercapto-
ethanol 
 
Sodium 
borohydride 
 
Solubility Water soluble 
Abbreviation TCEP DTT β-ME NaBH4 
Application Stoichiometric Minor excess Vast excess Variable 
Reduction 
driving force 
Thermodynamic 
forces 
Thiol-disulfide 
exchange favour-
ed by ring strain 
Thiol-disulfide 
exchange 
High S-nucleo-
philicity of the 
borohydride ion 
Removal Precipitation and filtration; 
Dialysis 
Dialysis; 
Removal in 
vacuo 
Decomposition 
into gaseous 
components after 
addition of 
acetone or acid 
Theoretical 
suitability for 
PEI 
Precipitation unsuitable,  
dialysis possible 
 
Removal in 
vacuo impossible 
Dialysis possible; 
Possible 
 
Suitability Unsuitable 
(Disulfide reformation possible due to long dialysis time) 
 
Well suited due 
to fast decom-
position in acidic 
environment pre-
venting disulfide 
reformation 
Chapter 3 Synthesis and characterization of thiol-modified low molecular weight lPEI 
100 
 
These two steps (the reduction and the activation) had to be performed immediately after each 
other because reformation of disulfides could occur if too much time between the two steps 
passed. Furthermore, the reaction had to be performed in aqueous solutions due to the solubility 
of the obtained PEI derivative. Unfortunately, NaBH4 is known to be instable in aqueous 
solutions. Thus, in order to obtain a good conversion the reaction series needed a fine tuning 
concerning reaction times and reaction pH´s for both steps. Therefore, a series of reactions was 
analyzed. In the first step different pHs were chosen as well as different reaction times. The 
values were chosen to be a compromise between PEI solubility on the one hand and NaBH4 
degradation on the other hand. Also the reaction times were a balance between sufficient time 
for the reduction and reoxidation of the generated thiols. After deletion of NaBH4 the samples 
were split and 3 other pH values were adjusted. The reason for this was that DTDP is known to 
react in acidic pH, while disulfides are formed more eagerly under less acidic conditions. The 
samples were then allowed to react for 15 min, 30 min, 60 min or overnight and the amount of 
DTDP conversion was measured spectrophotometrically. The results for a reaction time of 2 h 
for the second step are given in Figure 6. 
From the reddish colors in the single diagrams of Figure 6 it can be seen that pH 4 for the 
second step has the biggest influence on the conversion rate. For the first step a rather short 
reaction time (about 15 min) and the highest adjusted pH proved to be best. Thus, these 
reaction conditions were used for further experiments. 
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pH of 2nd 
reaction 
step: 
4 
 
 
Figure 6. Investigation of 
the influence of different 
parameters (pH 1, t 1, 
pH 2, t 2) on the conversion 
rate of the overall reaction 
sequence (measured as 
absolute absorbance of the 
resulting pyridyl disulfide 
derivative). Shown are the 
values for a reaction time of 
2h for the second step 
(t 2=2h). t 1 is given on the 
y-axis, pH 1 is on the z-axis 
while the x-axis shows the 
measured absorption and, 
thus, corresponds to the 
conversion rate. Bluish 
colors indicate minor 
conversion while red colors 
denote high conversions. 
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The results of the UV measurements of the obtained lPEI-SS-pyr could also be confirmed by 1H-
NMR. The conversion rates were in most cases about 80%. 
 
Figure 7. 1H-NMR of lPEI-SS-pyr recorded in D2O. The area of the backbone peak (a) was set 
to the expected value calculated from the molecular weight estimation after the first synthesis 
step. The ratio of the obtained peak areas compared to the theoretical value of 1 gave the 
conversion into PEI-SS-pyr. 
 
Determination of thiol content 
Knowledge about the thiol concentration of a sample is desirable in order to have a controlling 
device for the synthesis outcome and the improvement of the reaction conditions. This is 
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particularly important in the case of the synthesis of the thioether linked copolymers created 
here. Since the coupling step is performed without any further activation it is indispensable to 
calculate the appropriate net weight needed for the synthesis.  The thioacetate/thiol content can 
be assayed at the stage of pEtOXZ or PEI. For pEtOXZ the thioacetate conversion can be 
assayed by 1H-NMR. In the case of PEI the thiol content can be determined immediately after 
reduction by a lot of different assays [47,48] which are normally used for protein analytics. The 
most common ones are the Ellman assay [18, 36, 44, 49,50], the NTSB assay [51] and the DTDP 
assay [18, 42, 52, 53]. Figure 8 records the results of all these assays and the results from 1H-NMR 
measurements. In most cases, the NTSB assay shows the highest amount of thiols, which is 
probably due to the fact that it has the power to analyze both species -thiols and disulfides- at 
once. Despite this big advantage of double detection, the hitch of this method was that the assay 
needed pH 9.5 which was not suitable for all tested PEIs. The longer the PEI chain was, the 
higher was the probability of polymer precipitation which hampered the readout of the assay. 
The Ellman and the DTDP assay gave lower concentrations than the NTSB assay in many 
cases which can be ascribed to the single detection of thiols. If the upstream reduction step 
cannot comprise all disulfides the resulting calculated conversion rate is lower than the finding of 
the NTSB assay. But both assays were more suitable for the higher molecular weight PEIs 
because they needed a pH which was beneficial for complete PEI solubility. The results of the 
NMR were somewhere in between which was due to the fact that the integral setting was not 
always clear. Thus, the NTSB assay was most suited for the detection of the whole thiol content 
of a PEI sample as long as the molecular weight of PEI was not too high. Assays such as the 
Ellman or DTDP assay were more appropriate for high molecular weight samples since they 
required less basic pHs in which PEI was completely soluble. While integral setting for PEI 
thioacetate was sometimes spurred 1H-NMR offered the possibility to quickly check the purity of 
the product giving valuable information about the success of the work-up procedure.  
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Figure 8. Thiol-/thioacetate conversion of lPEI measured by Ellman´s assay, NTSB assay, 
DTDP assay at pH 6.8 or 1H-NMR. The x-axis gives the molecular weight of the polymer PEI 
and the y-axis gives the determined conversion into thiols (Ellman assay, NTSB assay, DTDP 
assay) or thioacetates (1H-NMR), respectively. 
 
Characterization of physicochemical properties 
After successful synthesis the polymers had to proof themselves suitable for gene delivery 
applications. One very important prerequisite for a carrier system is its ability to complex nucleic 
acids into particles and to protect its payload from degradation and displacement from the 
carrier. In order to test the polymers condensation of the cargo an ethidium bromide (EtBr) 
exclusion assay was performed. A carrier is well suited if it excludes EtBr from the intercalation 
with pDNA which indicates strong interaction between the carrier and the payload. It can be 
seen in Figure 9 that the exclusion of EtBr became more efficient with higher N/P ratio (the ratio 
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between the protonatable amines in the carrier and the negative charges along the backbone of 
the nucleic acid). Also a trend concerning the molecular weight of PEI was observed. The longer 
the chain became the more efficient was the displacement of EtBr from the pDNA double strand. 
So, these polymers fulfilled their most important task- the complexation of the nucleic acid- very 
well. 
 
Figure 9. Relative fluorescence loss of EtBr after complexation of plasmid DNA with PEI at 
different N/P ratios compared to the fluorescence of pure plasmid DNA. The N/P ratio is 
indicated at the x-axis, while the molecular weight of PEI is given in the legend. The relative 
fluorescence of all polymers at different N/P ratios was statistically different from the 
fluorescence of pDNA alone with p<0.005. The only exception was PEI 3.0. 
The complexation into particles was also analyzed by measuring the hydrodynamic size of the 
polyplexes. It can be seen from Figure 10 that the higher the N/P ratio became the larger the 
polyplexes got. However, the chain length seemed to play only a minor important role for the 
size of polyplexes. Nevertheless, all polymers were able to complex pDNA into particles which 
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made them suitable for gene delivery applications. Furthermore, the polydispersity indices of 
these polyplexes were all below 0.4 (data not shown) which indicated a quite homogenous size 
distribution. These rather uniform size distributions are desirable for gene delivery because it is 
easier to derive structure-activity relations if the particles in the collective are equal-sized. 
 
Figure 10. Size of the polyplexes built from plasmid DNA and PEI at different N/P ratios. The x-
axis indicates the molecular weight of and the legend gives the used N/P ratios. 
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Conclusion 
We successfully synthesized a library of 13 end group functionalized lPEI derivatives which can 
be employed for copolymer synthesis resulting in both stable thioether connected copolymers 
and cleavable disulfide linked copolymers. For this purpose we altered the polymerization 
sequence reported by [26] and [27] in such a way that a thioacetate group instead of a hydroxyl 
group terminated the polymer chain. In order to guarantee for the highest possible conversion 
rate we investigated the influence of different reaction conditions such as time, temperature and 
amount of terminating agent. This was essential since purification of polymers differing only in 
the terminal group is very difficult and impure products hamper further syntheses. Furthermore, 
we eliminated the problem of premature disulfide formation by introducing a reaction sequence 
which consisted of a reduction step and the formation of a stable storage form. For this 
procedure comprehensive investigations of reaction conditions such as pH and time were 
performed. Moreover, we introduced different assays for the determination of the thiol/disulfide 
content of the polymers in order to have a controlling device for the synthesis outcome and to 
get information about the polymer amounts needed for further copolymer synthesis. Beside 
these synthetic improvements we also checked the complexation ability of the thiol-modified 
polymers. As shown by an EtBr exclusion assay and the measurement of the polyplex sizes all 
polymers were able to form particles with plasmid DNA. Thus, they met the most important 
prerequisite for an efficient gene carrier and could be used for further modifications improving 
their characteristics. 
 
 
 
 
Chapter 3 Synthesis and characterization of thiol-modified low molecular weight lPEI 
108 
 
References 
[1] J. C.Venter et al., The Sequence of the Human Genome. Science. 291 (2001) 5507, 1304–
1351. 
[2] Tabor. Polyamines. Annual Reviews of Biochemistry (1984) 749-790. 
[3] L. C. Gosule, J. A. Schellman, Compact form of DNA induced by spermidine. Nature. 259 
(1976) 5541, 333–335. 
[4] A. E. Pegg, Polyamine Metabolism and Its Importance in Neoplastic Growth and as a Target 
for Chemotherapy. Cancer Research. 48 (1988) 4, 759-774. 
[5] O. Heby, Role of Polyamines in the Control of Cell Proliferation and Differentiation. 
Differentiation. 19 (1981) 1-3, 1-20. 
[6] H. Deng, Structural basis of polyamine–DNA recognition: spermidine and spermine 
interactions with genomic B-DNAs of different GC content probed by Raman 
spectroscopy. Nucleic Acids Research. 28 (2000) 17, 3379-3385. 
[7] A. A. Ouameur, H.-A. Tajmir-Riahi, Structural Analysis of DNA Interactions with Biogenic 
Polyamines and Cobalt(III)hexamine Studied by Fourier Transform Infrared and 
Capillary Electrophoresis. Journal of Biological Chemistry. 279 (2004) 40, 42041-
42054. 
[8] M. Saminathan, Ionic and Structural Specificity Effects of Natural and Synthetic Polyamines 
on the Aggregation and Resolubilization of Single-, Double-, and Triple-Stranded 
DNA. Biochemistry. 38 (1999) 12, 3821-3830. 
[9] O. Boussif,  A versatile vector for gene and oligonucleotide transfer into cells in culture and in 
vivo: polyethylenimine. Proceedings of the National Academy of Sciences. 92 
(1995) 16, 7297-7301. 
[10] W. T. Godbey, K. K. Wu, A. G.Mikos, Poly(ethylenimine) and its role in gene delivery. 
Journal of Controlled Release. 60 (1999) 2-3, 149-160. 
[11] J. Suh,  H. J. Paik, B. K. Hwang, Ionization of Poly(ethylenimine) and Poly(allylamine) at 
Various pH′s. Bioorganic Chemistry. 22 (1994) 3, 318-327. 
[12] W. T. Godbey,  K. K. Wu,  A. G.Mikos, Size matters: Molecular weight affects the efficiency 
of poly(ethylenimine) as a gene delivery vehicle. Journal of Biomedical Materials 
Research. 45 (1999) 3, 268-375. 
[13] K. Kunath,  A. von Harpe, D. Fischer , H. Petersen, U. Bickel, K. Voigt, T. Kissel, Low-     
molecular-weight polyethylenimine as a non-viral vector for DNA delivery: 
comparison of physicochemical properties, transfection efficiency and in vivo 
distribution with high-molecular-weight polyethylenimine. Journal of Controlled 
Release. 89 (2003) 1, 113-125. 
[14] J. W. Wiseman, C. A. Goddard, D. McLelland, W. H. Colledge, A comparison of linear and 
branched polyethylenimine (PEI) with DCChol//DOPE liposomes for gene delivery 
to epithelial cells in vitro and in vivo. Gene Therapy. 10 (2003) 19, 1654-1662. 
Chapter 3 Synthesis and characterization of thiol-modified low molecular weight lPEI 
109 
 
[15] L. Wightman, R. Kircheis, V. Rössler, S. Carott , R. Ruzicka, M. Kursa, Different behavior of 
branched and linear polyethylenimine for gene delivery in vitro and in vivo. The 
Journal of Gene Medicine. 3 (2001) 4, 362-372. 
[16] M. Breunig, U. Lungwitz, R. Liebl C. Fontanari, J. Klar , A. Kurtz, T.  Blunk, A.  Goepferich, 
Gene delivery with low molecular weight linear polyethylenimines. The Journal of 
Gene Medicine. 7 (2005) 10, 1287-1298. 
[17] T. W. Thannhauser, Y. Konishi, H. A.Scheraga, Sensitive quantitative analysis of disulfide 
bonds in polypeptides and proteins. Analytical Biochemistry. 138 (1984) 1, 181-
188. 
[18] C. Riener, G. Kada, H. Gruber, Quick measurement of protein sulfhydryls with Ellman's 
reagent and with 4,4'-dithiodipyridine. Analytical and Bioanalytical Chemistry. 373 
(2002) 4, 266-276. 
[19] T. Saegusa, H. Ikeda, H. Fujii, Isomerization Polymerization of 2-Oxazoline. IV. Kinetic 
Study of 2-Methyl-2-oxazoline Polymerization. Macromolecules. 5 (1972) 4, 359-
362. 
[20] J. E. McAlvin, S. B. Scott, C. L. Fraser, Synthesis of Thermochromic Iron(II) Tris(bipyridine)-
Centered Star-Shaped Polyoxazolines and Their Bipyridine-Centered 
Macroligand Counterparts. Macromolecules. 33 (2000) 19, 6953-6964. 
[21] M. Miyamoto, K. Naka, M. Tokumizu, T. Saegusa, End capping of growing species of 
poly(2-oxazoline) with carboxylic acid: a novel and convenient route to prepare 
vinyl- and carboxy-terminated macromonomers. Macromolecules. 22 (1989) 4, 
1604-1607. 
[22] T. Saegusa, Y. Hashimoto, S. Matsumoto, Ring-Opening Polymerization of Oxacyclobutane 
by Boron Trifluoride. Concentration of Propagating Species and Rate of 
Propagation. Macromolecules. 4, 1971, 1-3. 
[23] R. Tanaka, I. Ueoka, Y. Takaki, K. Kataoka, S. Saito, High molecular weight linear 
polyethylenimine and poly(N-methylethylenimine). Macromolecules. 16 (1983) 6, 
849-853. 
[24] T. Saegusa, A. Yamada, H. Taoada, S. Kobayashi, Linear Poly(N-alkylethylenimine)s. 
Macromolecules. 11 (1978) 2, 435-436. 
[25] K. Aoi, M. Okada, Polymerization of oxazolines. Progress in Polymer Science. 21 (1996) 1, 
151-208. 
[26] B. Brissault, A. Kichler, C. Guis, C. Leborgne, O. Danos, H. Cheradame, Synthesis of Linear 
Polyethylenimine Derivatives for DNA Transfection. Bioconjugate Chemistry. 14 
(2003) 3, 581-587. 
[27} U. Lungwitz, S. Drotleff, A. Goepferich, Synthesis and Characterization of poly(2-ethyl-2-
oxazoline) and linear polyethylenimine, in U. Lungwitz. Poly(ethylenimine)-derived 
gene carriers and their complexes with plasmid DNA- Design, Synthesis and 
Characterization. Thesis, Regensburg (2006). 
Chapter 3 Synthesis and characterization of thiol-modified low molecular weight lPEI 
110 
 
[28] O. Nuyken, P. Persigehl, R. Weberskirch, Amphiphilic poly(oxazoline)s – synthesis and 
application for micellar catalysis. Macromolecular Symposia. 177 (2002) 1, 163-
174. 
[29] G. Hochwimmer, O. Nuyken, U. Schubert, S. 6,6′-Bisfunctionalized 2,2′-bipyridines as 
metallo-supramolecular initiators for the living polymerization of oxazolines. 
Macromolecular Rapid Communications. 19 (1998) 6, 309-313. 
[30] R. Hoogenboom, M. W. Fijten, C. Brändli, J. Schroer, U. Schubert, Automated Parallel 
Temperature Optimization and Determination of Activation Energy for the Living 
Cationic Polymerization of 2-Ethyl-2-oxazoline. Macromolecular Rapid 
Communications. 24 (2003) 1, 98-103. 
[31] T. Saegusa, H. Ikeda, H. Fujii, Isomerization Polymerization of 2-Oxazoline. IV. Kinetic 
Study of 2-Methyl-2-oxazoline Polymerization. Macromolecules. 5 (1972) 4, 359-
362. 
[32] K. M. Kem, Kinetics of the hydrolysis of linear poly[(acylimino)-ethylenes]. Journal of 
Polymer Science: Polymer Chemistry Edition. 17 (1979) 7, 1977-1990. 
[33] J. A. Burns, J. C. Butler, J. Moran., G. M. Whitesides, Selective reduction of disulfides by 
tris(2-carboxyethyl)phosphine. Journal of Organic Chemistry. 56 (1991) 8, 2648-
2650. 
[34] E.B. Getz, M. Xiao, T. Chakrabarty, R. Cooke, P.R. Selvin, A Comparison between the 
Sulfhydryl Reductants Tris(2-carboxyethyl)phosphine and Dithiothreitol for Use in 
Protein Biochemistry. Analytical Biochemistry. 273 (1999) 1, 73-80. 
[35] W. R. Gray, Disulfide structures of highly bridged peptides: A new strategy for analysis. 
Protein Science. 2 (1993) 10, 1732-1748. 
[36] J. C. Han, G. Y. Han, A Procedure for Quantitative Determination of Tris(2-
Carboxyethyl)phosphine, an Odorless Reducing Agent More Stable and Effective 
Than Dithiothreitol. Analytical Biochemistry. 220 (1994) 1, 5-10. 
[37] K. Tyagarajan, E. Pretzer, J. E. Wiktorowicz, Thiol-reactive dyes for fluorescence labeling of 
proteomic samples. ELECTROPHORESIS. 24 (2003) 14, 2348-2358. 
[38] W. W. Cleland, Dithiothreitol, a New Protective Reagent for SH Groups. Biochemistry. 3, 
(1964) 4, 480-482. 
[39] K. Iyer Subramonia , W. A. Klee, Direct Spectrophotometric Measurement of the Rate of 
Reduction of Disulfide Bonds. Journal of Biological Chemistry. 248 (1973) 2, 707-
710. 
[40] M. Svoboda, W. Meister, W. Vetter, A method for counting disulfide bridges in small proteins 
by reduction with mercaptoethanol and electrospray mass spectrometry. Journal 
of Mass Spectrometry. 30 (1995) 11, 1562-1566. 
[41] L.-O. Andersson, Reduction and reoxidation of the disulfide bonds of bovine serum albumin. 
Archives of Biochemistry and Biophysics. 133 (1969) 2, 277-285. 
Chapter 3 Synthesis and characterization of thiol-modified low molecular weight lPEI 
111 
 
[42] R. E. Hansen, H. Ostergaard, P. Norgaard, J. R. Winther, Quantification of protein thiols and 
dithiols in the picomolar range using sodium borohydride and 4,4′-dithiodipyridine. 
Analytical Biochemistry. 363 (2007) 1, 77-82. 
[43] M. B. Mathews, The reductionn of cozymase by sodium borohydride. Journal of Biological 
Chemistry. 176 (1948) 1, 229-232. 
[44] A. F. S. A. Habeeb, A sensitive method for localization of disulfide containing peptides in 
column effluents. Analytical Biochemistry. 56 (1973) 1, 60-65. 
[45] S.-Y. Huang, S. Pooyan, J. Wang, I. Choudhury, M.J.  Leibowitz, S. Stein,  A Polyethylene 
Glycol Copolymer for Carrying and Releasing Multiple Copies of Cysteine-
Containing Peptides. Bioconjugate Chemistry. 9 (1998) 5, 612-617. 
[46] T. P. King, Y. Li, L. Kochoumian, Preparation of protein conjugates via intermolecular 
disulfide bond formation. Biochemistry. 17 1978) 8, 1499-1506. 
[47] R. E.Hansen,  J. R. Winther, An introduction to methods for analyzing thiols and disulfides: 
Reactions, reagents, and practical considerations. Analytical Biochemistry. 394, 
2009,  2, 147-158. 
[48] H. Cui, J. Leon, E. Reusaet, A. Bult, Selective determination of peptides containing specific 
amino acid residues by high-performance liquid chromatography and capillary 
electrophoresis. Journal of Chromatography A. 704 (1995) 1, 27-36. 
[49] N. I. Escobar, A. Morales, G. Núñez, Micromethod for quantification of SH groups generated 
after reduction of monoclonal antibodies. Nuclear Medicine and Biology. 23 
(1996) 5, 641-644. 
[50] P. Eyer, F. Worek, D. Kiderlen, G. Sinko, A. Stuglin, V. Simeon-Rudolf, Molar absorption 
coefficients for the reduced Ellman reagent: reassessment. Analytical 
Biochemistry. 312 (2003) 2, 224-227. 
[51] M. Neu, J. Sitterberg, U. Bakowski, T. Kissel, Stabilized Nanocarriers for Plasmids Based 
Upon Cross-linked Poly(ethylene imine). Biomacromolecules. 7 (2006) 12, 3428-
2438. 
[52] D. R. Grassetti, J. F.Murray [JR.], Determination of sulfhydryl groups with 2,2′- or 4,4′-
dithiodipyridine. Archives of Biochemistry and Biophysics. 119 (1967) 41-49. 
[53] J. Bai, B. Acan, A. Ghahary, B.  Ritchie, V. Somayaji, H. Uluda,  
Poly(ethyleneimine)/arginine–glycine–aspartic acid conjugates prepared with N-
succinimidyl 3-(2-pyridyldithio)propionate: An investigation of peptide coupling 
and conjugate stability. Journal of Polymer Science Part A: Polymer Chemistry. 
42 (2004) 23, 6143-6156. 
 
 
 
 112 
 
 
 
Chapter 4 
 
Synthesis of libraries of poly(ethylene 
glycol)-poly(ethylene imine) copolymers 
connected via stable thioether and 
degradable disulfide bonds 
 
 
 
 
 
 
 
 
 
Chapter 4 Synthesis of libraries of stable and degradable PEG-PEI copolymers  
113 
 
Abstract 
The development of safe and efficient gene therapy methods strongly demands well 
characterised nonviral carrier systems. Some very promising carriers are based on poly(ethylene 
imine) (PEI) supported by a shielding  moiety such as poly(ethylene glycol) (PEG). 
Unfortunately, most known copolymers are not well defined. Here, we report on the synthesis of 
two PEG-PEI copolymer libraries where every PEI molecule is just connected with one PEG 
molecule at the chain end. Thus, these copolymers meet the requirement of good definition. We 
synthesized copolymers with both stable thioether bonds and degradable disulfide linkages in 
order to obtain structure-activity-relationships from the thioethers and to test if the degradable 
carriers are superior compared to the nondegradable copolymers. The complexation ability of 
the thioether connected copolymers was tested for different nucleic acids. Efficient exclusion 
was found for both nucleic acids. Furthermore all polymers generated small particles when 
complexed with small interfering RNA. The situation was somewhat different in the case of 
plasmid DNA. The polyplexes of pDNA and PEI or PEI-PEG 2 kDa generally resulted in rather 
large polyplexes whereas the polyplexes built from PEI-PEG 5 kDa or PEI-PEG 10 kDa were 
significantly smaller. To conclude, all our copolymers were equally suited for the complexation of 
siRNA while the copolymers with longer PEG chains were better suited for pDNA than those 
without or with only a small PEG chain. 
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Introduction 
A lot of novel drugs such as proteins and antibodies or drug carriers such as micelles and 
polyplexes (complexes made from polymers and nucleic acids) experience severe limitations. 
This is due to their short half-life times and their cytotoxicity which is associated with their 
positive surface charge. In order to enhance the half-lives and mask these charges, shielding 
moieties can be attached which inhibit the interactions. A lot of different polymers can be 
employed for this task such as poly(acrylamide), poly(vinylpyrrolidone), poly(ethyl-oxazoline), 
dextranes or poly(ethylene glycol) (PEG) [1, 2].The most commonly used polymer is PEG (for 
review see  [3-8]) and numerous strategies for PEG attachment exist  [9-14]. ADAGEN, PEGASYS, 
Pegintron or Oncaspar are some of the PEGylated drugs on the market which proof the 
effectiveness of this approach [8]. But PEGylation is not only restricted to these protein 
modifications. The circulation time of carrier systems such as micelles or polyplexes could be 
improved, too. Among the plethora of different carriers also poly(ethylene imine) (PEI), the gold 
standard in nonviral gene therapy, was equipped with PEG. Grafted or star-like copolymers with 
linear or branched PEG moieties of different molecular weight were synthesized [15-27]. All of 
them share a reduced zeta potential, improved colloidal stability and lower toxicity as well as 
longer circulation times in vivo. But product mixtures of different PEG-PEI copolymers are 
possible due to the way of their synthesis. Furthermore, if the PEG moiety is not clearly 
separated from the PEI moiety the shielding moiety may interfere with the complex formation 
resulting in less stable polyplexes. Thus, we hypothesized that the synthesis of strictly linear 
PEG-PEI copolymers would be beneficial for the formation of stronger polyplexes and the 
drawing of structure activity correlations. We synthesized a library of non degradable PEG-PEI 
copolymers connected via a thioether bond for the analysis of the physicochemical 
characteristics as well as the performance in cell culture which results only from the copolymer 
structure. But since the stably attached PEG moiety could also hamper the endosomal escape 
and the subsequent processing of the polyplexes [28] we prepared a second set of degradable 
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polymers. Here, we report on the synthesis of both the stable and the cleavable copolymers and 
the suitability of the thioether connected copolymers for the formation of polyplexes with plasmid 
DNA (pDNA) as well as small interfering RNA (siRNA).  
 
Materials 
All chemicals and materials were from Merck KGaA (Germany), Acros Organics (Belgium), 
Sigma-Aldrich Chemie GmbH (Germany), J.T. Baker (The Netherlands) or IRIS Biotech 
(Germany).  
The plasmid DNA encoding enhanced green fluorescent protein (EGFP) (pEGFP-N1, Clontech, 
Germany) was used as reporter gene and was isolated from E. coli JM 109 strain using a 
Qiagen Plasmid Maxi Kit (Qiagen, Germany).  
Synthesis poly(ethylene glycol)-S-poly(ethylene imine) 
Uncleavable PEI-S-PEG copolymers were obtained by coupling reactive lPEI-SH (description of 
the synthesis in chapter PEI synthesis) with a PEG maleimide (MW 2, 5 or 10 kDa). For this 
purpose the lPEI derivative was dissolved in water and the pH was adjusted to 8-9. Then 30 eq. 
NaBH4 were added and the mixture was stirred at room temperature (rt) for 20 min. Thereafter 
unreacted NaBH4 was destroyed by the addition of fuming HCl which resulted in pH 1. After 
2 min the pH was again raised to 7.2, the PEG maleimide was added and the mixture was 
stirred under a nitrogen atmosphere overnight at rt. The crude product was purified by extensive 
dialysis against water and then lyophilized. Afterwards 1H-NMRs were recorded in D2O. The 
NMRs only showed the two backbone peaks of the polymers (2,65-3,08 ppm -CH2-O-CH2-; 3,49-
3,75 ppm CH2-NH-CH2) . These peaks were used to calculate the purity of the product. The ratio 
of the peak areas corrected for the molecular weights of each polymer were used for the 
analysis of the purity. 
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Formation of polyplexes 
The polyplexes of plasmid DNA (pDNA) or shirt interfering RNA (siRNA) and polymer were 
prepared at different N/P ratios (ratio of nitrogens in polymer to phosphates in the backbone of 
the nucleic acid). The polymer and the nucleic acid were each diluted in equal volumes of 150 
mM NaCl. The polymer solution was added to the nucleic acid solution, the mixture was 
vortexed for 20 seconds and then incubated for 20 min before use. The amount of plasmid DNA 
or siRNA and the total volume of the polyplex solution are given in each section. 
Ethidium bromide quenching assay 
The polyplexes were prepared at a N/P ratio of 3 by diluting 1 µg of pDNA in a final volume of 
100 µl. After incubation for 20 min the polyplexes were pipetted in a 96-well plate and mixed with 
2.5 µl of a 0.1 µg/µl ethidium bromide (EtBr) solution. The fluorescence of EtBr was excited at 
518 nm and recorded at 605 nm using a LS 55 fluorescence spectrometer (Perkin Elmer, 
Germany) and expressed as relative fluorescence compared to uncomplexed plasmid DNA or 
siRNA, respectively. Measurements were performed in quadruplet. The relative fluorescence 
loss was calculated as follows:  
relative fluorescence loss = relative fluoresencePEG-PEI-polyplexes/relative fluorescencePEI-polyplexes. 
Hydrodynamic diameter and zeta potential measurements 
The hydrodynamic diameter and the zeta potential of the polyplexes was measured using a 
Zetasizer Nano-ZS from Malvern Instruments (Germany) at 25°C. A 4 mW He-Ne laser at a 
wavelength of 633 nm was used as the light source. For the determination of the size, the 
measurement position was at 4.65 mm with automated laser attenuation. Scattered light was 
detected at an angle of 173° backscatter. The viscosity and refractive index of the dispersant 
were used as follows: 150 mM NaCl: 0.90 mm2/s and 1.33, respectively. Three measurements 
with 10 sub-runs were performed for each sample. Data were analyzed by the general purpose 
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mode and expressed as mean ± standard deviation (SD). The zeta potential of the polyplexes 
was measured at 25°C. Three measurements with 10 sub-runs were performed for each sample. 
Data were processed in the monomodal mode which guarantees for good sample stability due to 
short measurement duration and then expressed as mean (± SD). For size measurements, 
polyplexes were formed by mixing 2 µg pDNA or siRNA and varying amounts of polymer to 
achieve different N/P ratios in a final volume of 500 µl, while for zeta potential measurements the 
polyplexes were built with 4 µg pDNA or siRNA in a final volume of 1000 µl.  
Synthesis of methoxyPEG-thioacetate 
methoxy PEGthioacetate (mPEG-SAc) , was prepared in a 2-step procedure: for the synthesis of 
mPEG-tosylate dry methoxy PEG-OH (2 or 5 kDa) was reacted with  0.5 eq of 
4-dimethylaminopyridine (DMAP), 1.5 eq. of p-toluene sulfonate and 2.0 eq. of triethylamine. 
The reaction mixture was dissolved in dichloromethane and stirred overnight at rt, followed by 
the replacement of the dichloromethane by chloroform and washing the crude product 3 times 
with water and 2 times with 0.1 M HCl. The resulting mPEG-tosylate was dried over magnesium 
sulfate and in vacuo.1H-NMRs were recorded in CDCl3 on a Avance 300spectrometer (300MHz, 
Bruker BioSpin GmbH, Germany). The aromatic tosylate protons could be seen at 7.75-
7.85 ppm and 7.30-7.40 ppm as well as the adjacent methyl group at 2.35-2.50 ppm. 
Furthermore, the PEG backbone peak is visible at 3.45-3.80 ppm and the peaks for the methoxy 
group are at 3.35-3.44 ppm. For the determination of the conversion degree the peak for the 
methoxy group of PEG was set to 3 and the area of the tosylate protons was calculated 
according to this setting. The conversion degree was calculated from the ratio of the theoretical 
area of 2 for each aromatic tosylate peak and the area determined by 1H-NMR. 
 The second step involved the exchange of the tosylate group by the thioacetate gruop. Here, 
2.5 eq. of potassium thioacetate were added to the mPEG-tosylate in DMF and the mixture was 
stirred for 8 h at rt. The mixture was concentrated, poured into a 10 fold volume of water and 
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washed with chloroform 3 times. The organic phase was dried over magnesium sulfate and 
evaporated to dryness yielding mPEG-SAc. As for the former step the methoxy peak from 3.35-
3.44 ppm was used for scaling and was set to 3. Two other peaks could be used for the 
determination of the conversion degree: the methyl peak of the thioacetate (2.30-2.35 ppm) and 
the peak of the methylene group between the PEG chain and the thioacetate at 3.05-3.12 ppm. 
These peaks accounted for 3 or 2 protons, respectively. The conversion degree was again 
determined as the ratio of the theoretical values and the gained peak areas. 
Thioacetate cleavage conditions  
In order to determine suitable reaction conditions for the thioacetate cleavage 3 different 
solvents and 10 different reaction times were tested. For this purpose PEG thioacetate was 
dissolved either in 0.1M methanolic HCl or a 1:1 mixture of methanol and water which was 
acidified with 8 drops fuming HCl. In the case of methanolic HCl one sample was heated to 
95°C, while the other one was stirred at rt. The water-methanol-mixture was heated to 95°C. At 
predetermined time points (0.5, 1, 2 ,3, 4, 5, 6, 7, 8 and 18 h). samples of 1 ml were taken, 
diluted with 4 ml water and mixed with 125 µl 2,2`-dithio dipyridine (DTDP) assay solution. This 
assay solution was prepared by dissolving 88 mg DTDP in 100 µl fuming HCl and 3 ml water 
and further dilution to 100 ml with a solution of 100 mM NaH2PO4 and 0.2 mM EDTA at pH 7. 
After incubation at rt for 5 min the absorbance was measured on a TitertekPlus Microplate 
Reader (Bartolomey Labortechnik, Germany) at 343 nm. All samples were measured 3 times 
and the concentrations were determined relative to cysteine standards. 
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Synthesis PEI-SS-PEG 
For the synthesis of PEG-SS-PEI, lPEI-SS-pyr and PEG-SH were needed. PEG-SH was 
obtained by cleavage of PEG thioacetate in situ. Here mPEG thioacetate (mPEG-SAc) was 
dissolved in a 1:1 mixture of water and methanol which was acidified with 8 drops fuming HCl. 
This mixture was heated to 90°C for 8 h. After that time 1 thiol eq. of the activated PEI (lPEI-SS-
pyr, description of the synthesis in chapter 3) was added and the mixture was stirred overnight. 
This was followed by excessive dialysis against water and lyophilisation. Afterwards 1H-NMRs 
were recorded in D2O on a Avance 300 spectrometer (300MHz, Bruker BioSpin GmbH, 
Germany) In the NMRs the two backbone peaks for the PEI and the PEG chains were clearly 
visible (2.82-3.30 ppm CH2-NH-CH2, 3.51-3.65 ppm CH2-O-CH2). Unfortunately, the methoxy 
peak of PEG was no longer clearly separated from the PEG backbone. Thus, scaling was 
performed according to the results of the previous 1H-NMRs. The purity of the product was 
determined as the ratio of the peaks for PEG and PEI corrected for the molecular weight of each 
polymer.  
Statistics 
Results are shown as mean (± SD). Experiments were performed in triplicate if not otherwise 
indicated. Significance between two groups was tested using a one-tailed Student's t-test. A 
p-value < 0.01 was considered to be significant. Significance between the mean values of the 
homopolymer and copolymer polyplexes was calculated using one-way ANOVA analysis 
followed by Bonferroni t-test. A p-value of 0.05 was considered to be significant. Analysis was 
performed with Sigma Plot (Version 12.2, Systat Software, Chicago, IL, USA). 
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Results and discussion 
The goal of the syntheses was to couple the PEG moiety directly to the functionalized end of the 
PEI chain. As can be seen from Figure 1 two different synthesis strategies for the attachment of 
a shielding moiety onto PEI were employed. The difference between the two synthesis routes 
was that the first one yielded nondegradable copolymers (Figure 1, component 6) which were 
synthesized with the help of maleimides while the second one resulted in reductively degradable 
copolymers connected via disulfide bonds (Figure 1, component 9). The advantage of this 
strategy was that it only allowed for the formation of linear copolymers where one PEI was 
attached to one PEG chain. Product mixtures or multiple graftings were excluded. Furthermore,  
5 8
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fuming HCl,
95°C, 1d
1) 90°C, 3-6 d
2) sodium thioacetate, rt, 4 h 
    
 
Figure 1. Synthesis scheme for both copolymers synthesis routes yielding stable thioether 
bonds (left side) or degradable disulfides (right side). 
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both segments were strictly separated which reduced the probability of interference of the PEG 
chain with the polyplex formation. The library of stable polymers was used to deduce the 
influence of PEGylation and PEI chain length on the physiochemical characteristics and the 
performance in cell culture. In a second step cleavable copolymers were synthesized for a 
comparison between stable and cleavable copolymers. 
Synthesis of PEI-S-PEG 
The first synthetic approach aimed at the formation of non cleavable copolymers which were 
connected via thioether bonds. These polymers were synthesized by adding a solution of lPEI-  
 
Figure 2. 1H-NMR of PEG-S-PEI copolymer recorded in D2O. The NMRs showed the two 
backbone peaks (a) and (b) of the polymers. The ratio of the peak areas corrected for the 
molecular weights of each polymer were used for the analysis of the purity. 
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thiol to commercially available mPEG-maleimide (Figure 1, left side).  
In the first step the PEI part was reduced with NaBH4 generating thiol ends in situ. Then it was 
mixed with mPEG-maleimide, the pH was adjusted to 7.2 according to the manufacturer´s 
instructions as well as literature [29] and the mixture was stirred overnight. After excessive dialysis 
and subsequent lyophilisation the product was dissolved in D2O and analyzed by 
1H-NMR 
(Figure 2).  
 
Characterization of the complexation ability 
The resulting non cleavable copolymers had to proof their performance as compacting agents 
for nucleic acids. They were tested for their complexation ability for the different demands of 
large, flexible pDNA with a molecular weight of several kilo base pairs as well as the 
requirements of short, stiff siRNA made from 21-23 base pairs [30-32]. The two main parameters 
which were screened were the complex formation monitored by polyplex size as well as the 
stability of the polyplexes examined by an ethidium bromide (EtBr) exclusion assay. In both 
cases different N/P ratios (the ratio between the number of protonatable amines of the carrier 
and negatively charged phosphates in the nucleic acid backbone) were examined. The analysis 
of polplexes built from pDNA at N/P 3 gave clear differences between the polyplexes built from 
homo- and copolymers. The polyplexes with pure PEI were very large (up to 900 nm) whereas 
the copolymers with longer PEG chains formed smaller polyplexes (Figure 3). In many cases a 
short PEG chain of 2 kDa was not enough to completely shield the nucleic acids and, thus, the 
resulting polyplexes aggregated and were nearly as large as the polyplexes from the 
homopolymer PEI. If PEIs with a molecular weight (MW) of up to 4.9 kDa were used the sizes of 
the polyplexes with 5 kDa as well as 10 kDa PEG chains were small (about 100 nm). If the MW 
of PEI increased then the shielding effect of PEG seemed to be diminished, especially for the 
PEG 5 kDa polyplexes. Thus, there was a clear trend: the longer the PEG chain was the smaller 
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were the resulting polyplexes. A similar tendency could also be observed for the polydispersity 
indices (Pdis) (data not shown). They are a measure for the homogeneity of the polyplex sizes. 
The smaller the Pdi the more homogene is the sample. The smallest values were obtained for 
copolymers with PEG 10 kDa while the highest values were characteristic for polyplexes from 
pDNA and unmodified PEI. 
 
 
Figure 3. Polyplex size for polyplexes built from PEI-S-PEG copolymers and pDNA at a N/P 
ratio of 3 in 150 mM NaCl. The molecular weight of PEI is presented on the x-axis, while the 
legend gives the molecular weight of the PEG part of the copolymers.  "-" indicates unmodified 
PEI. The hydrodynamic diameter of all copolymer polyplexes was significantly different from PEI-
polyplexes with p>0.05. The only exception was PEI 6.7-S-PEG 2000. 
Compared to pDNA siRNA generally formed smaller polyplexes with every polymer (Figure 4). 
Again if the PEI MW was not higher than 4.9 kDa the polyplexes were not larger than 250 nm. If 
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the molecular weight of PEI increased then the polyplexes grew up to about 400 nm. But there 
were no big differences in size if the polyplexes from pure PEI and the copolymers were 
compared. Only the polyplexes with the PEG 10 kDa showed slightly reduced sizes but not as 
distinct as in the case of pDNA. The same was true for the Pdis (data not shown). All of them 
were small (0.05-0.30) indicating homogenous polyplexes. 
 
Figure 4. Polyplex size for polyplexes built from PEI-S-PEG copolymers and siRNA at a N/P 
ratio of 3 in 150 mM NaCl. The molecular weight of PEI is presented on the x-axis, while the 
legend gives the molecular weight of the PEG part of the copolymers. "-" indicates unmodified 
PEI. Whenever the hydrodynamic diameter of the polyplexes made from copolymers was 
statistically different from the polyplexes with PEI (p<0.05) it is indicated with    . 
Beside polyplex sizes we also investigated the ability to exclude EtBr from the intercalation with 
nucleic acids. In order to directly compare the homo- and copolymers, the relative fluorescence 
of EtBr in PEG-PEI polyplexes was related to PEI polyplexes and the relative quenching was 
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plotted. Most polyplexes from copolymers and pDNA quenched EtBr better than polyplexes 
made from PEI alone (Figure 5). The better EtBr is prevented from the intercalation with the 
nucleic acid the stronger is the interaction between the polymer and its payload and, thus, the 
more stable is the whole complex resulting in relative quenching values below 1. In most cases 
the polyplex stability seemed to profit from the PEG attachment. Only sometimes longer PEG 
chains seemed to be obstructive. 
 
Figure 5. Relative fluorescence loss of EtBr after complexation of pDNA with PEI and the 
corresponding PEG-S-PEI copolymers at a N/P ratio of 3. The MW of PEG is indicated on the x-
axis (“-“ indicates the homopolymer), while the MW of PEI is given in the legend. Statistically 
significant differences between the polyplexes from copolymers and those from PEI were found 
for all copolymers (p<0.05).  
In the case of siRNA the differences in fluorescence loss was not as pronounced as for pDNA 
and these differences were not always significant (especially for the copolymers with PEG 
2 kDa). But it can be seen from the small quenching ratio compared to polyplexes from pure PEI 
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that especially polyplexes with PEG 5 kDa were very stable (Figure 6). The next best performing 
polyplexes were those from polymers with PEG 10 kDa. In the case of PEG 2 kDa large 
differences in the quenching ability of the copolymers were obtained. It seemed that there was a 
lower PEI molecular weight limit for beneficial complexation performance especially with siRNA. 
Furthermore, PEG chains normally did not interfere with complex formation but even boosted 
complex formation independently of the nucleic acid used. The small performance differences 
between pDNA and siRNA were probably due to the different structures of the nucleic acids. 
Although it is known that not all carriers which are suitable for pDNA delivery perform well for 
siRNA [33-34] our copolymers seemed to be suitable carriers for both nucleic acids. So copolymers 
with strictly linear assembly allow for the condensation of large and flexible DNAs as well as for 
  
Figure 6. Relative fluorescence loss of EtBr after complexation of siRNA  with PEI and the 
corresponding PEG-S-PEI copolymers at N/P 3.The MW of PEG is indicated on the x-axis (“-“ 
indicates the homopolymer), while the MW of PEI is given in the legend. 
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the short and stiff RNAs. By fine-tuning of the PEG-PEI ratio superior condensing agents can be 
obtained. Thus, our results suggest that PEG chains with a molecular weight above 2 kDa are 
needed for the formation of stable polyplexes- independent of the nucleic acid used. 
Synthesis of PEI-SS-PEG 
For the synthesis of the degradable copolymers (Figure 1, component 9) two different 
components were needed: On the one hand the activated PEI-SS-pyr (Figure 1, component 7, 
see chapter 3 for the description of the synthesis) and on the other hand a PEG with a thiol end 
or a group which could be converted into a thiol in situ such as the thioacetate (Figure 1, 
component 8, PEG synthesis depicted in Figure 7).  
 
 
Figure 7. Synthesis scheme for the conversion of mPEG-OH into mPEG-SH. 
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As seen for the PEI synthesis in the previous chapter it was again important to create thiols in 
situ in order to avoid their oxidation forming PEG-SS-PEG copolymers. The best suited 
functional group for this task is the thioacetate group which can be cleaved in acidic as well as 
basic media and whose cleavage by-product acetic acid can be easily removed by evaporation 
or dialysis. A convenient starting material for all syntheses with PEG is the commercially 
available methoxyPEG-OH (mPEG-OH).  
Since the hydroxyl group is not very eager to react it has to be activated first. This is commonly 
performed by tosylation replacing the hydroxyl group by a good leaving group [35-38]. 
 
Figure 8. 1H-NMR of mPEG-tosylate recorded in CDCl3. The peak for the methoxy group of 
PEG (a) was set to 3 and the area of the tosylate protons (c) and (d) was calculated according to 
this setting. The conversion degree was calculated from the ratio of the theoretical area of 2 for 
each aromatic tosylate peak and the area determined by 1H-NMR. 
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With the help of DMAP as catalyst and triethylamine as base the tosylate was added to the PEG 
end (Figure 7). The successful conversion could be monitored by 1H-NMR (Figure 8). Typical 
conversion degrees were about 90%. 
According to Figure 7 the second step of the synthesis involved the substitution of the tosylate 
by a thioacetate which was the precursor for the thiol. Once more the successful conversion was 
monitored by 1H-NMR (Figure 9). Typical overall conversation degrees were about 80-85%.  
 
Figure 9. 1H-NMR of mPEG-SAc recorded in CDCl3. The methoxy peak (a) was used for scaling 
and was set to 3. The methyl peak of the thioacetate (d) and the peak of the methylene group 
between the PEG chain (b) and the thioacetate (c) accounted for 3 or 2 protons, respectively. 
The conversion degree was determined as the ratio of the theoretical values and the obtained 
peak areas. 
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In the following step the obtained thioacetate had to be cleaved in order to gain the requested 
thiol (Figure 7). Due to the instability of this thiol which prohibited any time-consuming analyses 
it was important to find suitable reaction conditions for the thioacetate cleavage. So three 
different cleavage conditions were tested, namely stirring the PEG in 0.1M HCl in methanol at 
95°C or at rt [39] or boiling it at 95°C in a 1:1 mixture of water and methanol which was acidified 
with fuming HCl [40]. At different times samples were taken and mixed with DTDP assay solution. 
The DTDP reacted with the available thiols forming a mixed disulfide between PEG and DTDP 
which could be analyzed spectrophotometrically after 5 min incubation time. The maximum 
amount of thiol was calculated from the initial weight of PEG and its conversion degree which 
was determined by 1H-NMR. It can be seen from Figure 10 that the amount of thiol increased 
with longer reaction times for all three cleavage conditions. The reaction at rt was the 
 
Figure 10. Influence of different reaction conditions and reaction times on the cleavage of the 
thioacetate moiety. The reaction time is given on the x-axis, while the percentage of cleavage is 
indicated by the y-axis. The reaction conditions can be found in the legend. 
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slowest reaction and was only after the longest reaction time (18 h) comparable with the two 
other conditions. The cleavage in boiling 0.1M HCl in methanol reached a plateau after about 
4 h. In contrast, the acidified mixture of water and methanol needed about 7 h until it reached its 
plateau but this condition resulted in the highest cleavage rates. Thus, to guarantee for the best 
cleavage rate for further syntheses the thioacetate was boiled in the acidified water methanol 
mixture for 8 h.  
For the coupling of the two polymers 1 thiol eq. of the activated lPEI-SS-pyr was added to the 
acidified PEG-SAc solution after the cleavage time of 8 h and the mixture was stirred overnight. 
Subsequently, the product was analyzed by 1H-NMR in D2O (Figure 11). 
Figure 11. 1H-NMR of a PEG-SS-PEI copolymer recorded in D2O. The two backbone peaks for 
the PEI  (b) and the PEG chains (a)  were used for scaling. The purity of the product was 
determined as the ratio of the peaks for PEG and PEI corrected for the molecular weight of each 
polymer.  
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The resulting library of copolymers was analyzed for its complexation ability as well as for its 
transfection efficiency. The results of these investigations are given in Chapter 5. 
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Conclusion 
We successfully synthesized libraries of both stable thioether connected and degradable 
disulfide linked PEG-PEI copolymers. The library of stable thioethers was built from PEI and 
mPEG maleimide. The obtained copolymers were used for a first test of the complexation 
abilities for pDNA and siRNA carried out by an EtBr exclusion assay and determination of 
polyplex sizes. In the case of pDNA the measured polyplex sizes revealed a distinct division. 
While homopolymers and polymers with a short 2 kDa PEG chain built rather large polyplexes 
(up to 900 nm), the particles from copolymers with longer PEG chains (5 kDa and 10 kDa) gave 
much smaller sizes (commonly below 150 nm) and their size distribution was more uniform. In 
contrast, the polyplexes assembled from siRNA were all comparably small (about 100-350 nm). 
Furthermore, the quenching assay proved better complexation ability for siRNA as well as pDNA 
for nearly all copolymers compared to the homopolymers. This makes the PEG-PEI copolymers 
very promising carriers for such structurally diverse nucleic acids as siRNA and pDNA. For the 
synthesis of degradable copolymers a thiol-functionalized PEG was created. Here we 
established a reaction were thiols were formed in situ and instantly coupled the PEI moiety to the 
PEG chains. The resulting library can be used for an investigation of structure-activity-
relationships as well as intracellular processing of the cleavable copolymers.  
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Abstract 
A library of 39 strictly linear poly(ethylene glycol)-poly(ethylene imine) (PEG-PEI) diblock 
copolymers was synthesized for the delivery of plasmid DNA using PEG of 2, 5 or 10 kDa in 
combination with linear PEI with a molecular weight (MW) ranging from 1.5 to 10.8 kDa. In 
contrast to other approaches, the copolymers demonstrated a clear separation between the 
hydrophilic PEG and the nucleic acid condensing PEI moieties. Hence, the hypothesis was that 
PEG may not sterically counteract the interaction between the nucleic acid and PEI and that 
consequently, the copolymers are perfectly suited to build small and stable polyplexes. Analysis 
of the polyplexes revealed structure-function relationships and a general guideline was that the 
PEG domain had a greater influence on the physicochemical properties of the polyplexes than 
PEI. A PEG content higher than 50% led to small (< 150 nm), nearly neutral polyplexes with 
favorable stability. The transfection efficacy of these polyplexes was significantly reduced 
compared to the PEI homopolymer, but restored by the application of the corresponding 
degradable copolymer, which involved a redox triggerable PEG domain. In conclusion, valuable 
design criteria for the optimization of gene delivery carriers, which is only possible through the 
screening of such a large library, was gained. 
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Introduction 
The development of efficient and safe carriers for the delivery of nucleic acids would be an 
outstanding achievement for the treatment of genetic disorders as well as cancer [1,2]. Since its 
introduction in 1995 [3], poly(ethylene imine) (PEI) has asserted its position as one of the most 
intensively investigated polymer-based non-viral gene carriers [4,5]. The favorable properties of 
PEI allow for condensation and protection of the genetic material in the extracellular 
environment, and also achieve endosomolysis and subsequent release of the nucleic acid into 
the cell interior [4,5]. Despite these advantages, the broad use of PEI experiences severe 
limitations because the transfection efficacy and toxicity of PEI-polyplexes (polyelectrolyte 
complexes built of PEI and nucleic acids) are strongly correlated [6-9]. Moreover, PEI-polyplexes 
tend to aggregate under physiological conditions [4,5], which may be particularly 
counterproductive for in vivo application [5,10]. 
A common approach to address these shortcomings is to shield the positive surface charge of 
PEI-polyplexes by the covalent attachment of a hydrophilic, protective polymer layer using 
poly(ethylene glycol) (PEG) [4,5,11], a strategy also called PEGylation. Different types of PEG-PEI 
copolymers have been synthesized with block, alternating, or statistical composition arranged in 
linear, branched, graft, or star topology and varying molecular weight (MW) of PEG [11-17]. The 
PEG moiety of these copolymers is generally believed to provide for polyplexes with reduced 
surface charge and a lower tendency towards aggregation [18,19]. In contrast, the effect of PEG on 
the transfection efficacy is controversially discussed [11]. Depending on the degree of PEGylation, 
a reduced transfection rate was reported [20,21], while other studies revealed a similar or even 
higher transfection efficacy of PEGylated versus non-PEGylated polyplexes [14,16,17,22,23]. Reasons 
for this controversy are manifold and may be returned to the following limitations: First, many of 
these PEG-PEI copolymers bear a PEG moiety that is not clearly separated from the PEI moiety. 
Consequently, PEG may sterically counteract the interaction between the DNA and the 
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polycation [11,24], thereby interfering with the particle formation process and the polyplex stability. 
Second, the synthesis routes proposed for these PEG-PEI copolymers lead to a product mixture 
because one PEI molecule is not connected to a defined number of PEG molecules. This makes 
the experimental readout difficult to interpret.  
We hypothesized that strictly linear PEG-PEI diblock copolymers may overcome these 
limitations. Therefore, we connected linear PEI with a MW ranging from 1.5 to 10.8 kDa via a 
thioether bond to PEG with a MW of 2, 5 or 10 kDa. This resulted in a library of 39 copolymers 
(PEG-S-PEI), which were compared to the respective homopolymers. To screen for the optimal 
copolymer composition, the size, zeta potential, stability and biological activity of the polyplexes 
were analyzed. Additionally, since the PEG moiety may hamper the endosomal escape and 
further intracellular processing of the polyplexes [25], we synthesized a set of reductively 
degradable copolymer counterparts (PEG-SS-PEI). The intention was that these degradable 
polymers would shed off the PEG domain in the intracellular environment thereby restoring the 
transfection efficacy. The detailed correlation of the copolymer composition with the 
physicochemical properties and biological activity of the polyplexes will reveal structure-function 
relationship and give key features for the design of future gene carriers. 
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 Materials and Methods 
Materials 
2-ethyl-2-oxazoline, methyl-p-toluene sulfonate, sodium borohydride (NaBH4), 2,2`-dithio 
dipyridine (DTDP), methoxy-PEG-OH, 4-dimethylaminopyridine (DMAP), triethylamine, 
magnesium sulfate, potassium thioacetate, ethidium bromide (EtBr), propidium iodide, calcium 
hydride, Tris, heparin, Ham´s F12 and MEM-Eagle medium were from Sigma-Aldrich Chemie 
GmbH (Steinheim, Germany). Acetonitrile, diethyl ether, fuming HCl, NaOH, chloroform were 
purchased from Merck KGaA (Darmstadt, Germany). Dimethylformamide (DMF), 
dichlormethane were obtained from Acros Organics (Belgium). PEG-maleimides of various MW 
were from or IRIS Biotech GmbH (Martkredwitz, Germany). Trypsin, PBS buffer, YOYO-1 and 
CellMaskTM deep red plasma membrane stain were received from Life Technologie GmbH 
(Darmstadt, Germany). CDCl3 and D2O were purchased from Deutero GmbH (Kastellaun, 
Germany). µ-silde 8 well ibiTreat microscopy chambers were from Ibidi GmbH (Martinsried, 
Germany). Acetonitrile, DMF and 2-ethyl-2-oxazoline were distilled over calciumhydride. Methyl-
p-toluene sulfonate was dried in vacuo before use. All other chemicals were used as received. 
The plasmid DNA encoding enhanced green fluorescent protein (EGFP) (pEGFP-N1, Clontech) 
was used as reporter gene and isolated from E. coli JM 109 strain using a Qiagen Plasmid Maxi 
Kit (Qiagen, Hilden, Germany). When indicated, plasmid DNA was stained with the intercalating 
dye YOYO-1. The labeling reaction was carried out with a molar ratio of 1 dye molecule per 300 
base pairs at room temperature (rt) in the dark. CHO-K1 cells (ATCC No. CCL-61) and HeLa 
cells (ATCC No. CCL-2) were grown in 75 ml culture flasks in a 5% CO2 atmosphere at 37°C as 
adherent culture to 90% confluency before seeding. CHO-K1 cells were cultivated in Ham´s F-12 
and HeLa cells in MEM-Eagle medium containing pyruvate. Both culture media were 
supplemented with 10% fetal bovine serum (Biochrom AG, Berlin, Germany). 
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Polymer synthesis 
An overview of the synthesis of the PEG-S-PEI and PEG-SS-PEI copolymers is given in Figure 
1. The process began with the cationic ring opening polymerization of 2-ethyl-2-oxazoline (1) 
(6.25 ml) in acetonitrile (25 ml) using varying amounts of methyl-p-toluene sulfonate (2), 
depending on the desired MW of PEI. After polymerization under a nitrogen atmosphere at 90°C 
for several days (3 to 6 days, depending on the calculated MW of PEI), the reaction was cooled 
down to rt and the MW of the resulting polymer was determined by 1H-NMR. Thereafter, 7.5 eq. 
(corresponding to the MW of PEI) of sodium thioacetate in DMF (10 ml) were added and the 
reaction mixture stirred for 4 hours (h). The solvent was then removed, the residue dissolved in 
chloroform and the solution washed 3 times with water. The raw product, poly(2-ethyl-2-
oxazoline)-thioacetate (pEtOXZ-SAc) (3), was precipitated in ice cooled diethyl ether, filtrated 
and dried in vacuo (yield: ~80%). In the next step, 3 was hydrolyzed in fuming HCl (100 ml) at 
95°C for one day. After removing the HCl, the product PEI-SH (4) was dissolved in water, 
precipitated with NaOH, washed with water until the supernatant became neutral and dried in 
vacuo (yield: ~95%). The third step was the activation of component 4 with NaBH4 at pH 8.5 for 
20 minutes (min), then the reaction mixture was acidified to pH 1 in order to destroy unreacted 
NaBH4. Subsequently, each PEI derivative was coupled with methoxy PEG-maleimide (5) with a 
MW of 2, 5 or 10 kDa at pH 7.2 overnight at rt yielding PEG-S-PEI (6) (yield: ~80%). Unreacted 
components were removed by dialysis against water (48 h, dialysis medium was changed twice). 
For the synthesis of PEG-SS-PEI (9), component 4 was activated with NaBH4 as described 
above. 3 eq. of DTDP were added to the reaction mixture at pH 4 and stirred overnight. The 
crude product, PEI-pyridyl disulfide (PEI-SSpyr, 7), was dialysed against water and lyophilized. 
The second component, methoxy PEG-SAc (8), was synthesized in a 2-step procedure: dry 
methoxy PEG-OH (5 g) was tosylated using 0.5 eq. of DMAP, 1.5 eq. of p-toluene sulfonate and 
2.0 eq. of triethylamine. The reaction mixture was dissolved in dichloromethane (30 ml) and 
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stirred overnight at rt, followed by the replacement of the dichloromethane by chloroform and 
washing the crude product 3 times with water and 2 times with 0.1 M HCl. The resulting mPEG-
tosylate was dried over magnesium sulfate and in vacuo (yield: ~90%). In the second step, 
2.5 eq. of potassium thioacetate were added to the mPEG-tosylate (5 g) in DMF (25 ml) and the 
mixture was stirred for 8 h at rt. The mixture was concentrated, poured into a 10 fold volume of 
water and washed with chloroform 3 times. The organic phase was dried over magnesium 
sulfate and evaporated to dryness yielding mPEG-SAc (8) (yield: ~80-90%). Component 8 (1g) 
was then dissolved in a mixture of water and methanol (1:1, 10 ml), acidified with 5 drops fuming 
HCl and brought to reflux for 8 h. After cooling to rt and adjusting the pH to 4, component 7 was 
added and stirred overnight. The product, PEG-SS-PEI (9) (yield: ~80%), was dialyzed against 
water (48 h, dialysis medium was changed twice) and lyophilized. 
Successful conversion was monitored by 1H-NMR. 1H-NMR spectra were recorded on an 
Avance 300 spectrometer (300MHz, Bruker BioSpin GmbH, Germany). Typical chemical shift 
were as follows: 1H-NMR (CDCl3, 300 MHz) compound 3 (pEtOXZ-SAc): δH (ppm) = 0.8-1.4 (br 
s, 3H NCO-CH2-CH3), 2.2-2.6 (br m, 2H, NCO-CH2-CH3), 2.9-3.0 (t, 3H, SCO-CH3) 3.1-3.9 (br s, 
4H, -N(COEt)CH2-CH2-); 
1H-NMR (D2O, 300 MHz) compound 6 (PEI-S-PEG): δH (ppm) = 2.6-3.1 
(br s, 4H, CH2-O-CH2), 3.5-3.8 (br s, 4H, CH2-NH-CH2); 
1H-NMR (D2O, 300 MHz) compound 7 
(PEI-SSpyr): δH (ppm) = 2.6-3.0 (br s, 4H, -CH2-NH-CH2-), 7.0 (t, 1H, CAr), 7.5 (d, 1H, CAr), 7.7 (t, 
1H, CAr), 7.8 (d, 1H, CAr); 
1H-NMR (D2O, 300 MHz) compound 9 (PEI-SS-PEG): δH (ppm) = 2.8- 
3.3 (br s, 4H, -CH2-NH-CH2-), 3.5-3.7 (br s, 4H, -CH2-O-CH2-) 
Formation of polyplexes  
The polyplexes of plasmid DNA (pDNA) and polymer were prepared at different N/P ratios (ratio 
of nitrogens in polymer to phosphates in DNA). The polymer and plasmid DNA were each diluted 
in equal volumes of 150 mM NaCl. The polymer solution was added to the DNA solution, the 
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mixture was vortexed for 20 seconds and then incubated for 20 min before use. The amount of 
plasmid DNA and the total volume of the polyplex solution are given in each section. 
Particle and zeta potential measurements 
The hydrodynamic diameter and the zeta potential of the polyplexes was measured using a 
Zetasizer Nano-ZS from Malvern Instruments (Malvern, Germany) at 25°C. A 4 mW He-Ne laser 
at a wavelength of 633 nm was used as the light source. For the determination of the size, the 
measurement position was at 4.65 mm with automated laser attenuation. Scattered light was 
detected at an angle of 173° backscatter. The viscosity and refractive index of the dispersants 
were used as follows: 150 mM NaCl: 0.90 mm2/s and 1.33, respectively; culture medium: 0.90 
mm2/s and 1.681, respectively. Three measurements with 10 sub-runs were performed for each 
sample. Data were analyzed by the general purpose mode and expressed as mean ± standard 
deviation (SD). The zeta potential of the polyplexes was measured at 25°C. Three 
measurements with 10 sub-runs were performed for each sample. Data were processed in the 
monomodal mode which guarantees for good sample stability due to short measurement 
duration and then expressed as mean (± SD). For size measurements, polyplexes were formed 
by mixing 2 µg DNA and varying amounts of polymer to achieve different N/P ratios in a final 
volume of 500 µl, while for zeta potential measurements the polyplexes were built with 4 µg 
plasmid DNA in a final volume of 1000 µl. For transmission electron microscopy (TEM), the 
polyplex solution was pipetted onto carbon coated copper grids, and the counterstaining was 
performed with an uranyl acetate solution (2% w/w). Images were taken at 120 keV using a 
Philips CM12 microscope (FEI, Eindhoven, The Netherlands). As an indirect measurement for 
the protonation capacity, the zeta potential of the polyplexes was measured after dilution in Tris 
buffer at a final pH of 5.5, 6.5 and 7.4, respectively.  
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Ethidium bromide quenching assay 
The polyplexes were prepared at a N/P ratio of 1 and 6 by diluting 1 µg of plasmid DNA in a final 
volume of 100 µl. After incubation for 20 min the polyplexes were pipetted in a 96-well plate and 
mixed with 2.5 µl of a 0.1 µg/µl ethidium bromide (EtBr) solution. The fluorescence of EtBr was 
excited at 518 nm and recorded at 605 nm using a LS 55 fluorescence spectrometer (Perkin 
Elmer, Germany) and expressed as relative fluorescence compared to uncomplexed plasmid 
DNA. Measurements were performed in quadruplet. The relative fluorescence loss was 
calculated as follows: relative  
fluorescence loss = relative fluoresencePEG-PEI-polyplexes/relative fluorescencePEI-polyplexes. 
Stability of the polyplexes 
The polyplex solution (500 µl) containing 2 µg of pDNA was incubated over a time period of 10 h 
and the hydrodynamic diameter of the polyplexes was recorded every 10 min as described 
above. Alternatively, the polyplexes of plasmid DNA and polymer were prepared at a N/P ratio of 
6 using 2 µg pDNA in a final volume of 100 µl. The polyplex solution was then diluted with 400 µl 
HAM´s F12 culture medium and the hydrodynamic diameter of the polyplexes was measured as 
described above. 
Transfection studies  
HeLa or CHO-K1 cells were seeded in 24-well plates at a density of 40,000 or 38,000 cells per 
well 24 h prior to transfection. 2 µg of plasmid DNA was used to prepare the polyplexes with the 
appropriate amount of polymer to yield different N/P ratios in a final volume of 100 µl. The cells 
were washed with PBS, then 900 µl of serum free culture medium and 100 µl of polyplex 
solution was added. After 4 h the transfection medium was removed and cells were incubated 
for an additional 20 h with culture medium containing serum. After detachment of the cells from 
the surface by trypsin, extensive washing with PBS and the addition of propidium iodide 
Chapter 5                            Linear PEG-PEI copolymers to perform structure-activity-relationship 
147 
 
(1µg/ml), the analysis of the EGFP expression and cell viability was performed by flow cytometry 
using a FACSCalibur (Becton-Dickinson, Germany). EGFP was excited at 488 nm and the 
fluorescence was detected using a 515 - 545 nm bandpass filter, whereas the propidium iodide 
emission was measured with a 670 nm longpass filter. The data were analyzed using WinMDI 
2.8 software by J. Trotter. To exclude doublets and cellular debris, cells were appropriately 
gated in forward/sideward scatter plots with 20,000 events per sample. The percentage of cells 
that was positive for EGFP indicated the transfection efficacy [%] and was expressed as means 
(± SD) from three independent samples. Cells that were negative for propidium iodide accounted 
for the cell viability [%]. Cells treated with 150 mM NaCl were used as control, they had a 
threshold value of 1%. The relative transfection was calculated as follows:  
relative transfection = transfection efficacy [%]PEG-PEI-polyplexes/transfection efficacy [%]PEI-polyplexes.  
Cellular uptake 
 80,000 CHO-K1 cells per well were seeded in a 24-well plate. The polyplexes were prepared at 
a N/P ratio of 6 in 100 µl using 2 µg of YOYO-1 labeled pDNA. The cells were then treated as 
described in the previous section, but detached from the surface after 4 h by trypsin that was 
supplemented with 20 mM sodium azide. Cells were analyzed by flow cytometry as described 
above, YOYO-1 was excited with a 488 nm argon laser and detected with a 515 - 545 nm 
bandpass filter. The mean fluorescence intensity (MFI) of 20,000 gated cells was recorded as a 
measure for the amount of internalized plasmid DNA. The values were expressed as means (± 
SD) from three independent samples.  
Confocal laser scanning microscopy was performed using a Zeiss Axiovert 200 M microscope 
coupled to a Zeiss LSM 510 scanning device (Carl Zeiss Co. Ltd., Germany). CHO-K1 cells 
were plated in µ-slide 8 well ibiTreat microscopy chambers at a density of 20,000 cells per well 
and incubated with YOYO-1 labeled polyplexes. After 2 h the cell membranes were stained with 
CellMaskTM deep red plasma membrane stain as indicated by the supplier. The fluorophores 
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were then excited with 488 and 633 nm and the fluorescence was recorded with a 505 - 530 
bandpass filter and a longpass filter of 650nm. The measurements were performed using a Plan-
Apochromat 63x/1.4 oil objective at 37°C and the thickness of the optical sections was 1.1 μm. 
Toxicity  
The MTT toxicity assay was performed according to Mosmann [26] with slight modifications. 
Briefly, HeLa cells were seeded at a density of 10,000 per well into 96-well plates 24 h before 
testing. The cells were incubated for 4 hours with polymer dilutions in serum-free cell culture 
medium or cell culture medium only as a control. Then, the medium was replaced with culture 
medium containing serum. After an additional 20 h, 200 µl of [3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyl tetrazolium bromide] (MTT) (0.6 mg/ml) was added to the cells for 4 h. Unreacted dye 
was removed and 110 µl of a 10 % SDS solution were added to each well for a further 22 h. The 
optical density (OD) of each well was determined on a TitertekPlus Microplate Reader 
(Bartolomey Labortechnik, Germany) with 570 nm as test wavelength and 690 nm as reference 
wavelength. Each polymer concentration was tested in sextuplet. The relative viability was 
calculated by ODtest/ODcontrol x 100%. The IC50 values were determined by fitting the calculated 
values in a four parameter logistic curve using Sigma Plot (Version 12.2, Systat Software, 
Chicago, IL, USA). 
Statistics  
Results are shown as mean (± SD). Experiments were performed in triplicate if not indicated 
otherwise. Significance between two groups was tested using a one-tailed Student's t-test. A p-
value < 0.01 was considered to be significant. Significance between the mean values of the 
homopolymer and copolymer polyplexes was calculated using one-way ANOVA analysis 
followed by Bonferroni t-test. A p-value of 0.05 was considered to be significant. Analysis was 
performed with Sigma Plot (Version 12.2, Systat Software, Chicago, IL, USA). 
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Results 
Synthesis of the PEG-PEI copolymers  
The library of PEG-PEI copolymers was prepared in a multi-step procedure starting with the 
polymerization and the activation of the PEI block, followed by the coupling of PEI and PEG 
either via a thioether or disulfide bond yielding non-degradable PEG-S-PEI or degradable PEG-
SS-PEI copolymers, respectively (Figure 1). 
 
Fig. 1. Synthesis scheme for PEG-S-PEI and PEG-SS-PEI block copolymers.  
 
To this end, 13 different linear PEI derivatives with a molecular weight (MW) ranging from 1.5 to 
10.8 kDa were polymerized in a parallel approach. Their MW was controlled by the ratio of the 
monomer 3-ethyl-2-oxazoline (1) and the starter methyltosylate (2) and was determined by 1H-
NMR (see Supporting Information, Figure S1 and Table S1). The reactive group was then 
introduced by stopping the reaction with a thioacetate, producing poly(2-ethyl-2-oxazoline)-
thioacetate (pEtOXZ-SAc) (3) (see Supporting Information for 1H-NMR, Figure S2), which was 
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hydrolysed to thiolated PEI (4). Each PEI derivative was then coupled to methoxy PEG-
maleimide (5) of 2, 5, or 10 kDa, leading to the final PEG-S-PEI (6) copolymers (see Supporting 
Information for 1H-NMR, Figure S3). According to Figure 2, the synthesis resulted in a library of 
39 co- and 13 homopolymers which are denoted as follows: PEG(x)-S-PEI(y) or PEI(y), where x 
represents the MW of the PEG and y the MW of the PEI. The PEG content of the copolymers 
covered a range of about 15 to 90%. 
 
Fig. 2. Composition of the PEG-S-PEI block copolymers. The MW of PEG (black bars) was 2, 5 
or 10 kDa and is indicated as received by the manufacturer. The PEI MW (gray bars) ranged 
from about 1.5 to 10.8 kDa and was determined by 1H-NMR. Because the MW of PEG and PEI 
were determined by two different methods (gel permeation chromatography and 1H-NMR, 
respectively), they can not be directly compared, and one should be aware that the MW is a 
distribution around an average value. The black dots indicate that more homo- and copolymers 
were synthesized than shown in the Figure. 
 
Additionally, a set of reductively degradable counterparts (PEG-SS-PEI, 9) was synthesized. In 
this case, component 4 reacted in a disulfide exchange reaction to form PEI-pyridyl disulfide 
(PEI-SSpyr, 7), which was thereafter coupled to mPEG-SAc (8) with a MW of 5 kDa. The PEG-
SS-PEI copolymers are denoted analogously to the PEG-S-PEI block copolymers. The synthesis 
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route only allowed for the coupling of one PEG to PEI molecule as proposed in Figure 1, and 
uncoupled PEG and PEI were removed by dialysis of the copolymers. The composition of the 
copolymers was calculated using the appropriate signals in 1H-NMR spectra as well as the PEG 
and PEI content of the copolymers (data not shown), and was in good agreement with 
theoretical values. 
Physicochemical characterization of the polyplexes 
Polyplexes of PEG-S-PEI copolymers and plasmid DNA were formed under physiological salt 
concentrations at a N/P ratio of 6 to study the influence of the copolymer composition on the size 
of the polyplexes (for other N/P ratios see Supplementary Information, Figure S4). With 
increasing MW of PEG in the copolymer, the hydrodynamic diameter of the polyplexes 
decreased (Figure 3A). The hydrodynamic diameter of pure PEI-polyplexes ranged from about 
650 to 950 nm, while polyplexes fabricated with PEG(10)-S-PEI were significantly smaller with 
hydrodynamic diameters from about 75 to 150 nm. Considering the polyplex size according to 
the PEG content of the copolymers, a minimum of about 50% PEG was necessary to form 
polyplexes smaller than 150 nm. In contrast, the influence of the PEI MW on the polyplex size 
was less pronounced. The polydispersity index (PI), which estimates the width of the size 
distribution of the polyplexes, showed a similar trend (Supplementary Information, Figure S5) 
indicating that polyplexes built with PEG(10)-S-PEI copolymers were more homogeneously 
distributed compared to the other ones. Transmission electron microscopy (TEM) images 
confirmed this trend. PEI-polyplexes were large and formed aggregates (Figure 3B), while 
PEG(10)-S-PEI-polyplexes were much smaller and had a spherical or elliptical morphology 
(Figure 3C). 
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Fig. 3. Physicochemical characterization of the polyplexes: (A) The hydrodynamic diameter of 
polyplexes assembled of plasmid DNA and PEG-S-PEI copolymers or PEI homopolymers at a 
N/P ratio of 6 in 150 mM NaCl as determined by dynamic light scattering. The MW of PEG [kDa] 
is presented on the x-axis (“-“ indicates the homopolymer), while the MW of PEI [kDa] is given in 
the legend. The hydrodynamic diameter of PEG(5)-PEI- and PEG(10)-PEI-polyplexes were 
significantly different from PEI-polyplexes with p < 0.05, which is indicated by *. (B and C) are 
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electron micrographs of PEI(4.0)- and PEG(10)-PEI(4.0)-polyplexes, respectively. The size of 
PEI-polyplexes is larger than measured by dynamic light scattering, most likely due to 
aggregation artifacts during sample preparation. (D) The zeta potential of the polyplexes at a 
N/P ratio of 6. The MW of PEG [kDa] is presented on the x-axis (“-“ indicates the homopolymer), 
while the MW of PEI [kDa] is given in the legend. The zeta potential of PEG(5)-PEI- and 
PEG(10)-PEI-polyplexes were significantly different from PEI-polyplexes with p < 0.05, which is 
indicated by *. Exceptions were the zeta potentials of PEI(2.1) and PEI(2.3). (E) shows the 
relative fluorescence of EtBr after complexation of plasmid DNA with PEG-S-PEI copolymers 
compared to pure PEIs at N/P 6. The MW of PEG [kDa] is presented on the x-axis (“-“ indicates 
the homopolymer), while the MW of PEI [kDa] is given in the legend.  
 
The zeta potential is one of the most important factors determining the stability of the polyplexes 
as well as their interaction with cells. As expected, polyplexes built with pure PEI showed a 
positive zeta potential of about +10 to +25 mV, which decreased with the MW of the PEG in the 
PEG-S-PEI copolymers (Figure 3D). The zeta potential of polyplexes formed with PEG(10)-S-
PEIs was particularly effectively reduced to values below ~ +3 mV, irrespective of the PEI 
derivative. Also at other N/P ratios, the PEG(10)-S-PEI polyplexes had a zeta potential around 
zero (see Supplementary Information, Figure S6). Considering again the polyplex properties with 
respect to the PEG content, copolymers with more than 50% PEG formed polyplexes with low 
zeta potential.  
The DNA condensation ability of the co- and homopolymers was investigated by the quenching 
of EtBr fluorescence. In order to directly compare the homo- and copolymers, the relative 
fluorescence of EtBr in PEG-PEI-polyplexes was related to PEI-polyplexes and expressed as 
“relative fluorescence” (Figure 3E). All PEG-PEI-polyplexes displayed a lower relative 
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fluorescence compared to the PEI-polyplexes, exceptions were PEG-S-PEI(1.5) and PEG-S-
PEI(2.1). 
To evaluate the stabilizing effect of PEG on the polyplexes, the complex size was monitored 
over a time period of 10 h (Figure 4). As expected, the hydrodynamic diameter of polyplexes 
built with pure PEI and with PEG(2)-PEI copolymers increased up to 4 fold. For PEG(5)-PEI or 
PEG(10)-PEI, the stability of the polylplexes depended on the PEG content in the copolymer. 
Copolymers with >50% PEG allowed for excellent stability of the corresponding polyplexes 
(Figure 4A and B). In contrast, a PEG content below 50% lead to aggregation or only limited 
stability (Figure 4C). The favorable stability of PEGylated polyplexes bearing a PEG content 
> 50% was also confirmed by measuring the size of the polyplexes after dilution in cell culture 
medium (Supporting Information, Table S2). Similar results were obtained by challenging the 
polyplex stability using the extracellular matrix component heparin (see Supporting Information, 
Figure S7) 
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Fig. 4. Hydrodynamic diameter of polyplexes at a NP ratio of 6 built with PEI of 3.0 (A), 4.1 (B) 
and 9.0 (C) kDa ( ) and the corresponding PEG(2)-S-PEI ( ), PEG(5)-S-PEI ( ) and 
PEG(10)-S-PEI ( ) copolymers as determined by dynamic light scattering over a time period 
of 10 h. 
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If PEG is attached to the surface of a nanoparticle in low density, it will take the mushroom 
conformation and presumably not provide for a good colloidal stability [27]. At higher packing 
density, the PEG chains are more extended and found in the brush conformation, and are 
consequently leading to a much better colloidal stability [27]. We roughly estimated, which 
conformation PEG may take on the surface of the polyplexes depending on the MW of PEG and 
PEI. These considerations were in very good agreement with polyplex stability data (Supporting 
Information, Table S3). 
Biological activity of the polyplexes 
The transfection efficacy of the PEI- and PEG-S-PEI-polyplexes at N/P 6 was determined by 
measuring the expression of EGFP in CHO-K1 cells (for other N/P ratios see Supplementary 
Information, Figure S8). The percentage of EGFP positive cells depended on the MW of PEG 
and PEI in the copolymers (Figure 5A). PEI with a MW of 4.9 kDa and lower yielded a moderate 
transfection efficacy, while PEIs with higher MW displayed very good transfection rates of about 
40%. If PEG(2)-PEI copolymers were used, no specific trend was observed compared to the 
corresponding PEI homopolymers. In contrast, the transfection was reduced for most PEG(5)-
PEI- and especially for PEG(10)-PEI-copolymers. The effect of PEG 10 kDa on the transfection 
efficacy of polyplexes became even more evident when the relative transfection, which is 
defined as the transfection efficacy of the PEG-PEI-polyplexes related to the PEI-polyplexes, 
was considered. Figure 5B impressively shows that the relative transfection rate of PEG(10)-
PEI-polyplexes was significantly lower than that of the PEI-polyplexes. The transfection results in 
HeLa cells were similar, and the polyplexes also provided for transfection under serum-
containing culture conditions (Supplementary Information, Figure S9 and S10, respectively).  
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Fig. 5. Transfection efficacy of polyplexes at a N/P ratio of 6 built with PEI ( ) and the 
corresponding PEG(2)-S-PEI ( ), PEG(5)-S-PEI ( ) and PEG(10)-S-PEI ( ) copolymers (A) in 
CHO-K1 cells. The MW of PEI [kDa] is indicated on the x-axis. Statistically significant differences 
of PEG(5)- and PEG(10)-PEI-polyplexes from PEI-polyplexes are indicated by * (p < 0.05). 
Additionally, the values of the transfection efficacy of the PEG-PEI-polyplexes were related to 
the corresponding PEI-polyplexes and expressed as relative transfection (B). Here, the MW of 
PEG [kDa] is shown on the x-axis (“-“ indicates the homopolymer), while the MW of PEI [kDa] is 
given in the legend.  
 
The reason for the suppression of the transfection by the application of the copolymers may be 
manifold. First, PEG(10)-PEI-polyplexes with zeta potential close to zero may be hindered from 
electrostatic interaction with cells, consequently leading to a reduced cellular uptake of the 
polyplexes and transfection rate. Alternatively, the polyplexes may still be taken up by the cells, 
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but the endosomal escape or other intracellular events may be prevented due to PEG. To test 
these possibilities, we first measured the cellular uptake of fluorescently-labeled polyplexes. 
Flow cytometry analysis revealed that there were only slight differences in the cellular uptake 
between polyplexes built with PEG-S-PEI copolymers and their corresponding PEI homopolymer 
(Supporting Information, Figure S11). To get a deeper insight into the process of cellular uptake, 
fluorescently-labeled polyplexes were incubated with CHO-K1 cells and observed by confocal 
laser scanning microscopy (Figure 6). The images illustrated that PEI- and PEG(2)-PEI-
polyplexes were much larger than PEG(5)-PEI- and PEG(10)-PEI-polyplexes. In addition, it was 
evident that more of the smaller polyplexes than the larger ones were internalized. However, a 
detailed image analysis revealed that despite the difference in the size and number of the  
 
Fig. 6. The cellular uptake of fluorescently-labeled polyplexes was observed by confocal laser 
scanning microscopy. The polyplexes are shown in green, while the cell membranes of HeLa 
cells are stained with CellMaskTM deep red plasma membrane stain and displayed in red. The 
bar indicates 10 µm.  
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polyplexes inside cells, the overall amount of plasmid DNA per cell was in the same range (data 
not shown) which corroborated the results from the flow cytometry measurements. 
To investigate the alternative possibility that PEG-S-PEI copolymers may be hampered by a 
limited intracellular processing, a set of reductively degradable PEG-SS-PEI copolymers was 
synthesized. As an example, 5 copolymers were chosen with a PEG moiety of 5 kDa and a PEI 
moiety of 2.3, 3.5, 4.0, 4.9 or 6.7 kDa. Both the PEG(5)-SS-PEI and the corresponding PEG(5)-
S-PEI copolymers were applied for transfection studies. Figure 7 clearly shows that the relative 
transfection was not only restored using PEG(5)-SS-PEI copolymers, but exceeded the relative 
transfection of PEG(5)-S-PEI-polyplexes by a factor 1.2 to 4.5.  
 
Fig. 7. Relative transfection of PEG(5)-S-PEI- and PEG(5)-SS-PEI-polyplexes at a N/P ratio of 6 
as determined by flow cytometry analysis. The MW of PEI is indicated in the legend. The relative 
transfection of degradable polyplexes was significantly different from non degradable polyplexes 
and is indicated by * (p < 0.001). 
 
To examine the reason for a limited intracellular processing in more detail, the endosomal 
escape capacity of the polyplexes was investigated. To follow up this goal, the protonation 
capacity of the polyplexes, which can be estimated by measuring their zeta potential as a 
function of pH, was determined. Figure 8 shows that the pH had no huge influence on the zeta  
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Fig. 8. The zeta potential of polyplexes assembled of plasmid DNA and PEG-S-PEI copolymers 
or PEI homopolymers at a N/P ratio of 6. The measurements were performed in Tris buffer at pH 
5.5, 6.5 and 7.4, respectively. The MW of PEI was 3.0, 4.0 and 9.0 kDa, and the MW of PEG 
[kDa] is given in the legend. 
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potential of the polyplexes. Though, as expected, the zeta potential of PEI-polyplexes tended to 
be slightly higher than for PEG-PEI-polyplexes at pH 5.5. This result was supported by an 
erythrocyte leakage assay (Supporting Information, Figure S12). 
The toxicity of the pure polymers was tested using the MTT assay. The IC50 values depended 
both on the MW of PEI and PEG. As expected, the IC50 values increased with decreasing MW of 
PEI and increasing MW of PEG (Figure 9). It was also remarkable that there was not a 
significant difference between pure PEIs and PEG(2)-PEI copolymers. Additionally, the viability 
of cells after treatment with polyplexes was evaluated using a propidium iodide staining. The 
results demonstrate that the polyplexes were not toxic to cells at the applied concentration 
(Supporting Information, Figure S13). 
 
Fig. 9. IC50 value of PEG-PEI copolymers and PEI homopolymers as evaluated by the MTT 
assay. As an example, the IC50 values of a set of 5 PEI derivatives and the corresponding 
copolymers is shown. The MW of PEG [kDa] is indicated on the x-axis (“-“ indicates the 
homopolymer), while the MW of PEI [kDa] is given in the legend. The IC50 values of PEG(10)-
PEI polyplexes were significantly different from other PEI- and PEG-PEI polyplexes, which is 
indicated by * (p < 0.05).  
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Finally, as already highlighted, the library of PEG-S-PEI copolymers was perfectly suited to draw 
correlations between the copolymer composition and the physicochemical and biological activity 
of the polyplexes. Therefore, the PEG content of PEG-S-PEI copolymers was plotted against the 
hydrodynamic diameter of the polyplexes, their zeta potential and their transfection ability 
(Figure 10). A PEG content higher than 50% led to small polyplexes (Figure 10A) with a zeta 
potential lower than 5 mV (Figure 10B). Despite the low zeta potential, these polyplexes were 
taken up by cells, but completely lost their transfection efficacy (Figure 10C). Copolymers with a 
lower PEG content were regarded as less suitable for a potential clinical application because the 
polyplexes were large, had a positive zeta potential and formed aggregates. However, those 
polymers may be less hampered concerning the endosomal escape, thereby reaching higher 
transfection rates. 
Chapter 5                            Linear PEG-PEI copolymers to perform structure-activity-relationship 
163 
 
 
Fig. 10. Correlation of the PEG content [%] of the polymers with the hydrodynamic diameter of 
the polyplexes (A), their zeta potential (B) as well as their transfection efficacy (C). The MW of 
PEG is given in the figure legend. For better clarity the standard deviations are omitted. 
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Discussion 
A new route for the synthesis of a library of well defined, linear PEG-PEI diblock copolymers 
forming polyplexes with plasmid DNA was successfully developed. These copolymers were 
prepared with the goal to elucidate the relationship between the polymer composition and the 
physicochemical properties as well as the biological activity of the polyplexes. To the best of our 
knowledge, such an extensive library of PEG-PEI copolymers with the approach to vary the MW 
of PEG and PEI has never been conducted before. The presented synthesis strategy was more 
time-consuming than other approaches leading to graft or statistical PEG-PEI 
copolymers [12,16,22], but the advantages outbalanced the alternative laborious procedure by far. 
First, a multiple addition of PEG to PEI was not possible. Consequently, the synthesis 
exclusively resulted in linear diblock copolymers. In order to determine how the polymer 
structure is related to the polyplex properties, it is necessary to produce such exactly defined 
PEG-PEI copolymers and not product mixtures. Second, in the presented linear diblock PEG-
PEI copolymers the PEG moiety is clearly separated from the PEI moiety. PEG is supposed to 
act as a shell forming, hydrophilic block, counteracting aggregation and maintaining the stability 
of the polyplexes, and the cationic PEI block is intended for interaction with the nucleic acid, 
thereby building the core of the polyplex. In contrast, PEG-PEI copolymers of other topologies 
bear no segregated hydrophilic and cationic domains, and hence the PEG moiety may provide 
for steric hindrance to the polyelectrolyte interaction [11]. Although branched PEI derivatives 
seem to have stronger condensation capacity of the nucleic acids [5,28,29], which may guarantee 
for a favorable cellular uptake and transfection efficacy [29], linear PEI was applied as cationic 
block for the copolymer synthesis. One big advantage of linear PEI is its more defined structure 
compared to branched PEI. Additionally, linear PEI seems to support the intracellular 
disintegration of polyplexes, which is very beneficial for the subsequent release of the nucleic 
acid and a high gene expression [29,30]. Moreover, we used linear PEI of low MW because it is not 
toxic to cells at the applied concentrations and N/P ratio [8]. 
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The physicochemical properties of polyplexes strongly determine their interaction with the 
biological system. Hence, the influence of PEG on these properties was of great interest. The 
size and zeta potential of the polyplexes strongly depended on the MW of PEG; they decreased 
with increasing PEG content in PEG-S-PEI copolymers. The shielding effect was particularly 
effective for PEG 10 kDa. PEG(10)-S-PEI copolymers produced polyplexes below 150 nm 
accompanied by a zeta potential close to zero, which is preferable for in vivo application [5,11,31]. 
In contrast, PEG with a MW of 2 kDa was most likely not properly oriented on the polyplex 
surface for a sufficient shielding, or long distance charge effects from the polyplex core were still 
dominating [32]. The zeta potentials of polyplexes that have been built with alternating PEG-PEI 
copolymers was not as efficiently reduced [14,16], and such a positive effect on the 
physicochemical properties of polyplexes has only been observed for triblock copolymers of 
PEG and PEI bearing an additional hydrophobic domain [33]. The favorable physicochemical 
properties of the presented PEG-PEI-polyplexes may indicate that the polyplex formation occurs 
in an oriented manner, with the PEG block squeezed away from the interaction between polymer 
and DNA [17,22,24]. An additional argument in favor of well-defined polyplexes was the quenching 
of the EtBr fluorescence, which was more efficient in copolymer- compared to homopolymer-
polyplexes. This phenomenon was also observed for other types of copolymers with PEG 
presented in a diblock like fashion [34]. The assumption that the polyplexes may be formed in an 
oriented manner was also supported by the high stability of PEG(5)-S-PEI and PEG(10)-S-PEI 
copolymer polyplexes in cell culture medium as well as in the heparin exclusion assay. Only a 
hydrophilic PEG layer pointing towards the outer regions of the polyplex may guarantee for 
stability in cell culture medium over such a long time period or against extracellular matrix 
components, respectively. In this environment, PEG chains of 5 and 10 kDa may take an 
extended conformation thereby enabling stealth properties [35]. In contrast, PEG with 2 kDa may 
have lost its flexibility or inefficiently cover the surface thereby reducing the polyplex stability. 
These findings have only been observed for grafted PEG-PEI copolymers if the grafting density 
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was close to 1, thereby yielding grafted copolymers with diblock copolymer-like character [17,22] or 
a diblock PEG-PEI copolymer built with branched PEI [13]. The latter has unfortunately not been 
tested in cell culture. However, it should be noted that these experiments give merely a hint 
towards controlled formation of the polyplexes, but no direct evidence. 
While there is a consensus about the intended influence of PEG on the physicochemical 
properties of the polyplexes, the biological activity of the polyplexes is still under debate [11]. To 
list some examples: a higher or similar transfection efficacy compared to the homopolymer was 
reported for grafted [17,22] or alternating [14,16] PEG-PEI copolymers, while a lower transfection 
ability was achieved in other studies with grafted PEG-PEI copolymers [20,21]. However, as these 
examples differ in the MW of PEG, the overall PEG content, the topology of the copolymer and 
the N/P ratio of the polyplexes and in the cell line used for transfection studies, it is hard to make 
comparisons between them. In the case of strictly linear PEG-S-PEI copolymer, the transfection 
rate of the polyplexes significantly decreased with increasing PEG content in the copolymer. 
Different reasons may be taken into account for this phenomenon and are discussed next. A 
change in the transfection rate upon PEGylation of polyplexes either to higher or lower levels is 
generally associated with changes in the cellular uptake of the polyplexes [25,36] and/ or due to 
limited intracellular processing [25]. However, both possibilities have not been systematically 
investigated for PEG-PEI copolymers to date. Surprisingly, the amount of plasmid DNA taken up 
by cells was similar for the PEG-PEI- and PEI-polyplexes and not suppressed by PEGylation of 
the polyplexes. Confocal microscopy supported these results, but additionally gave a deeper 
insight into the cellular uptake of polyplexes. PEI-polyplexes that were detected inside cells, 
were large and formed agglomerates, which was expected from the measurements of the size 
and stability. With increasing MW of PEG in the copolymers, the polyplexes inside cells became 
smaller. These findings suggested that the PEG moiety is very beneficial for producing small, 
nearly neutral polyplexes that can potentially experience cellular uptake. The exact mechanism 
of polyplex uptake is unclear and requires further investigation. An alternative explanation for the 
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reduced transfection efficacy of PEG-PEI-polyplexes may be that PEG may prevent further 
intracellular processing, as for example the endosomal escape of the polyplexes [25]. An 
argument in favor of the limited endosomal escape capacity of PEGylated polyplexes was their 
reduced protonation capacity compared to PEI-polyplexes at slightly acidic pH, which can be 
found in endosomes. Besides the reduced endosomal escape, other intracellular events may 
reduce the transfection efficacy of PEG-S-PEI-polyplexes: their higher stability may prevent an 
efficient intracellular disassembly of polyplexes, consequently leading to a limited intracellular 
release of plasmid DNA. A reversible PEG shielding that can be triggered upon a physiological 
stimulus has been proposed to restore the reduced transfection rate [11,37,38]. To follow up this 
goal, we introduced a disulfide bond between the PEG and PEI domain in the copolymer with 
the intention of triggering the PEG release due to the redox potential gradient between the extra- 
and intracellular environments [37]. As soon as the PEG layer would be shed off, the polyplexes 
would regain their higher endosomolytic properties and exhibit lower stability. Indeed, the 
introduction of a disulfide bond between the PEG and PEI moiety restored the reduced 
transfection efficacy. These results provide evidence that an intracellular mechanism could be 
involved in the limited transfection efficacy of non-degradable PEG-S-PEI copolymers. 
The investigations concerning the cytotoxicity completed the picture of PEG-PEI copolymers and 
supported the beneficial effect of the PEGylation on the properties of the polyplexes. As 
expected [18,21,22], PEGylation reduced the toxic effects of PEI. The longer the PEG chains was in 
the copolymers, the higher the IC50 values were. An exception was PEG 2 kDa, which was not 
sufficient to exert a positive effect on the cell viability compared to pure PEI. 
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Conclusion 
We successfully synthesized a library of strictly linear PEG-S-PEI copolymers. The hypothesis 
was that these copolymers would allow for systematic study of the influence of the PEG moiety 
on the physicochemical properties and biological activity of polyplexes formed with plasmid 
DNA. Non-degradable PEG-S-PEI copolymers with a PEG content higher than 50% led to small, 
nearly neutral polyplexes, eventually taking a kind of core-shell structure. The transfection ability 
of these polyplexes was lost, but restored by the application of degradable PEG-SS-PEI 
copolymer counterparts. This suggests that the intracellular cleavage of the PEG domain from 
the polyplex surface is a necessary prerequisite for the transfection process. Concerning the 
MW of the PEI moiety, two findings were relevant: first, a MW lower than 3 kDa was less suited 
to form compact and stable polyplexes. Moreover, it was evident that the transfection ability of 
the polyplexes increased with the chain length of PEI, but in the same order the toxicity also 
increased. Those toxic effects were at least partially reduced by the incorporation of a high MW 
PEG domain into the copolymer. We proved our hypothesis that strictly linear PEG-PEI 
copolymers are perfectly suited for performing structure property relationship and additionally 
gave new insights for the optimization of gene delivery carriers. 
 
 
 
 
 
 
. 
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Supporting Information 
Determination of the MW of the polymers 
The polymerization of 2-ethyl-2-oxazoline proceeds according to a living process, and all 
polymer chains have tosylate counterions at the end. Consequently, the average molecular 
weight (MW) of poly(2-ethyl-2-oxazoline) (pEtOXZ) was estimated by the ratio of the aromatic 
protons of the tosylate starter to the protons of the PEtOXZ backbone peaks (Figure S1) [1]. In 
detail, the aromatic protons d and e were each set to 2, while the methylene groups (a) and the 
propionyl side chain protons (b and c) and accounted for 4, 2 and 3 protons, respectively. This 
procedure allowed for the calculation of the amount of monomer units per molecule and finally 
for the estimation of the polymer MW. The theoretical and calculated MW of the polymers is 
given in Table S1. 
 
Fig. S1. Example of a 1H-NMR spectrum of pEtOXZ recorded in CDCl3. 
(ppm)
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Tab. S1. The theoretical and calculated MW of the polymers. 
Polymer 
MW 
pEtOXZ 
theory 
[g/mol] 
MW pEtOXZ 
calculated 
[g/mol] 
MW PEI 
theory 
[g/mol] 
MW 
PEI 
calculated 
[g/mol] 
designated 
PEI 1 3456 3456 1501 1501 PEI 1.5 
PEI 2 4606 4752 2001 2064 PEI 2.1 
PEI 3 5648 5346 2453 2322 PEI 2.3 
PEI 4 6860 6831 2980 2967 PEI 3.0 
PEI 5 7938 8019 3448 3483 PEI 3.5 
PEI 6 8415 8811 3655 3827 PEI 3.8 
PEI 7 9114 9108 3959 3956 PEI 4.0 
PEI 8 10256 9405 4455 4085 PEI 4.1 
PEI 9 11389 11385 4947 4945 PEI 4.9 
PEI 10 13622 15518 5917 6740 PEI 6.7 
PEI 11 19372 18612 8414 8084 PEI 8.1 
PEI 12 21285 20790 9245 9030 PEI 9.0 
PEI 13 22790 24849 9899 10793 PEI 10.8 
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1H-NMR of poly(2-ethyl-2-oxazoline)-thioacetate (pEtOXZ-SAc) 
 
Fig. S2. Example of a 1H-NMR spectrum of pEtOXZ-SAc recorded in CDCl3. 
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1H-NMR of the PEG-S-PEI copolymer 
 
Fig. S3. Example of a 1H-NMR spectrum of PEG-S-PEI recorded in D2O. 
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Fig. S4. Hydrodynamic diameter of polyplexes assembled of plasmid DNA and PEI ( ) or the 
corresponding PEG(2)-S-PEI ( ), PEG(5)-S-PEI ( ) and PEG(10)-S-PEI ( ) copolymers. The 
MW of PEI is indicated in each graph. The polyplexes were built at various N/P ratios in 150 mM 
NaCl and measurements were performed by dynamic light scattering. Values are expressed as 
mean ± standard deviation (SD) of three measurements of one sample.
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Fig. S5. Polydispersity indices of polyplexes assembled of plasmid DNA and PEG-S-PEI 
copolymers or PEI homopolymers at a N/P ratio of 6 in 150 mM NaCl as determined by dynamic 
light scattering. The MW of PEG [kDa] is presented on the x-axis (“-“ indicates the 
homopolymer), while the MW of PEI [kDa] is given in the legend. 
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Fig. S6. Zeta potential of polyplexes assembled of plasmid DNA and PEI ( ) or the 
corresponding PEG(2)-S-PEI ( ), PEG(5)-S-PEI ( ) and PEG(10)-S-PEI ( ) 
copolymers. The MW of PEI is indicated in each graph. 
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Tab. S2. Colloidal stability of polyplexes built with PEI derivatives of a MW ranging from 1.5 to 
10.8 kDa and the corresponding PEG(2)-PEI, PEG(5)-PEI and PEG(10)-PEI copolymers after 
dilution in culture medium. Polyplexes that remained stable after dilution in cell culture medium 
are denoted by “+”. They only slightly increased in the hydrodynamic diameter (less than 1.5 
fold, data not shown). All other polyplexes rapidly aggregated and sedimented after dilution in 
culture medium, hence a measurement of the hydrodynamic diameter by dynamic light 
scattering was not possible. 
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Heparin exclusion assay 
 
Fig. S7. The stability of the polyplexes was also examined by an heparin exclusion assay. To 
this end, polyplexes containing 2 µg plasmid DNA were prepared at N/P 6 in a final volume of 90 
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µl (n=3). Polyplexes were prepared with PEI(3.0), PEI(4.0) and PEI(9.0) and the corresponding 
copolymers. Subsequently, the polyplexes were incubated with 20 IU heparin (10µl) for 10 min 
at rt ( ) and compared to polyplexes without heparin treatment ( ). Then 2.5 µl of a 0.1 µg/µl 
ethidium bromide (EtBr) solution was added, and the plasmid DNA release was analyzed 
measuring the fluorescence of EtBr (excitation 518 nm, emission 605 nm, LS 55 fluorescence 
spectrometer (Perkin Elmer, Germany)). The fluorescence of plasmid DNA was related to the 
fluorescence of uncomplexed plasmid DNA and expressed as “relative fluorescence”. 
The release of plasmid DNA from polyplexes built with PEG-PEI(3.0) and PEG-PEI(4.0)-
copolymers was much lower than from the corresponding homopolymer-polyplexes indicating a 
stabilizing effect of PEG on the polyplexes. PEI(9.0) allowed for a much lower release of plasmid 
DNA than the PEI derivatives of lower MW after heparin treatment. Consequently, the plasmid 
DNA release from PEG-PEI(9.0)-polyplexes was in a similar range as from the homopolymer-
polyplexes indicating a similar stability against the extracellular matrix component heparin. 
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Estimation of the PEG conformation and stability of polyplexes 
If PEG moieties are attached to a surface, they can take either the so-called brush or mushroom 
conformation [2]. In the mushroom conformation, the chains have a low packing density and are 
randomly oriented. Polyplexes bearing PEG chains in the mushroom conformation are most 
likely insufficiently protected and unstable. In the brush conformation, the PEG chains maintain a 
higher packing density and are more extended. Consequently, the polyplexes are most likely 
stable. 
The conformation of PEG can be estimated as follows [2,3]: The number of PEG molecules on the 
surface of a polyplex allows for the determination of the packing density Γ and hence, the 
distance dp between two PEG chains on the polyplex surface. Furthermore, the radius of the 
random coil form of PEG in solution is expressed by the Flory radius RF = aN
3/5 (a: monomer 
size; N: degree of polymerization). The comparison of dp and RF allows for the determination of 
the conformation that PEG takes on the polyplex surface. If dp > 2 RF, PEG takes the mushroom 
conformation. If the PEG chains form the brush conformation, then dp is smaller than RF. 
For the calculation, the following assumptions were made: Complete charge neutralization of 
polyplexes is realized at N/P ~ 2.5 and according to [4] one polyplex contains about 3.5 plasmid 
DNA molecules. Furthermore, we assumed that PEI and plasmid DNA are located in the 
polyplex core with PEG forming a corona. The diameter of the polyplex core was calculated from 
the hydrodynamic diameter of the polyplexes at N/P 2.5 as measured by dynamic light scattering 
minus two times the Flory radius RF of PEG. The PEG grafting density Γ arises from the number 
of PEG molecules per surface area and was calculated with dp = Γ
-0.5. 
 
 
Tab. S3. Estimation of the distance of PEG chains on the polyplex surface at N/P 2.5. If dp > 2 
RF, PEG should take the mushroom conformation, consequently producing unstable polyplexes. 
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These polyplexes are indicated by the yellow color. These theoretical considerations and 
calculations are in quite good agreement with polyplex stability data. 
 
PEG 10kDa, RF = 9.08 nm
PEI [kDa] PEI [kDa]
PEG-PEI 
molecules/ 
polyplex
diameter 
polyplex
[nm]
diameter 
polyplex core
[nm]
surface 
polyplex core
[nm
2
]
PEG grafting
density Γ
distance polymer 
chains dp
[nm]
1500 1.5 2223 89 71 15764 0.1410 2.6
2100 2.1 1588 84 66 13685 0.1160 2.9
2300 2.3 1450 85 67 14180 0.1022 3.0
3000 3.0 1112 80 62 11876 0.0936 3.2
3500 3.5 953 109 91 26123 0.0365 5.1
3800 3.8 878 110 91 26218 0.0335 5.3
4000 4.0 834 167 149 69627 0.0120 8.9
4100 4.1 813 89 71 15956 0.0510 4.3
4900 4.9 681 82 64 12999 0.0524 4.2
6700 6.7 498 99 80 20296 0.0245 6.2
8100 8.1 412 172 154 74575 0.0055 13.1
9000 9.0 371 91 73 16753 0.0221 6.5
10800 10.8 309 123 105 34494 0.0090 10.3
PEG 5kDa, RF = 5.99 nm
PEI [Da] PEI [kDa]
PEG-PEI 
molecules/ 
polyplex
diameter 
polyplex
[nm]
diameter 
polyplex core
[nm]
surface 
polyplex core
[nm
2
]
PEG grafting
density Γ
distance polymer 
chains dp
[nm]
1500 1.5 2223 148 136 57925 0.0384 5.0
2100 2.1 1588 85 73 16564 0.0959 3.1
2300 2.3 1450 84 72 16296 0.0890 3.3
3000 3.0 1112 81 69 14773 0.0752 3.5
3500 3.5 953 107 95 28590 0.0333 5.3
3800 3.8 878 85 73 16712 0.0525 4.2
4000 4.0 834 235 223 155526 0.0054 13.3
4100 4.1 813 90 78 19232 0.0423 4.7
4900 4.9 681 99 87 23764 0.0286 5.7
6700 6.7 498 217 205 132072 0.0038 15.8
8100 8.1 412 611 599 1127970 0.0004 50.8
9000 9.0 371 148 136 57783 0.0064 12.1
10800 10.8 309 700 688 1488121 0.0002 67.4
PEG 2kDa, RF = 3.34 nm
PEI [Da] PEI [kDa]
PEG-PEI 
molecules/ 
polyplex
diameter 
polyplex
[nm]
diameter 
polyplex core
[nm]
surface 
polyplex core
[nm
2
]
PEG grafting
density Γ
distance polymer 
chains dp
[nm]
1500 1.5 2223 737 730 1673095 0.0013 26.6
2100 2.1 1588 139 132 55033 0.0289 5.7
2300 2.3 1450 256 249 195028 0.0074 11.3
3000 3.0 1112 558 551 952917 0.0012 28.4
3500 3.5 953 312 306 293097 0.0033 17.0
3800 3.8 878 192 185 107336 0.0082 10.7
4000 4.0 834 282 275 237901 0.0035 16.4
4100 4.1 813 411 404 511452 0.0016 24.3
4900 4.9 681 480 473 701581 0.0010 31.2
6700 6.7 498 557 550 950382 0.0005 42.4
8100 8.1 412 696 689 1491146 0.0003 58.4
9000 9.0 371 679 672 1419187 0.0003 60.1
10800 10.8 309 704 697 1524072 0.0002 68.2
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Fig. S8. Transfection efficacy of polyplexes at various N/P ratios with PEI ( ) and the 
corresponding PEG(2)-S-PEI ( ), PEG(5)-S-PEI ( ) and PEG(10)-S-PEI ( ) copolymers in 
CHO-K1 cells. The MW of PEI is indicated in each graph. The number of EGFP positive cells 
was determined by flow cytometry. 
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Fig. S9. Transfection efficacy of polyplexes at a N/P ratio of 6 built with PEI ( ) and the 
corresponding PEG(2)-S-PEI ( ), PEG(5)-S-PEI ( ) and PEG(10)-S-PEI ( ) copolymers (A) 
measured in HeLa cells. The MW of PEI [kDa] is indicated on the x-axis. Additionally, the values 
of the transfection efficacy of the PEG-PEI-polyplexes were related to the corresponding PEI-
polyplexes and expressed as relative transfection (B). Here, the MW of PEG [kDa] is shown on 
the x-axis (“-“ indicates the homopolymer), while the MW of PEI [kDa] is given in the legend. 
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Fig. S10. Transfection efficacy of polyplexes in serum-free versus serum-containing culture 
conditions at a N/P ratio of 6 built with PEI ( ) and the corresponding PEG(2)-S-PEI ( ), 
PEG(5)-S-PEI ( ) and PEG(10)-S-PEI ( ) copolymers (A) measured in CHO-K1 cells. The 
MW of PEI was (A) 3.0 and (B) 9.0 kDa. 
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Fig. S11: The cellular uptake of fluorescently-labeled polyplexes built with PEI ( ) and the 
corresponding PEG(2)-S-PEI ( ), PEG(5)-S-PEI ( ) and PEG(10)-S-PEI ( ) copolymers into 
CHO-K1 cells was measured by flow cytometry. The mean fluorescence intensity is an indirect 
measure of the cellular uptake of the polyplexes. The MW of PEI [kDa] is indicated on the x-axis. 
0
100
200
300
400
500
600
700
1.5 2.1 2.3 3.0 3.5 3.8 4.0 4.1 4.9 6.7 8.1 9.0 10.8
PEI [kDa]
M
e
a
n
 f
lu
o
re
s
c
e
n
c
e
 i
n
te
n
s
it
y
Chapter 5                            Linear PEG-PEI copolymers to perform structure-activity-relationship 
188 
 
Erythrocyte leakage assay 
 
Fig. S12. Human erythrocytes were isolated from heparin treated blood by centrifugation (800 g 
for 10 min at 4°C). Subsequently, the erythrocytes were washed in PBS buffer several times at 
800 g for 10 min at 4°C. The erythrocytes were then diluted 1:10 in PBS. 500µl of the 
erythrocyte dilution was mixed with 500 µl polyplexes at pH 5.5 or 7.4 (Tris buffer), respectively, 
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and incubated on a shaker for 1 h at 37°C. The supernatant was measured for haemoglobin 
release at 405 nm using a TitertekPlus Microplate Reader (Bartolomey Labortechnik, Germany). 
Triton at a final concentration of 0.04% was applied as positive control, while erythrocytes 
treated with buffer only served as negative control. Polyplexes were prepared at N/P 6 using 
30 µg plasmid DNA. Experiments were performed in triplicate. PEI with a MW of 3.0, 4.1 and 
9.0 kDa was used, and the MW of PEG [kDa] is indicated in the Figure legend. 
The pH had no huge influence on hemolysis induced by polyplexes. As expected, the hemolytic 
capacity of PEI-polyplexes was slightly higher than for PEG-PEI-polyplexes at pH 5.5. 
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Fig. S13. Relative cell viability of CHO-K1 cells after transfection with polyplexes at N/P 6 with 
PEI ( ) and the corresponding PEG(2)-S-PEI ( ), PEG(5)-S-PEI ( ) and PEG(10)-S-PEI ( ) 
copolymers in CHO-K1 cells. The MW of PEI is indicated on the x-axis. The number of viable 
cells was determined by flow cytometry after staining with propidium iodide. 
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Chapter 6 
 
Linear disulfide-connected poly(ethylene 
imine)-poly(ethylene glycol) copolymers 
– 
A library screening for their redox 
response
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Abstract 
Strictly linear reductively degradable poly(ethylene imine)-poly(ethylene glycol) diblock 
copolymers connected via a disulfide bond (PEI-SS-PEG) were synthesized from PEG 2 kDa 
and 5 kDa and 13 PEIs with a molecular weight ranging from 1.5 to 10.8 kDa as well as a set of 
fluorescently labeled copolymers with PEG 3 kDa, 5 kDa and 10 kDa. These polymers were 
intended for the formation of environment responsive polymeric carriers which deliver plasmid 
DNA (pDNA) to cells. Thus, the physicochemical properties of the complexes from pDNA and 
the polymers (the so called polyplexes) in response to a reductive trigger were examined and 
the performance in cell culture was studied. While polyplexes made from PEIs with short chains 
were generally rather instable and transfected poor, copolymers from PEIs of intermediate 
molecular weight were stable under nonreductive conditions, but degraded after addition of a 
reductant. Furthermore these degradable polyplexes performed well in cell culture. In contrast, 
copolymers with long chain PEIs could not be degraded under reductive conditions and 
differences in transfection performance between homo- and copolymers were not seen. So there 
is a small window of polymer molecular weight in which reductively degradable PEI-SS-PEG 
copolymers can be formed. If the PEI molecular weight is too low the resulting polyplexes are 
generally instable, while a PEI molecular weight which is too high results in nondegradable 
bonds. 
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Introduction 
Although the last decades were characterized by a fast progress in medicine, there is still a need 
for efficient therapies for such severe diseases as genetic disorders and cancer. One very 
promising novel approach is the delivery of nucleic acids, but safe and efficient polymer-based 
carrier systems for their broad application are still needed. The probably most important polymer 
to fulfill this task is poly(ethylene imine) (PEI). It is the gold standard concerning transfection 
efficiency but unfortunately it is also rather toxic. This is due to its inherent positive charge which 
causes interactions with blood components and extracellular matrices. In order to overcome this 
problem shielding moieties such as poly(ethylene glycol) (PEG) have been attached to PEI -a 
widely used technique which is called PEGylation. This shield masked PEIs charge and lowered 
its toxicity [1, 2]. Up to now numerous different PEG-PEI copolymers are known which differ in 
their structure, grafting density and chain length. The first generation of copolymers was 
characterized by the formation of rigid, nondegradable bonds [1-7]. These copolymers efficiently 
enhanced colloidal stability [8, 9] and reduced the interference with blood components [8, 10], but the 
PEG moiety was permanently fixed to PEI. This possibly hampered intracellular events such as 
the endosomal escape of the vector (Figure 1) and, thus, the shielding sometimes led to reduced 
transfection efficiency [2, 3].  
In order to improve this situation the carriers of the second generation were equipped with a 
labile bond connecting the PEI and PEG chains [11]. Researchers were looking for a special 
trigger upon which the copolymers degraded. One very prominent example is acidic pH because 
after cellular uptake the pH within endosomes drops during processing. Thus, copolymers 
connected by different esters [12, 13] or pyridylhydrazones [14-16] were synthesized. Depending on 
their exact structure the half-life of these copolymers varies a lot [17]. But as soon as these bonds 
come in contact with water they start to hydrolyze and this bears the risks of hydrolysis during 
storage or premature release in the bloodstream. If the linking bond is too stable the half time of 
hydrolysis may be too long and the carrier stays intact even inside cells, inhibiting the release of 
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Figure 1. The most important steps in gene delivery. After transport with the bloodstream the 
polyplex must be extravasated and then be taken up by a target cell. Thereafter the PEG 
shielding must be removed and the polyplex has to escape from the endosome before it can be 
transported to the nucleus. If the carrier is not deshielded its further processing is hampered and 
the transfection efficiency is severely affected. 
the cargo at the target site. So another more specific trigger would be beneficial such as the 
difference in the redox potential between the extracellular and intracellular compartments. It is 
known that the intracellular glutathione concentration is much higher than that of the extracellular 
space (roughly 1-10 mM to 10 µM, respectively) [18]. This sudden, huge difference could be used 
to cause polymer degradation and was exploited for polymeric carriers with disulfides in the 
backbone [19-25]. The rationale behind this was that high molecular weight polymers are generally 
known to achieve higher transfection rates than low molecular weight polymers, but they are 
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more toxic at the same time. So researchers tried to build high molecular weight polymers from 
low molecular weight parts by linking them through disulfide bonds. And in fact, these carriers 
combined the high transfection efficiency of high molecular weight polymers with the reduced 
toxicity of the low molecular weight fragments in which they could be degraded after exposure to 
reductive environment [19-25]. While this approach gained much attention only little is known about 
the triggered detachment of shielding moieties which were connected with the polymeric carrier 
via disulfide bonds [26-28]. This is astounding because it is generally acknowledged that the issue 
of shielding detachment is one of the most important steps in non-viral gene delivery. Since the 
redox trigger has not been exploited thoroughly so far, we synthesized a library of strictly linear, 
redox active PEI-SS-PEG copolymers. Our intention was to investigate the mobility of the 
copolymer particles in matrices and the possibility to cleave the labile bonds within these 
particles. Our focus lay on the cleavage under physiologic conditions and the deduction of 
structure-activity-relationships as to the chain length of both the PEG and the PEI part. Thus, we 
investigated the cleavage of the polyplexes (the complexes made from pDNA and polymers) 
under reductive conditions and performed uptake and transfection studies elucidating the 
usefulness of our approach. 
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Materials 
All chemicals and materials were from Merck KGaA (Germany), Acros Organics (Belgium), 
Sigma-Aldrich Chemie GmbH (Germany), J.T. Baker (The Netherlands) or IRIS Biotech 
(Germany). Acetonitrile, dimethylformamide (DMF) and 2-ethyl-2-oxazoline were distilled over 
calciumhydride. Methyl-p-toluene sulfonate was dried in vacuo before use. All other chemicals 
were used as received.  
The pDNA encoding enhanced green fluorescent protein (EGFP) (pEGFP-N1, Clontech, 
Germany) was used as reporter gene and isolated from E. coli JM 109 strain using a Qiagen 
Plasmid Maxi Kit (Qiagen, Germany). When indicated, plasmid DNA was stained with the 
intercalating dye YOYO-1 (Invitrogen/ Molecular Probes, The Netherlands). The labeling 
reaction was carried out with a molar ratio of 1 dye molecule per 300 base pairs at room 
temperature (rt) in the dark. 
CHO-K1 cells (ATCC No. CCL-61) and HeLa cells (ATCC No. CCL-2) were grown in 75 ml 
culture flasks in a 5% CO2 atmosphere at 37°C as adherent culture to 90% confluency before 
seeding. CHO-K1 cells were cultivated in Ham´s F-12 and HeLa cells in MEM-Eagle medium 
containing pyruvate. Both culture media were supplemented with 10% fetal bovine serum 
(Biochrom AG, Germany). 
Polymer synthesis (Synthesis of PEI-SS-PEG and fluorescently labelled PEI-SS-PEG) 
The synthesis started with the cationic ring opening polymerization of 2-ethyl-2-oxazoline (1) in 
acetonitrile using varying amounts of methyl-p-toluene sulfonate (2), depending on the desired 
moleculr weight (MW) of PEI. After polymerization under a nitrogen atmosphere at 90°C for 
several days (3 to 6 days, depending on the calculated MW of PEI), the reaction was cooled 
down to rt and the MW of the resulting polymer was determined by 1H-NMR. Thereafter, 7.5 
equivalents (eq. corresponding to the MW of PEI) of sodium thioacetate in DMF were added and 
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the reaction mixture stirred for 4 hours (h). The solvent was then removed, the residue dissolved 
in chloroform and the solution washed 3 times with water. The raw product was precipitated in 
ice cooled diethyl ether, filtrated and dried in vacuo. In the next step, 3 was hydrolyzed in fuming 
HCl at 95°C for one day. After removal of the HCl, the product was dissolved in water, 
precipitated with NaOH, washed with water until the supernatant became neutral and dried in 
vacuo. The third step was the activation of this component with NaBH4 at pH 8.5 for 20 minutes 
(min), then the reaction mixture was acidified to pH 1 in order to destroy unreacted NaBH4.  The 
pH was adjusted to 4 and 3 eq. of 2,2`-dithiodipyridine (DTDP) were added to the reaction 
mixture. After stirring at overnight at rt the crude product, lPEI-SSpyr was dialysed against water 
and lyophilized. 
For the synthesis of mPEG-SS-PEI, methoxy PEG-thioacetate (mPEG-SAc) (6) had to be 
synthesized in a 2-step procedure: dry methoxy PEG-OH was tosylated using 0.5 eq. of 4-
dimethylaminopyridine (DMAP), 1.5 eq. of p-toluene sulfonate and 2.0 eq. of triethylamine. The 
reaction mixture was dissolved in dichloromethane and stirred overnight at rt, followed by the 
replacement of the dichloromethane by chloroform and washing the crude product 3 times with 
water and 2 times with 0.1 M HCl. The resulting mPEG-tosylate was dried over magnesium 
sulfate and in vacuo. In the second step, 2.5 eq. of potassium thioacetate were added to the 
mPEG-tosylate in DMF and the mixture was stirred for 8 h at rt. The mixture was concentrated, 
poured into a 10 fold volume of water and washed with chloroform 3 times. The organic phase 
was dried over magnesium sulfate and evaporated to dryness yielding mPEG-SAc . This 
component was then dissolved in a mixture of water and methanol (1:1), acidified with 5 drops 
fuming HCl and brought to reflux for 8 h. After cooling to rt and adjusting the pH to 4, the 
activated PEI component was added and stirred overnight. The product, mPEG-SS-PEI (7), was 
dialyzed against water and lyophilized. 
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For the synthesis of the fluorescein labelled copolymer PEI-SS-PEG-Fl (9), HS-PEG-NH-Boc (8) 
and lPEI-SS-pyr (5) were dissolved in water and the pH was adjusted to 4. The mixture was 
stirred overnight under nitrogen atmosphere at rt. Unreacted components were removed by 
dialysis and the resulting product was lyophilized. In the next step the Boc protection group was 
removed by stirring the copolymer in 2 M HCl at 40°C for 30 min. Subsequently the solvent was 
removed and the product dialysed against water and dried in vacuo. For the following labelling 
procedure the copolymer was dissolved in 0.05 M potassium phosphate buffer pH 8 and a 
solution of fluorescein-5-EX (Invitrogen/ Molecular Probes, The Netherlands) in DMF was added. 
This mixture was stirred for 2 h and afterwards dialysed against water. The resulting product was 
dried in vacuo. Successful conversion was monitored by 1H-NMR. All 1H-NMRs were recorded 
on an Avance 300 spectrometer (300MHz, Bruker BioSpin GmbH, Germany). The polymers 
were dissolved in 150 mM NaCl, and the pH was adjusted to 7.0. 
Formation of polyplexes 
The polyplexes of plasmid DNA and polymer were prepared at different N/P ratios (ratio of 
nitrogens in polymer to phosphates in DNA). The polymer and plasmid DNA were each diluted in 
equal volumes of 150 mM NaCl. The polymer solution was added to the DNA solution, the 
mixture was vortexed for 20 seconds and then incubated for 20 min before use. The amount of 
pDNA and the total volume of the polyplex solution are given in each section. 
Fluorescence recovery after photobleaching (FRAP) 
For the investigation of the mobility of polyplexes in extracellular matrices polyplexes of plasmid 
DNA and polymer were prepared with 2 µg pDNA at an N/P ratio of 6. The polymer and plasmid 
DNA were each diluted in 25 µl of 5% glucose. The polymer solution was added to the DNA 
solution, the mixture was vortexed for 20 seconds and then incubated for 20 min before use. 
Subsequently, the polyplex solution was mixed with 200 µl matrigel (BD Matrigel™ basement 
membrane matrix phenol red free, BD Biosciences, Europe) and transferred into Lab-Tek 
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Chambered Cover glass (Thermo Fisher Scientific, Germany). The FRAP experiments were 
performed at an Zeiss Axiovert 200 M microscope (Carl Zeiss, Jena, Germany). A Plan-Neofluar 
10x objective lens with a numerical aperture of 0.30 was used and the confocal pinhole was 
opened completely. The bleaching experiments were performed with the 488 nm-line of a 30mW 
Argon laser which operated at full power. A time-series of 800 images with a resolution of 
128x256 pixel and a laser beam with 0.15% transmission was recorded for each sample. 5 
pictures were recorded ahead of the bleaching. Then the sample was bleached (200 iterations) 
and pictures were recorded immediately after the end of the bleaching procedure without any 
delay between the single pictures. The fluorescence recovery curve and the fractions of mobile 
and immobile phase were calculated with the Zeiss FRAP tool.   
Cellular uptake 
80,000 CHO-K1 cells per well were seeded in a 24-well plate. The polyplexes were prepared at 
a N/P ratio of 6 in 100 µl using 2 µg of YOYO-1 labeled plasmid DNA. The cells were washed 
with PBS, then 900 µl of serum free culture medium and 100 µl of polyplex solution was added. 
After 4 h the transfection medium was removed and the cells were detached from the surface by 
trypsin that was supplemented with 20 mM sodium azide. Cells were analyzed by flow cytometry 
using a FACSCalibur (Becton-Dickinson, Germany). YOYO-1 was excited with a 488 nm argon 
laser and detected with a 515 - 545 nm bandpass filter. The mean fluorescence intensity (MFI) 
of 20,000 gated cells was recorded as a measure for the amount of internalized plasmid DNA. 
The values were expressed as means (± SD) from three independent samples.  
Hydrodynamic diameter and zeta potential measurements 
The hydrodynamic diameter and the zeta potential of the polyplexes was measured using a 
Zetasizer Nano-ZS from Malvern Instruments (Malvern, Germany) at 25°C. A 4 mW He-Ne laser 
at a wavelength of 633 nm was used as the light source. For the determination of the size, the 
measurement position was at 4.65 mm with automated laser attenuation. Scattered light was 
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detected at an angle of 173° backscatter. The viscosity and refractive index of the dispersants 
were used as follows: 150 mM NaCl: 0.90 mm2/s and 1.33, respectively; 5% glucose: 0,98 
mm2/s and 1.33, respectively. Three measurements with 10 sub-runs were performed for each 
sample. Data were analyzed by the general purpose mode and expressed as mean ± standard 
deviation (SD). The zeta potential of the polyplexes was measured at 25°C. Three 
measurements with 10 sub-runs were performed for each sample. Data were processed in the 
monomodal mode which guarantees for good sample stability due to short measurement 
duration and then expressed as mean (± SD). For size measurements, polyplexes were formed 
by mixing 2 µg DNA and varying amounts of polymer to achieve different N/P ratios in a final 
volume of 500 µl, while for zeta potential measurements the polyplexes were built with 4 µg 
pDNA in a final volume of 1000 µl.  
For the determination of the polyplex stability under reducing conditions polyplexes were 
prepared at an N/P ratio of 6 in HBG buffer pH 7.4 which consisted of 20 mM 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid and 5% glucose. 2 µg pDNA were mixed with the corresponding 
amount of polymer yielding a volume of 450 µl. After 20 min incubation 50 µl of a 150 mM DTT 
stock solution were added. The polyplexes were measured all 15 min over a period of 10 h. The 
measurement of the zeta potential under reducing conditions was performed with polyplexes 
built in 900 µl HBG buffer pH 7.4 at an N/P ratio of 6 from 4 µg pDNA and various amounts of 
polymer. The polyplexes were incubated for 20 min at rt and then 100 µl of a 150mM DTT 
solution was added. The samples were measured only once either directly after addition of DTT 
or after 2 h, 8 h or 24 h, respectively. Three measurements with 10 sub-runs were performed for 
each sample. 
Transfection studies 
HeLa cells were seeded in 24-well plates at a density of 40,000 cells per well 24 h prior to 
transfection. 2 µg of pDNA was used to prepare the polyplexes with the appropriate amount of 
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polymer to yield different N/P ratios in a final volume of 100 µl. The cells were washed with PBS, 
then 900 µl of serum free culture medium and 100 µl of polyplex solution was added. After 4 h 
the transfection medium was removed and cells were incubated for an additional 20 h with 
culture medium containing serum. After detachment of the cells from the surface by trypsin and 
extensive washing with PBS, the analysis of the EGFP expression of cells was performed by 
flow cytometry using a FACSCalibur (Becton-Dickinson, Germany). EGFP was excited at 488 
nm and the fluorescence was detected using a 515 - 545 nm bandpass filter. The data were 
analyzed using WinMDI 2.8 software by J. Trotter. To exclude doublets and cellular debris, cells 
were appropriately gated in forward/sideward scatter plots with 20,000 events per sample. The 
percentage of cells that was positive for EGFP indicated the transfection efficacy [%] and was 
expressed as means (± SD) from three independent samples. The relative transfection was 
calculated as follows:  
relative transfection = transfection efficacy [%]PEG-PEI-polyplexes/transfection efficacy [%]PEI-polyplexes. 
Confocal microscopy 
Confocal laser scanning microscopy was performed using a Zeiss Axiovert 200 M microscope 
coupled to a Zeiss LSM 510 scanning device (Carl Zeiss Co. Ltd., Germany). HeLa cells were 
plated in 1µ-Slide 8 well ibiTreat microscopy chambers (ibidi, Germany) at a density of 20,000 
cells per well. pDNA was labelled with TO-PRO dye as indicated by the supplier. Polyplexes 
were built from TO-PRO labelled pDNA and fluorescein labelled polymers. Cells were incubated 
with polyplexes for 2 h, washed and examined under the microscope. The fluorophores were 
then excited with 488 and 633 nm and the fluorescence was recorded with a 505–530 nm 
bandpass filter and a longpass filter of 650 nm. The measurements were performed using a 
Plan-Apochromat 63x/1.4 oil objective at 37°C and the thickness of the optical sections was 1.1 
μm. 
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Results  
Polymer synthesis 
For the library of PEI-SS-PEG copolymers, PEG and PEI were prepared separately and 
subsequently coupled yielding redox active copolymers. The synthesis of PEI implied 
polymerization and activation steps (Fig. 2). 13 different linear PEI derivatives with a molecular 
weight ranging from 1.5 to 10.8 kDa were obtained in the polymerization step. The molecular 
weight was controlled by the ratio of the monomer 3-ethyl-2-oxazoline (1) and the starter 
methyltosylate (2) and was determined by 1H-NMR. Subsequently, potassium thioacetate was 
added yielding poly(2-ethyl-2-oxazoline)-thioacetate (pEtOXZ-SAc) (3) which was thereafter 
hydrolysed to thiolated PEI (4). This component was further modified leading to PEI-pyridyl 
disulfide (PEI-SSpyr, 5), which could be coupled to methoxyPEG thioacetate (mPEG-SAc) (6) 
with a molecular weight of 2 kDa or 5 kDa under acidic conditions. The PEG derivative mPEG-
SAc was made by activation of mPEG with a tosylate in the first step and by a nucleophilic 
attack of potassium thioacetate in the second step. 
Furthermore fluorescein modified copolymers (9) were synthesized in order to perform 
fluorescence recovery after photobleaching (FRAP) experiments and to detect polyplexes inside 
cell preparations. For this purpose, 5 was reacted with Boc-NH-PEG-thiol (8) at pH 4. The Boc-
group was cleaved afterwards by addition of HCl. The freed amino group was then reacted with 
fluorescein-5-EX yielding PEI-SS-PEG-fluorescein (9). 
 The overall synthesis route allowed for a selective coupling of only one PEG to one PEI 
molecule as proposed in Figure 2. Uncoupled PEG, PEI and fluorescein were removed by 
extensive dialysis of the copolymers. The composition of the copolymers was calculated by 1H-
NMR spectra and was in good agreement with theoretical values. 
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Figure 2. Synthesis of PEI-SS-PEG copolymers and their labeled counterparts PEI-SS-PEG-
Fluorescein. 
 
FRAP experiments 
In order to determine if the polyplexes made from different fluorescently labelled polymers were 
able to diffuse through extracellular matrices, FRAP experiments were performed. This method 
allowed to determine the mobility of the polyplexes in a model matrix such as Matrigel™. 
Polyplexes made from pDNA and labelled PEI or PEI-SS-PEG copolymers were incorporated 
into Matrigel™ and their mobility after photobleaching was investigated. PEI 9.0 and its 
copolymers were chosen as an example. Figure 3 shows that the amount of mobile fraction was 
lowest for the polyplexes from the homopolymer PEI and pDNA and grew when the PEG chain 
of the copolymers became longer. While there was nearly no difference between PEI 9.0 and 
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PEI 9.0-SS-PEG 2, PEI 9.0-SS-PEG 5 exhibited better mobility and was even outperformed by 
PEI 9.0-SS-PEG 10 which showed the best mobility by far.  
 
 
Figure 3. Amounts of mobile ( ) and immobile ( ) polyplex fractions of a series of polyplexes 
made from PEI and three different copolymers (PEI 9.0-PEG 3, PEI 9.0-PEG 5, PEI 9.0-PEG 10) 
and pDNA at N/P 6 as determined by FRAP experiments. 
 
Uptake studies 
After proving the mobility of the polyplexes in a model matrix, it was interesting to see if these 
polyplexes could also achieve the next delivery step: the uptake by cells. For this purpose 
particles were formed from YOYO labeled pDNA and different PEI or PEI-SS-PEG polymers. 
Figure 4 shows the results of this experiment. The flow cytometry analysis demonstrated that all 
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polyplexes from PEGylated and unPEGylated polymers were taken up by CHO-K1 cells. Apart 
from some minor exceptions, only slight uptake differences were observed. Thus, all copolymers 
and most homopolymers were able to form polyplexes suitable for cellular uptake. 
 
Figure 4.  The cellular uptake of fluorescently-labeled polyplexes built with PEI ( ) and the 
corresponding PEI-SS-PEG 2 ( ) and PEI-SS-PEG 5 ( ) copolymers at N/P 6 into CHO-K1 
cells was measured by flow cytometry. The mean fluorescence intensity (MFI) is an indirect 
measure of the cellular uptake of the polyplexes. The molecular weight of PEI [kDa] is indicated 
on the x-axis.  
 
Changes in size and zeta potential after incubation in reductive environment 
After examining the diffusion ability and cellular uptake of our polyplexes a closer look at their 
response to external stimuli was important. It is a major prerequisite for every carrier to protect 
its payload from degradation as long as it has not reached its target site. But as soon as the 
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polyplex arrives at its destination, it has to release its cargo triggered by a specific stimulus such 
as a change in redox potential [29, 30]. Thus, the reductive environment inside cells was mimicked 
by incubating the polyplexes with dithiothreitol (DTT) which is a good substitute for the 
intracellularly occurring reductant glutathione. In a first experiment the zeta potentials of 
polyplexes after different incubation times was measured. Immediately after incubation with DTT 
the polyplexes made from the copolymers with PEG 2 kDa (Figure 5 A) as well as the polyplexes 
made from the copolymers with PEG 5 kDa (Figure 5B) exhibited a positive zeta potential 
ranging from about 25 mV to 35 mV for polyplexes with PEG 2 kDa and from about 10 mV to 
40 mV for those with PEG 5 kDa, respectively. Despite of 3 exceptions all polyplexes showed 
reduced zeta potentials after 2 h of incubation compared to the beginning of the measurements. 
After 8 h and 24 h all polyplexes exhibited lower zeta potentials (around zero) than at the 
beginning of the measurement. This was also true for those polyplexes with slightly higher zeta 
potentials after 2 h.  
Changes in the course of time were not only seen for the zeta potentials but could also be 
observed in measurements of the polyplex sizes. Again polyplexes were built at N/P 6 from 
different polymers and the polyplex sizes after incubation with and without DTT was measured 
by dynamic light scattering. In order to compare the absolute differences in the increase in size 
over time, size measurements of polyplexes incubated with or without DTT were set in relation 
and Figure 6 was built from these values. Compared to polyplexes without DTT all polyplexes 
incubated with DTT grew more in size over the observed time of 10 h than the polyplexes 
without DTT (Figure 6). The growth depended on the used polymers. In most cases the size 
increase was not higher than 5 fold. An extraordinary difference between starting and end point 
was observed for PEI 2.3-SS-PEG 2 and PEI 3.0-SS-PEG 2 with a 16 fold and 24 fold increase, 
respectively. The highest increase for copolymers made from PEG 5 kDa was found for PEI 5.0-
SS-PEG 5 and PEI 6.7-SS-PEG 5 with 9 fold and 12 fold increase, respectively. In general, the 
increase in size was more pronounced for copolymers containing PEG 2 kDa. 
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Figure 5. Zeta potentials of polyplexes assembled of pDNA and copolymers with PEG 2 kDa (A) 
and copolymers with PEG 5 kDa (B) at N/P 6 after incubation with DTT at different time points. 
Chapter 6                                                             Linear disulfide-connected PEG-PEI copolymers 
208 
 
 
Figure 6. Relative increase in polyplex size after incubation with DTT compared to the increase 
in size without addition of DTT for polyplexes made from copolymers containing PEG 2 kDa ( ) 
and PEG 5 kDa ( ) and pDNA at N/P 6. 
Beside the fact that the polyplexes responded to a reductive environment it was also very 
interesting to have a closer look at the polyplexes made from copolymers with different PEI 
chain length. A detailed analysis brought big differences between the polyplexes made from 
PEIs with different molecular weight to light (Figure 7). In the case of polyplexes made from PEI-
SS-PEG copolymers with lower PEI molecular weight (Figure 7 A 1 and A 2) it could be seen 
that both the polyplexes incubated with DTT as well as the polyplexes without DTT became 
larger over the observed period of 10 h. Starting with a size of about 200 nm, they reached 
dimensions up to 2000 nm. Over the observed 10 h also their polydispersity indices (PdIs) grew 
steadily. For the polyplexes made from high molecular weight PEIs (Figure 7 C 1 and C 2) the 
situation was completely different. Although the polyplexes incubated with DTT gained a bit 
more in size over time than the non-treated polyplexes, it must be stated that both carriers 
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remained at rather constant small size (around 100-200 nm) with nearly unchanged PdIs. The 
balance between stability in non-reductive environment and cleavability under reducing 
conditions was best for the polyplexes made from PEIs of medium molecular weight (Figure 7 B 
1and B 2). A huge difference between the DTT treated and untreated polyplexes could be seen. 
While the untreated carriers remained at constant size and PdI, the treated ones clearly gained 
in size combined with an increasing PdI. 
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Figure 7. Hydrodynamic diameter and polydispersity indices (PdI) of polyplexes assembled of 
pDNA and PEI-SS-PEG copolymers at a N/P ratio of 6 in HBG buffer pH 7.4 as determined by 
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dynamic light scattering. The polyplexes were incubated with ( ) and without DTT ( ) and 
measurements were performed over 10 h. A1, B1 and C1 show polyplexes made from 
copolymers with PEG 2 kDa while A2, B2 and C2 show polyplexes made from copolymers with 
PEG 5 kDa. A shows polyplexes from PEI 2.3, B those with PEI 3.5 and C the polyplexes made 
from copolymers with PEI 8.1. 
 
Transfection efficiency 
Although stability and ability to diffuse in matrices are very important features of a gene carrier, 
the main criterion for a well suited gene delivery vehicle is its transfection ability. Thus, the 
transfection efficacy of all polymers was determined in HeLa cells by measuring the expression 
of EGFP. The amount of expressed EGFP depended mainly on the molecular weight of PEI 
(Figure 8). Polyplexes made from low molecular weight PEI such as PEI 1.5, PEI 2.1 or PEI 3.1 
showed only very low EGFP expression (around 1%) while especially the polyplexes made from 
PEI of high molecular weight such as PEI 8.1, PEI 9.0 or PEI 10.8 exhibited a high transgene ex-
pression of about 40%. In most cases the EGFP expression mediated by polyplexes made from 
pDNA and PEI-SS-PEG copolymers exceeded the EGFP expression obtained by the 
corresponding polyplexes made from the PEI homopolymers. In order to simplify the comparison 
of the efficiency of different copolymer carriers, we calculated the relative transfection efficiency 
which relates the efficiency of the polyplexes made from PEI-SS-PEG copolymers to the 
efficiency of polyplexes made from PEI homopolymers. As seen before, all polyplexes made 
from copolymers except those from PEI 3.0-SS-PEG 5, PEI 5.0-SS-PEG 5 and PEI 9.0-SS-
PEG 5 mediated higher transfection efficiency than the polyplexes from PEI alone (Figure 8). 
The overall differences in transfection efficiency were especially pronounced for the polyplexes 
from copolymers with low molecular weight PEIs since the basis for the calculation was a 
transfection efficacy below 1% for short chain PEIs. In such a case only a minor increase in 
transfection efficiency -such as for example 1%- results in very pronounced increases in trans- 
Chapter 6                                                             Linear disulfide-connected PEG-PEI copolymers 
214 
 
 
 
Figure 8.  (A) Transfection efficacy of polyplexes at a N/P ratio of 6 built with PEI ( ) and the 
corresponding PEI-SS-PEG 2 ( ) and PEI-SS-PEG 5 ( ) copolymers in HeLa cells. The 
molecular weight of PEI [kDa] is indicated on the x-axis. Additionally, the values of the 
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transfection efficacy of the PEI-SS-PEG-polyplexes were related to the corresponding PEI-
polyplexes and expressed as relative transfection (B). Here, the molecular weight of PEG [kDa] 
is shown on the x-axis (“-“ indicates the homopolymer), while the molecular weight of PEI [kDa] 
is given in the legend.  
 
fection efficiency while 1% does not really matter in case of a transfection efficiency of about 
40% or 50%. The efficiency of the carriers from high molecular weight PEI which did not gain 
size after incubation with DTT (e.g. PEI 8.1-SS-PEG) exhibited only slight increases in 
transfection efficiency compared to the homopolymers. Polyplexes made from copolymers which 
could be cleaved reductively (i.e. copolymers with PEIs of medium molecular weight such as PEI 
3.5-SS-PEG) showed higher transfection efficiencies than the polyplexes from the corresponding 
homopolymers. So efficient transfection can be achieved by using intracellular cleavable PEI-
SS-PEG copolymers which are stable in the extracellular space due to their PEG shielding. 
Beside transfections analyzed by FACS, transfected cells were also observed in the confocal 
microscope. Both the pDNA and the polymers were stained. The polymers were labeled with 
fluorescein while the pDNA was reacted with a TO-PRO dye. So the pDNA was visible as red 
spots while the polymers gave green spots. If pDNA and polymers were colocalized yellow spots 
appeared. We chose PEI 4.0 as example because it exhibits medium molecular weight which 
makes it a well suited representative for our polymers. The polyplexes made from the 
homopolymer PEI were taken up by cells as well as the copolymers from PEI and PEG 3 kDa, 
PEG 5 kDa and PEG 10 kDa (Figure 9). The polyplexes made from PEI alone gave rather big 
spots within the cells. pDNA and PEI could be observed alone and colocalized (Figure 9 A). The 
cells treated with polyplexes from copolymers also showed green, red and yellow spots (Figure 9 
A, B and C). But these spots were smaller and better distributed over the cells. Furthermore, 
there was a tendency towards smaller spots for polymeric carriers with longer PEG chains. 
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Figure 9. Confocal images of HeLa cells treated with polyplexes made from TO-PRO labeled 
pDNA and fluorescein labeled A) PEI 4.0, B) PEI 4.0-SS-PEG 3, C) PEI 4.0-SS-PEG 5 and D) 
PEI 4.0-SS-PEG 10 at N/P 6. 
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Discussion 
Prerequisites for a good gene carrier are excellent diffusion through extracellular matrix, efficient 
uptake by cells, triggered disassembly inside cells combined with stability outside cells and 
finally high transfection efficiency [29, 30]. In order to guarantee for mobility in matrices, the carrier 
should be uncharged or bear only minor surface charge. This prevents slowing interactions or a 
sticking of the carrier to surrounding charged matrix components such as glycosamino glycans. 
Furthermore the carrier should be rather small, enabling its crawling through the network-like 
surrounding. It is known that reduced surface charge and small particles can be achieved by the 
attachment of a PEG shell [29, 30]. Thus, copolymers bearing PEG and PEI were synthesized. 
Their special feature was that they were strictly linear and that the synthesis allowed just for a 
single attachment of one PEG chain to one PEI molecule. Connected this way disturbing 
interactions of the PEG chain with the condensation of PEI and the nucleic acids are thought to 
be minimised due to the formation of a core-shell-structure. We expected these carriers to form 
smaller particles than those made from branched copolymers with multiple PEG-attachments. 
Such small carrier systems are also needed for cellular uptake because there is an upper uptake 
limit for particles. After internalization the carrier must detach its PEG shell and afterwards 
unload its cargo. This detachment should be triggered by a specific stimulus such as a change in 
the redox environment which is able to cleave disulfide bonds [29]. Having the change in redox 
potential in mind the strictly linear PEI-PEG-copolymers were connected via a disulfide bond 
which we expected to be cleaved more specifically inside cells than pH-responsive copolymers. 
In the step following the detachment of the PEG shell, the nucleic acid must traffic to the nucleus 
and achieve high transfection efficiency [29]. All these steps must be mastered in order to proof 
the usefulness of a carrier for nucleic acids. Thus, in order to mimic the single steps in gene 
delivery, the mobility of the polyplexes made from these new strictly linear and redox-cleavable 
copolymers was tested by FRAP experiments in the first step. Afterwards uptake studies were 
performed and the disulfide cleavage after addition of DTT was observed. In a last step the 
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transfection efficiency was estimated and polyplex treated cells were examined under the 
confocal microscope.  
In order to determine if the polyplexes made from different fluorescently labelled polymers were 
able to diffuse through extracellular matrices, FRAP experiments were performed. For this 
purpose Matrigel™ was chosen as model matrix which consists of different extracellular matrix 
proteins such as laminin, collagen and heparin sulphate proteoglycan extracted from Englebreth-
Holm-Swarm tumors [31]. Most tumors derived from endothelial cells produce significant amounts 
of this kind of basement matrix [31] and, thus, Matrigel™ is an ideal model for the investigation of 
diffusion processes in and around tumors. PEI 9.0 and its copolymers were chosen as an 
example because it has been shown that a PEG content of about 50% yields polyplexes with 
beneficial features [32]. PEI 9.0-SS-PEG 10 exactly corresponds to the ideal of 50% PEG content 
while the PEG content of the other copolymers was lower (23% and 33%). The finding that the 
mobility in this matrix became better, the longer the PEG chain was, can be explained with the 
structure of the polyplexes. If only PEI was applied for polyplex formation, the resulting particles 
had an overall positive surface charge which allowed for interactions with the charged 
components of Matrigel™. If the polyplexes were made from PEI-SS-PEG copolymers PEG 
shielded the charges of the polyplex core at least partially and, thus, less interactions with the 
surrounding matrix were possible. This effect was more pronounced for PEG chains of higher 
molecular weight which are thought to be better suited for shielding due to their longer size and 
their higher flexibility. Furthermore, polyplexes with better PEG shielding are generally 
smaller [32, 33] and are expected to diffuse easier than big carrier systems. Similar results were 
found by Lélu et al. who performed FRAP experiments with PEGylated chitosan particles in 
different collagen gels. They found that their chitosan polyplexes needed a PEG shell in order to 
diffuse through the gels [34]. Nevertheless, further experiments with other fluorescently labeled 
copolymers will be performed to back up our findings. 
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But good diffusion is not enough. In the course of the delivery cascade the polyplexes have also 
to be taken up by cells. The uptake studies revealed that there was nearly no difference in the 
uptake between the polyplexes made from PEI homopolymers and the corresponding 
copolymers. Only a slight improvement in uptake of most PEI homopolymers could be seen 
which is probably due to their high unshielded surface charge making interactions between the 
negatively charged cell surface and the polyplexes more probable. But although PEGylated 
copolymers generally exhibit a lower zeta potential than unshielded polymers [32] and interactions 
between cell surfaces and polyplexes are therefore weaker, these complexes were taken up as 
well. The absence of significant differences could have several reasons. One of them could be 
that the cleavage of the disulfide bonds partially starts when the carrier reaches the cell 
surface [35, 36]. A second reason may be the fact that the PEG shielded polyplexes are generally 
smaller than their counterparts built from PEI homopolymers. Since there is an upper uptake 
size limit of about 200 nm for clathrin-dependent endocytosis [37] -the most likely way of 
internalization- it is reasonable to assume that not all polyplexes from PEI homopolymers can be 
taken up due to their size. Thus, the reduced interactions with the cell surface due to a PEG 
shielding may be balanced out by the inability of cellular uptake due to PEI-polyplex sizes over 
200 nm, leading to nearly no differences in the uptake levels between homo- and copolymers.  
After cellular uptake the PEG shielding has to be removed in order to restore the endosomolytic 
activity of PEI and to destabilize the carrier system resulting in a release of the nucleic acid. This 
should be accomplished as a result to a specific stimulus such as a change in redox potential. 
There is a big difference in the redox potential inside and outside cells. While the glutathione 
concentration in the extracellular space is about 10 µM, it increases to 1-10 mM inside cells [18]. 
Our intention was to exploit this huge difference with disulfide linked carrier systems. Thus, we 
mimicked the reductive environment inside cells by incubating the polyplexes with DTT. The 
most interesting aspects concerning this treatment were the changes in zeta potential and size. 
The zeta potential decreased after incubation with DTT over time. This was a bit astounding 
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since the positively charged polyplex core should be exposed after PEG deshielding and, thus, 
we expected increasing zeta potentials. But since the zeta potential was measured over 24 h 
there was plenty time for rearrangements of the polyplexes after the cleavage of the PEG shield. 
The longer the incubation time, the more disulfide bonds were cleaved, removing the PEG shield 
step by step. As soon as the shielding moieties were removed, charge interactions were likely 
which could lead to severe aggregation and restructuring of the polyplexes. This could possibly 
result in reduced zeta potentials over time as observed. The removal of the PEG shield could 
also be traced by the measurement of the polyplex sizes after incubation with DTT. Most of the 
tested polyplexes grew a lot, especially those from medium chain PEIs. This strongly indicates 
that the disulfide bond between the PEI and the PEG moiety was cleaved by DTT. It can be 
assumed that as soon as the hydrophilic outer PEG layer was shed off, the charged cores of the 
polyplexes were exposed and ionic interactions led to the formation of aggregates. Thus, the 
increase in polyplex size indicated that the carrier lost its PEG shield and was probably able to 
restore its endosomolytic activity inside cells which is a prerequisite for efficient transfection. 
Such a detachment of PEG shields was also observed for a carrier system based on copolymers 
from PEG and poly-L-lysine. The components of this carrier system were connected by a 
disulfide bond and responded to a treatment with glutathione with a comparable increase in 
size [38]. Polyplexes made from low molecular weight PEI were generally instable over longer 
times, probably due to insufficient electrostatic interactions between the short PEI chains and the 
nucleic acids as seen from growing sizes and PdIs. In consequence the use of polyplexes made 
from PEIs with low molecular weight as long circulating gene carriers will be rather limited. In 
contrast, the polyplexes made from PEI of high molecular weight seemed to resist the complete 
cleavage of the disulfides. It is known that the electrostatic interaction between the positively 
charged PEIs and the negatively charged nucleic acids become stronger the longer the PEI part 
is [39-41]. Due to these increased interactions the formed polyplexes are generally stronger and in 
most cases also smaller which makes it harder for molecules in solution to get into the 
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polyplexes and cleave the bonds connecting PEI and PEG. We could observe this for our 
polyplexes made from PEI with higher molecular weight. Thus, there were upper and lower limits 
for the molecular weight of PEI in order to create extracellularly stable, but reductively cleavable 
carriers.  
The last step in the delivery cascade is the transcription of the nucleic acid and the expression of 
a protein such as EGFP. In transfection experiments all polyplexes which were made from small 
PEIs performed rather poor. As in the case of the size measurements this can probably be 
ascribed to the instability of these polyplexes due to the short PEI chain. The attachment of a 
PEG chain enhanced their stability a bit and increased their transfection efficiency, but the 
overall gene expression was very low. In contrast, the polyplexes made from high molecular 
weight PEIs exhibited good transfection efficiency -no matter if they were PEGylated or not. The 
PEG chain seemed to have nearly no influence on the transfection efficiency. As the PEG chain 
cannot be cleaved in these cases it is not astounding that the differences between homo- and 
copolymers were not pronounced. The most interesting transfection results came from the 
polyplexes made from PEIs of intermediate chain length. They exhibited relevant differences in 
the transfection efficiency between the homo- and copolymers. All copolymers performed better 
than their corresponding homopolymers. An explanation for this behavior is that the extracellular 
stable polyplexes were small enough to be taken up by cells. Inside cells they were deshielded, 
restored the endosomolytic activity of PEI and released their payload efficiently resulting in 
enhanced transfection efficiency. So efficient transfection can be achieved by the use of 
intracellular cleavable PEI-SS-PEG copolymers which are stable in the extracellular space due 
to their PEG shielding, but can be deshielded in reducing environment. 
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Conclusion 
A library of reductively degradable PEI-SS-PEG copolymers was successfully synthesized. In a 
second approach such linear copolymers were labeled with fluorescein and these copolymers 
were used for FRAP experiments. In these experiments it could be shown that the built 
polyplexes needed a PEG shell for beneficial diffusion in a model tumor matrix. Beside the 
diffusion behavior the cellular uptake of these polyplexes was investigated and it was found that 
all of them were picked up by HeLa cells. Furthermore the cleavability of the disulfide linked 
carriers was of great interest. Therefor these carriers were treated with DTT and their size and 
zeta potential was monitored. Especially from the size measurements it could be concluded that 
there were three types of polyplexes. The polyplexes made from low molecular weight PEIs 
were instable over time, while the polyplexes from high molecular weight were too stable to be 
completely degraded reductively. Only if the polyplexes were built from PEIs of intermediate 
molecular weight they could shed off their PEG shield triggered by the presence of the model 
reductant DTT. In transfection studies and with confocal microscopy it could be shown that 
polyplexes made from these cleavable polymers were able to disassemble intracellular and to 
transfect cells depending on their molecular weight. Thus, these copolymers guide the way 
towards safe, well-defined stimulus-responsive gene carriers which exhibit the possibility to 
further improve them by the attachment of targeting ligands  or nuclear localization sequences 
instead of fluorescent labels. 
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Summary 
In the last years the delivery of nucleic acids has emerged as a promising strategy for the 
modulation of gene expression. It has been shown to be a useful tool for both, the insertion of 
therapeutic genes via DNA and the inhibition of harmful or non-functional proteins by the 
application of therapeutic RNA [1, 2]. These approaches proofed to be helpful for the therapy of 
severe acquired or inherited diseases as well as in the field of tissue engineering. While the first 
approaches mainly used viral vectors, more and more attention has been paid to non-viral 
delivery systems. Viral vectors especially bear the risks of infections and insertional 
oncogenesis, nevertheless they are very efficient vehicles which use sophisticated ways for the 
expression of their payload. But due to the high risks associated with viral vectors, non-viral 
carriers gained growing attention. Although up to now their transfection efficiency cannot 
compete with viral vectors, they exhibit lots of other advantages such as safety, ease of 
modification and production in large scale as well as chemical stability. The second big 
disadvantage beside their lower transfection efficiency is their cytotoxicity which correlates with 
the molecular weight of the carrier. This is especially true for the most used polymer 
poly(ethylene imine) (PEI) [3]. But it has been shown that also PEIs of low molecular weight can 
mediate efficient transfection while they exhibit no or nearly no toxicity [4]. Based on these 
findings, the scope of this thesis was to further modify these low molecular weight PEIs with a 
shielding moiety forming small, stable and over all non-toxic particles which do not interact with 
extracellular matrix components. The intention was to form strictly linear copolymers from PEI 
and poly(ethylene glycol) (PEG) which were either connected by a stable thioether bond or a 
cleavable disulfide bond. The rationale behind the disulfide bonds was to exploit the large 
extra/intracellular redox gradient every carrier has to face upon cell entry. As response to this 
trigger the disulfide bridge between the PEI and the PEG chain should be cleaved and, thus, the 
transfection efficiency of PEI which is reduced upon the addition of a shielding moiety [5] was 
expected to be restored. The importance of disulfides in carrier systems for the delivery of 
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nucleic acids was reviewed in Chapter 1. Here the biological rationale for the use of redox-
active substances was explained and basic synthetic approaches for introducing disulfide bonds 
into molecules were described. Additionally, examples that provided the significance of disulfide 
bonds for the different aspects of delivery and tissue engineering were given.  
The first practical objective of this thesis was the synthesis and analysis of thiol-modified, 
storage stable linear PEIs (lPEI) of low molecular weight (Chapter 3). Therefore, 13 lPEIs with a 
molecular weight ranging from 1.5 kDa to 10.8 kDa were synthesized. The standard synthesis 
route was modified in such a way that the resulting products of the first synthesis step had a thiol 
precursor-group at the chain end instead of the common hydroxyl group. In order to obtain high 
conversion rates different reaction conditions were tested and an excess of 7.5 equivalents 
modification reagent, room temperature and 4 h reaction times proofed to be best. The thiol 
precursor was cleaved in the second synthesis step yielding the desired thiol group. But since 
the resulting thiol group is known to be instable, a stable storage group had to be found.  In 
order to obtain this group an optimized 2-step synthesis was introduced which comprised a 
reduction step with NaBH4 followed by the addition of the activating disulfide reagent 2,2`-dithio 
dipyridine. Thus, polymers for the attachment of a second polymer were obtained. Moreover, it 
could also be shown by an ethidium bromide exclusion assay and the measurement of the 
polyplex sizes that all polymers were able to form particles with pDNA -an indispensable 
prerequisite for any efficient carrier.  
The next step after the synthesis of thiol-modified lPEIs was the generation of copolymer 
libraries made from these polymers (Chapter 4). PEGs of different molecular weights (2, 5 and 
10 kDa) were attached to these lPEIs -either via a stable thioether bond using methoxyPEG-
maleimides or via a degradable disulfide bond made from a self-synthesized methoxyPEG-
thioacetate. In contrast to other approaches, these copolymers demonstrated a clear separation 
between the hydrophilic PEG and the nucleic acid condensing PEI moieties due to the end-to-
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end connection of the two polymers. This was thought to avoid sterical interference of the PEG 
chain with the interaction between the nucleic acid and PEI and in consequence the copolymers 
were expected to be perfectly suited to build small and stable polyplexes. The thioether-
connected copolymers were used for a first test of the complexation abilities for pDNA and 
siRNA. The polyplexes made from pDNA revealed a distinct size division. While homopolymers 
and polymers with a short 2 kDa PEG chain built rather large polyplexes (up to 900 nm), the 
particles from copolymers with longer PEG chains (5 kDa and 10 kDa) gave much smaller sizes 
(commonly below 150 nm) and their size distribution was more uniform. In contrast, the 
polyplexes assembled from siRNA were all comparably small (about 100-350 nm). Furthermore, 
a quenching assay proved better complexation ability for siRNA as well as pDNA for nearly all 
copolymers compared to the homopolymers. These features make the PEG-PEI copolymers 
very promising carriers for such structurally diverse nucleic acids as siRNA and pDNA.  
The library of thioether connected copolymers was further examined in detail in order to deduce 
structure-property-relationships (Chapter 5). A general guideline was that the PEG domain had 
a greater influence on the physicochemical properties of the polyplexes than PEI. A PEG content 
higher than 50% led to small (< 150 nm), nearly neutral polyplexes with favorable stability. Due 
to the PEG shielding the transfection efficiency of these polyplexes was significantly reduced 
compared to the PEI homopolymer. For the molecular weight of the PEI moiety, two findings 
catched the eyes: first, a molecular weight lower than 3 kDa was less suited to form compact 
and stable polyplexes. Second, it appeared that the transfection ability of the polyplexes 
increased with the chain length of PEI, but in the same order the toxicity also increased. Those 
toxic effects were at least partially reduced by the incorporation of a high molecular weight PEG 
domain into the copolymer. Thus, principles for the design of optimized gene carriers were 
found. Furthermore, it could be proven with selected copolymers that the transfection efficiency 
which was reduced due to the stable addition of PEG could be restored by the application of the 
corresponding degradable copolymer due to the redox trigger of the cells. 
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In a follow-up study the redox-active copolymers were further examined (Chapter 6). Therefore, 
also fluorescently labelled PEI-PEG copolymers were synthesized where fluorescein was 
selectively attached to the end of the PEG chain. The resulting polymers where used for 
fluorescence recovery after photobleaching (FRAP) experiments. The hypothesis was that the 
mobility of polyplexes in model matrices was the higher, the better the PEG shielding was due to 
reduced interactions with the surrounding matrix. With model copolymers it could be proven that 
polyplexes with longer PEG chain exhibited higher mobility in the model matrix than those 
without shielding and that the mobility corresponded to the molecular weight of the shielding 
moiety. The second aim was to test whether there were differences in the cleavability of the 
disulfide bonds and their transfection ability which depended on the molecular weight of PEI or 
PEG. It was found that there were three types of polyplexes. While polyplexes made from PEIs 
with short chains were generally rather instable and transfected poor, copolymers from PEIs of 
intermediate molecular weight were stable under nonreductive conditions, but degraded upon a 
redox trigger. Furthermore, their transfection performance was good. In contrast, copolymers 
with long chain PEIs could not be degraded under reductive conditions and differences in 
transfection efficiency between homo- and copolymers were not found. So it could be deduced 
that there is a small window of polymer molecular weight in which reductively degradable PEI-
SS-PEG copolymers can be formed. If the PEI molecular weight is too low the resulting 
polyplexes are generally instable, while a PEI molecular weight which is too high results in 
nondegradable bonds. 
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Conclusion and outlook 
In conclusion, this thesis successfully demonstrated the synthesis of strictly linear copolymer 
libraries and the usefulness of these libraries for the systematic investigation of structure-
property-relationships. Due to the developed synthesis route it was possible to create strictly 
linear copolymers with an end-to-end connection of the PEG and PEI chains. This assembly 
seemed to prevent the interference of the shielding PEG moiety with the interaction between the 
PEI moiety and the nucleic acid. By the comprehensive evaluation of the influences of the 
molecular weights of both the PEI and the PEG moieties on polyplex properties, it was possible 
to deduce general guidelines for optimized carrier systems. Furthermore, it could be shown with 
the library of disulfide connected copolymers that not only the physicochemical properties of the 
polyplexes were determined by the molecular weights of the copolymer components but also the 
response to a redox trigger. Thus, a careful fine tuning of the polymeric carrier systems is 
indispensable for their efficiency. The presented redox-active copolymeric carriers are an 
excellent basis for the further development of non-viral carrier systems which are devoid of the 
risks of viral vectors, but are as efficient as their viral counterparts. In order to achieve efficient in 
vivo results further aspects of delivery have to be addressed by future non-viral vectors. They 
will need to be equipped with further targeting and endosomolytic sequences in order to 
specifically and efficiently transfect their target cells. Therefore, it will be necessary to keep to 
the approach of a selective attachment of these moieties onto the carrier in order to get detailed 
information of the obtained effect and to guarantee for uniform, reproducible carrier systems. 
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List of abbreviations 
 
AA alkyl acrylates 
ADPD N-[4-(p-azidosalicylamido)butyl]-3`-(2`-
pyridyldithio)propionamide 
AEDP bis(2-aminoethyl)-1,3-propandiamine 
AMBH 2-acetamido-4-mercaptobutyric acid 
hydrazide 
AMPT ethyl S-acetyl propioniidate 
APC antigen presenting cell 
asODN antisense oligodesoxynucleotide 
ASPG asialoglycoprotein 
BASED bis-[β-(4-acidosalicylamido)ethyl]disulfide 
Bcl2 B-cell lymphoma 2 
BFA brefeldin A 
BMA alkyl methacrylate 
BMM bone marrow-derived macrophage 
bPEI branched poly(ethylene imine) 
C10-C
G+ guanidinocysteine N-decylamide 
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CBA cystamine bisacrylamide 
CDPT 3-(4-carboxyamidophenyldithio)-
propionthioimidate 
CHDTAEA cholesteryl hemidithioglycolyl 
tris(aminoethyl)amine 
CHEMS cholesteryl hemisuccinate 
CLSM confocal laser scanning microscopy 
DAE N-Boc-1,2-diaminoethane 
DAH N-Boc-diaminohexane 
DBA N-Boc-1,4-diaminobutane 
DETA diethylenetriamine 
DMAEMA dimethylaminoethyl methacrylate 
DMAP dimethylaminopyridine 
DMF dimethylformamide 
DMSO dimethylsulfoxide 
DOGSDSO 1,2-dioleoyl-sn-glycero-3-succinyl-2-
hydroxyethyl disulfide ornithine 
DOPE L-dioleoyl phosphatidyl ethanolamine 
DOTAP N-(1-(2,3-dioleoyloxy)propyl)-N,N,N-
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trimethylammonium chloride 
DPDPB 1,4-di[3`-(2`-pyridyldithio) 
propionamido]butane 
DPPC dipalmitoylphosphatidylcholin 
DSP dithiobis(succinimidylpropionate) 
DTBP dimethyl  3,3-dithiopropionimidate 
DTDP 2,2`-dithio dipyridine 
DTNB 5,5`-dithio-bis(2-nitrobenzoic acid) 
DTSSP dithiobis(sulfosuccinimidyl propionate) 
DTT dithiothreitol 
ECV endosome carrier vehicle 
EDA ethylenediamine 
EDTA ethylene diamine tetra acetate 
EGFP enhanced green fluorescent protein 
EGFP enhanced green fluorescent protein 
eq. equivalent 
ER endoplasmatic reticulum 
EtBr ethidium bromide 
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FITC fluorescein isothiocyanate 
FR folate receptor 
FRAP fluorescence recovery after photobleaching 
FRET fluorescence resonance energy transfer 
GFP green fluorescent protein 
GILT gamma-interferon-inducible lysosomal thiol 
reductase 
GR glutathione reductase 
Grx glutaredoxin 
GSH glutathione 
GSSG glutathione disulfide 
h hour 
HER2 human epidermal growth factor receptor 2 
HPMA (N-(2-hydroxypropyl)methacrylamide) 
LbL layer-by-layer 
LC-SPDP long-chain N-succinimidyl 3-(2-
pyridyldithio)propionate 
LE late endosome 
Lipolex lipid incorporating nucleic acids 
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LLO listeriolysin O 
LLO-SS-PN listeriolysin O coupled to protamine via 
disulfide 
lPEI linear poly(ethylene imine) 
l-PEIS linear poly(ethylene imine disulfide) 
M6P mannose-6-phosphate 
M6P-BSA mannose-6-phosphate bovine serum 
albumine 
MAAc metharylic acid 
MALS muliple angle light scattering 
MFI mean fluorescence intensity 
MHC major histocompatibility complex 
min minute 
mPEG-OH methoxy poly(ethylene glycol)-OH 
mPEG-SAc methoxy poly(ethylene glycol)thioacetate 
mPEG-S-S-DSPE N-[2-ω-methoxypoly(ethylene glycol)-α-
aminocarbonylethyl-dithiopropionate] 
covalently coupled to 
disteaorylphosphatidylethanolamine 
MPP membrane permeant peptide 
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mRNA messenger ribonucleic acid 
MTX methotrexat 
MW molecular weight 
N/P ratio of nitrogen to phosphorous 
NADPH nicotinamide adenine dinucleotide 
phosphate 
NLS nuclear localization sequence 
OD optical density 
ODN oligodesoxynuleotide 
P[Asp(DET)] poly(aspartatamide) 
p75NTR p75 neurotrophin receptor 
pAA poly(α,β-aspartic acid) 
PCBS-b-PEG poly(L-cysteine bisamide-g -sulfadiazine)-b-
poly(ethylene glycol) 
PDI protein disulfide isomerise 
PdI polydispersity index 
pDNA plasmid desoxyribonucleic acid 
PDPH 3-(2-pyridyldithio)propionyl hydrazide 
PDSA pyridyldisulfide acrylate 
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PEG poly(ethylene glycol) 
PEG-PEI poly(ethylene glycol)-poly(ethylene imine) 
PEG-pLL poly(ethylene glycol)-poly(L-lysine) 
PEG-SS-P[Asp(DET] poly(ethylene glycol) coupled to 
poly(aspartatamide) via disulfide bonds 
PEG-thiopLL thiolated Poly(ethylene glycol)-block-poly(L-
lysine) 
PEI poly(ethylene imine) 
PEI-SS-PEG poly(ethylene imine)-poly(ethylene glycol) 
diblock copolymers connected via a disulfide 
bond 
pEtOXZ poly-2-ethyl-2-oxazoline 
pEtOXZ-SAc poly(2-ethyl-2-oxazoline)-thioacetate 
PHEA α,β-poly(N-2-hydroxyethyl)-D,L-
aspartatamide 
PHPMA poly[N-(2-hydroxypropyl)methacrylamide] 
PIC micelle polyion micelle 
pLL poly(L-lysine) 
PLLA-b-PEG poly(L-lactic acid)-B-poly(ethylene glycol) 
PN protamine 
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poly(EDA/CBA) poly(ethylene diamine/cystamine 
bisacrylaminde) 
poly(TETA/CBA) poly(triethylenetetramine/cystamine 
bisacrylamide) 
polyplex nucleic acid complexed with a polymer 
PVP poly(vinylpyrrolidon) 
RNA ribonucleic acid 
roGFP1 reduction-oxidation-sensitive green 
fluorescent protein 
rpLL reducible poly(L-lysine) 
RR rhodamine red 
SADP N-succinimidyl(4-azidophenyl)-1,3`-
dithiopropionate 
SAED sulfosuccinimidyl-2(7-azido-4-methyl 
coumarin-3-acetamide)ethyl-1,3`-
dithiopropionate 
SAMSA S-acetylmercaptosuccinic anhydride 
SAND sulfosuccinimidyl-2-(m-azido-o-
nitrobenzamido)-ethyl-1,3´-dithiopropionate 
SASD sulfosuccinimidyl-2-(p-
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acidosalicylamido)ethyl-1,3`-dithiopropionate 
SATA N-succinimidyl S-acetylthioacetate 
SATP N-succinimidyl acetylthiopropionate 
SBT S-4-succinimidyloxycarbonyl benzyl 
thiosulfate 
SD standard deviation 
siRNA small interfering ribonucleic acid 
SMBT S-4-succinimidyloxycarbonyl-α-methyl-
benzyl thiosulfate 
SMPT 4-succinimidyloxycarbonyl-α-methyl-α(2-
pyridyldithio)toluene 
sNHS-ATMBA Sulfosuccinimidyl N-[3-(acetylthio)-3-
methylbutyryl-β-alaninate 
SPDP N-succinimidyl 3-(2-pyridyldithio)propionate 
SPP N-succinimidyl 4-(2-pyridyldithio)pentanoate 
SS-PAED reducible disulfide poly(amido 
ethylenediamine) 
SS-PAEI reducible poly(amido ethylene imine) 
ssPEI disulfide cross-linked poly(ethylene imine) 
Sulfo-LC-SMPT Sulfosuccinimidyl-6-[α-methyl-α-(2-
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pyridyldithio)toluamido]hexanoate 
Sulfo-LC-SPDP watersoluble longchain N-succinimidyl 3-(2-
pyridyldithio)propionate 
Sulfo-SADP N-sulfo-succinimidyl(4-azidophenyl)-1,3`-
dithiopropionate 
TAT HIV-1 transcriptional activator 
TCEP tris(2-carboxyethyl)phosphine 
TE tissue engineering 
TEM transmission electron microscopy 
TETA triethylenetetramine 
TfR transferrin receptor 
TGN trans-Golgi network 
trastuzumab-SPP-RR trastuzumab coupled to rhodamine red via 
N-succinimidyl 4-(2-pyridyldithio)pentanoate 
TRIS tris(hydroxymethyl)aminomethane 
Trx thioredoxin 
VEGF vascular endothelial growth factor 
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